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SUMMARY
The herpes simplex virus type 1 (HSV-I) genome
contains two distinct origins of viral DNA replication of
related sequence. One (ori^) lies close to the centre of
the long unique region whilst two copies of the other (ori )s
are present within the inverted repeat regions flanking the 
short unique region. Previous experiments identified DNA 
fragments of 100 bp or less which specify a functional ori s
and include a 45 bp near perfect palindrome with a central 
AT-rich region. Moreover, DNase I footprint assays 
demonstrated the presence of a specific binding site for an 
HSV-1 encoded polypeptide which overlapped the end of the 
palindromic sequence. By analogy with other well- 
characterised origin binding proteins, the HSV-1 encoded 
origin binding protein was thought likely to play an 
important role in initiation of HSV DNA synthesis.
The work presented in this thesis describes the
identification of the HSV-1 gene encoding this origin
binding activity and investigates the role of its
interaction with ori„.
a
A sensitive gel retardation assay was set up to 
allow the identification of the virus induced origin binding 
activity. Incubation of nuclear extract from cells infected 
with wt HSV-1 with a radio-labelled orig fragment resulted 
in the formation of a major specific retarded complex. 
Experiments with synthetic oligonucleotides demonstrated the 
presence of two specific binding sites within the origin 
region, one of which (site I) corresponded to the previously 
described site whilst the other (site II) was located on the 
opposite side of the palindromic sequence.
While these experiments were in progress, Challberg 
and colleagues identified a set of seven HSV-1 genes which 
were necessary and sufficient for HSV DNA synthesis. These 
genes encoded the viral DNA polymerase (UL30), a 
single-strand-specific DNA binding protein (UL29), a 
double-stranded DNA binding protein (UL42) and four less 
well understood functions (UL5, UL8, UL9 and UL52). It was 
considered very likely that one of these latter four genes 
would encode the protein which binds specifically to ori^.
Several approaches were used in attempts to 
identify the gene encoding origin binding activity. These 
included analysis of origin binding activity induced by ts 
mutants with defects in DNA synthesis at the non-permissive 
temperature and transfection of tissue culture cells with 
fragments encoding individual replication genes. Neither of 
these approaches however was successful.
HSV-1 tsK recombinants which express individual 
replication genes UL5, UL8 , UL9 or UL52 at the non- 
permissive temperature were available in the laboratory.
When these were tested, only the tsK/UL9 recombinant virus 
expressed origin binding activity at the non-permissive 
temperature. The protein-DNA complex obtained with extracts 
from cells infected with the tSK/UL9 recombinant virus 
exhibited a smeared binding pattern of lower mobility than 
previously seen with extracts from cells infected with wt 
HSV-1. Treatment of the tsK/UL9 extract with protease 
produced a smaller complex of similar mobility to that seen 
with wt HSV-1 extracts. In addition, antibody reactive with 
the UL9 protein further retarded the major complex observed 
with wt HSV-1 extracts, demonstrating that this complex 
contained a portion of the UL9 polypeptide.
Taken together, the above results suggested that a 
specific domain of the UL9 protein was probably responsible 
for sequence-specific binding. Fragments of the UL9 gene 
were therefore expressed as fusion proteins in Escherichia 
coli and the C-terminal 317 amino acids were found to bind 
specifically to HSV ori , indicating that sequence-specific
O
recognition and binding activities resided within the 
C-terminal 1/3 of the protein. This result was 
independently confirmed by expressing the C-terminal 1/3 of 
the UL9 gene in an in vitro transcription and translation 
system.
Of the two UL9 binding sites within ori , one (site
I) contains an 11 bp sequence which is also present in HSV-2
ori , HSV oriT and varicella-zoster virus oriq, and the 
S b
other (site II) includes a related sequence element which 
differs in two positions from the corresponding region of 
site I. A third 11 bp sequence (motif III) which lies 
adjacent to site I and differs from the site I element at
only a single position was also recognised. Each of the 
three 11 bp sequences was deleted from within functional 
copies of HSV-1 orig and the effect on origin activity and 
binding of the UL9 protein examined. Gel retardation assays 
confirmed the importance of the 11 bp elements deleted from 
site I and II for UL9 binding. In transient replication 
assays, copies of orig lacking site I or site II elements 
exhibited undetectable or residual activity respectively. 
Hence, the 11 bp element in site I is essential for ori
O
activity whilst the element in site II is required for fully 
efficient origin function.
The UL9 protein did not bind to motif III, even in 
the absence of site I sequences, although deleting motif III 
from orig caused a small reduction in activity. A single 
base change which converted the sequence of the 11 bp 
element within site I to that of motif III was sufficient to 
abolish both the interaction of the UL9 gene product at this 
locus and the replicative ability of orig . These results 
establish that the interaction of the UL9 protein with 
binding site I is essential for origin activity.
The implications of these results regarding the 
possible role of the UL9 protein and its recognition sites 
in the initiation of HSV DNA synthesis are discussed.
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ABBREVIATIONS
Abbreviations for media and solutions are given in Chapt 
2A: Materials, and those for the HSV genome given in the 
legend to Figs. 1.1 and 1.5.
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PAGE polyacrylamide gel electrophoresis
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SDS sodium dodecyl sulphate
sec second(s)
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SV40 simian virus 40
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AMINO ACID SYMBOLS
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S serine 
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W tryptophan
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CHAPTER 1: INTRODUCTION
The research presented in this thesis concerns the 
interaction of a herpes simplex virus (HSV) type 1 gene 
product with a viral origin of DNA replication, and includes 
the identification of this protein and an investigation of 
its possible role in initiation of HSV DNA synthesis. The 
aim of this introduction therefore is to provide a 
background to the HSV lytic cycle and review our current 
knowledge of HSV DNA replication. Other aspects of the 
biology of herpesviruses, not directly related to this area, 
have, of necessity, been omitted or are dealt with only 
briefly.
SECTION 1A: The Herpesviruses
1. Description and classification
The family Herpesviridae contains a diverse array 
of large DNA containing viruses capable of infecting a wide 
variety of higher eukaryotes from reptiles to birds, fish to 
man (Roizman et a l ., 1981). Viruses are assigned to the 
family on the basis of distinct morphological features and 
all contain a double-stranded linear DNA genome in an 
enveloped virion particle, 150-200 nm in diameter. More 
specifically, the virus particle is composed of four 
distinct elements,namely the core, capsid, tegument and 
envelope (Roizman and Batterson, 1985).
The core of the virion contains the viral DNA 
(Epstein, 1962). The calculated dry mass of capsids 
(diameter <31 nm) indicates that some protein is present 
within the core in addition to the genomic DNA (Schrag et 
al., 1989). The HSV nucleocapsid also contains spermine 
which probably neutralises the charge of the DNA, 
facilitating dense packing of the genome (Roizman and 
Furlong, 1974) .
Surrounding the virion core is an icosahedral 
capsid characteristically 100-110 nm in diameter and
composed of 162 capsomeres, 12 pentameric and 150 hexameric, 
arranged in 5:3:2 axial symmetry. Hexameric capsomeres are 
typically 12.5nm in diameter, 14nm in length and contain a 
4nm wide axial hollow (Wildy et al ., 1960).
Roizman and Furlong (197 4) introduced the term 
'tegument' to describe the layer of amorphous material 
between the capsid and the lipid envelope (Morgan et al ., 
1959) . The tegument has no distinctive features in thin 
sections but does appear fibrous on negative staining 
(Morgan et a l ., 1959, Schwartz and Roizman, 1969). Fong et 
al. (1973) demonstrated differences in the thickness of the 
tegument depending on the location of the virion in the 
infected cell; nuclear enveloped particles on average being 
smaller then those found in cytoplasmic vacuoles. Other 
evidence suggests that the size of the tegument layer is 
determined by the virus strain (McCombs et al ., 1971).
The outermost structure of the virion is the 
envelope which has a trilaminar appearance with surface 
spikes approximately 8nm long projecting from its outer 
surface (Wildy and Watson, 1963). The envelope itself is 
derived from nuclear and plasma membranes (Asher et a l ., 
1969, Nii et a l ., 1968).
Apart from common morphological characteristics, a 
significant aspect of the biology of the Herpesviridae is 
their ability to establish and maintain a latent infection 
in their host. For the purposes of classification, the 
family has historically been divided into three 
sub-families, Alpha, Beta and Gammaherpesvirinae, based on 
biological properties such as host range, duration of 
reproductive cycle, cytopathology and characteristics of 
latent infection (Roizman et a l ., 1981).
Alphaherpesviruses
Members of this subfamily have a wide experimental 
host range in vivo and in vitro. The reproductive cycle is 
short and infection of cell cultures results in the 
destruction of the susceptible cell. Latent infections are 
primarily established in the ganglia. Examples are herpes 
simplex virus types 1 and 2 (HSV-1, HSV-2; human 
herpesviruses 1 and 2) and varicella-zoster virus (VZV; 
human herpesvirus 3).
Betaherpesviruses
Characteristic of this subfamily is the narrow in 
vivo host range with infection often restricted to the 
species or genus of the host. The reproductive cycle is 
relatively long with infected cells frequently becoming 
enlarged (cytomegalia). Latent infections are established 
in the secretory glands, lymphoreticular cells, kidneys and 
other tissues. Human cytomegalovirus (HCMV; human 
herpesvirus 5) is a member of this group.
Gammahe rpe svi ru se s
The host range of this group is often limited to 
the same family or order as the natural host. Viruses in 
this group are specific for either B or T lymphocytes with 
latent infection being frequently established in lymphoid 
tissue. The length of the reproductive cycle and 
cytopathology are variable. Epstein-Barr virus (EBV; human 
herpesvirus 4) belongs to this group.
It is now becoming increasingly evident that 
classification of the herpesviruses on the basis of 
biological properties may not accurately reflect their 
phylogenetic relationships. Limited sequence analysis of 
the recently identified human lymphotropic virus, HHV-6 
(Salahuddin et a l ., 1986) has shown that it is more closely 
related to the betaherpesvirus subfamily (Lawrence et a l ., 
1990) whereas its host range more closely resembles that of 
the gammaherpesviruses.
2. Epidemiology of human herpesviruses
There are six known herpesviruses that cause 
infection in man: HSV-1, HSV-2, VZV, EBV, HCMV and HHV-6 .
HSV has a wide range of effects in infected 
individuals from totally asymptomatic to sporadic 
life-threatening diseases in a very small number of children 
and adults. HSV-1 is normally expressed as cold sore 
lesions of the lips and mouth (herpes labialis) and the eyes 
(herpes keratoconjunctivitis) whereas HSV-2 infections 
normally result in genitial lesions (herpes genitalis;
4Whitley, 1985). Both infections are passed from person to 
person by direct contact. Following primary infection HSV 
can establish a latent infection in the neurons of sensory 
ganglia and brain tissue (Baringer and Swoveland, 1973; 
Fraser et al ., 1981). Factors such as stress, fatigue and 
exposure to sunlight have been affiliated with the 
reactivation of latent virus and the recurrence of HSV-1 
lesions. HSV has also been associated with skin infections 
(herpes herpeticum), a broad spectrum of neonatal infections 
from skin vesicles to liver and lung infections and sporadic 
fatal encephalitis (Whitley, 1985).
Varicella-zoster virus (VZV) causes both varicella 
(chicken-pox) and herpes zoster (shingles). Varicella is 
normally a childhood disease spread by the respiratory route 
and direct contact, resulting in a rash of skin lesions 
leading to pustules. VZV can establish a latent infection 
in the dorsal root ganglia and spinal cord (Bastian et al ., 
1974). The hypothesis of Hope-Simpson in 1965, that herpes 
zoster infection is due to the reactivation of a latent 
varicella infection, is now generally accepted to be true, 
based on various clinical and virological observations. The 
herpes zoster manifests itself in a painful rash with 
dermatomal distribution. The incidence and severity of 
herpes zoster increases with age as well as in 
immunocompromised individuals (Kennedy, 1987).
Primary infection with Epstein-Barr virus (EBV) 
usually takes the form of benign disease in children but if 
initial infection is delayed until adolescence or early 
adulthood, infectious mononucleosis normally results. EBV 
can produce a latent infection in B lymphocytes and 
epithelial cells. Unlike HSV, EBV has been directly 
associated with human cancers. Infection with EBV has been 
recognised as a contributory factor in the development of 
African Burkitt's lymphoma and the virus has also been 
linked to the high incidence of nasopharyngeal carcinoma in 
South East Asia (Epstein and Achong, 1986).
Human cytomegalovirus (HCMV) infections are 
normally asymptomatic with only an elevated antibody titre 
as evidence of infection. Latent HCMV infection has been 
detected in a number of cells which are implicated in the 
transmission of virus i.e. blood, kidney and sperm and also
in cells with a host-defence function such as macrophages 
(Huang et a l ., 1978). HCMV can also cause infectious 
mononucleosis but congenital HCMV infections are clinically 
the most significant due to the high percentage of cases 
resulting in mental retardation (Hamilton, 1982).
In 1986, Salahuddin et a l . described a new human 
herpesvirus termed human B lymphotropic virus (now named 
human herpesvirus 6 ) which had been isolated from patients 
with AIDS or lymphoproliferative diseases. More recently, 
the virus has been etiologically implicated with exanthem 
subitum in children (Downing et a l ., 1987; Tedder et al ., 
1987; Yamanishi et a l ., 1988).
3. Structures of the human herpesvirus genomes
The human herpesviruses contain large 
double-stranded linear DNA genomes ranging in molecular 
weight from 80 x 10^ (VZV) to approximately 150 x 10^
(HCMV). The structures of the DNA genomes of the six human 
herpesviruses are shown in Fig. 1.1.
The HSV-1 genome has now been completely sequenced 
(McGeoch et a l ., 1985; McGeoch et al., 1986; Perry and 
McGeoch, 1988; McGeoch et al., 1988), contains approximately
g
152 kbp and has a molecular weight of 100 x 10 (Becker et 
al., 1968; Kieff et al ., 1971). The DNA consists of two 
covalently joined segments, termed the long (L) and short 
(S) segments, and each contains unique DNA sequence (U^ and 
Ug). Each unique segment is flanked by a pair of oppositely 
orientated distinct repeat elements; the terminal and 
internal copies flanking U^ and Ug named TR^ and IR^, TRg 
and IRg respectively (Sheldrick and Berthelot, 1974). The 
inverted repeats of L (R ) are approximately 9200 bp longIj
while those of S (RG ) are approximately 6600 bp long 
(McGeoch et a l ., 1986). A 400 bp sequence called the 'a' 
sequence (Davison and Wilkie, 1981) is present as a direct 
repeat at the termini of the genome and also in the inverted 
orientation at the joint between the L and S segments 
(Grafstrom et al ., 1974; Sheldrick and Berthelot, 1974; 
Wadsworth et al ., 1975, 1976; Fig. 1.2). The ends of the 
terminal 'a' sequences each have one overhanging residue
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Figure 1.1 Structures of the genomes of the human
herpesviruses
The genomes are presented as linear molecules. The bold 
lines represent unique DNA sequences and the boxes represent 
repeat sequences with arrows indicative of the relative 
sequence orientations.
Abbreviations
UT - long unique
Li
Ug - short unique
IRt/TR - internal/terminal long repeat
Li L
IRC/TR - internal/terminal short repeat
b O
MIR - major internal repeat
Dt - left direct repeat
Li
Dd - right direct repeatR
ori - origin of DNA replication
This figure was adapted from McGeoch (1989) with 
permission of D. McGeoch.
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Figure 1.2 Schematic representation of the HSV genome
The genome consists of a long (L) and short (S) region
flanked by inverted repeats (TR^/IR^, TRg/IRg). The 'a'
sequence is present as a direct repeat at the genome termini
and in inverted orientation at the L-S junction. Inversion
of the L and S segments occurs between inverted copies of
the 'a' sequence to generate four isomeric forms of viral
DNA found in equimolar amounts. These are designated P
(prototype), I_ (inversion of the short segment), I 
s u
(inversion of the long segment) and I (inversion of theLi O
long and short segments).
with a free 3' hydroxyl group (Mocarski and Roizman, 1982). 
In some virion DNA preparations the 'a' sequence is present 
in multiple copies at the L-S joint and the L terminus only 
(Wagner and Summers, 1978).
HSV-1 DNA preparations have been shown to contain 
equal amounts of four sequence orientation isomers arising 
from the L and S segments inverting relative to each other 
about the joint regions. These isomers are designated P 
(prototype), Ig (inversion of S), IL (inversion of L) and 
IgL (inversion of S and L) (Fig. 1.2; Hayward et al., 1975; 
Delius and Clements, 1976; Wilkie and Cortini, 1976;
Roizman, 1979)
Through sequence analysis of HSV DNA, families of 
multiple copies of short direct repeat sequences have been 
identified and these are located mainly in the repeat 
regions, R^ and Rg . These sequences display a high G+C 
content and copy numbers are variable between individual 
plaque isolates (Davison and Wilkie, 1981; McGeoch et al., 
1985; Rixon et a l ., 1984).
To date, nearly 3 3 kbp of HSV-2 DNA sequence has 
been published (Davison and Wilkie, 1981; McLauchlan and 
Clements, 1983; Swain and Galloway, 1983,1986; Whitton and 
Clements, 1984a,b; Swain et a l ., 1985; Lockshon and 
Galloway, 1986; Draper et a l ., 1986; McGeoch et al ., 1987; 
Stuve et a l ., 1987; Worrad and Caradonna. 1988). HSV-1 and 
HSV-2 are closely related; they show many serological 
cross-reactions and DNA hybridisation studies have shown 
that the genome sequences are closely co-linear (Davison and 
Wilkie, 1983a). Coding sequences of corresponding genes 
show 70-80% nucleotide homology (McGeoch et al., 1987).
Complete sequencing of the 125 kbp VZV genome was 
carried out by Davison and Scott (1986). The overall 
structure of VZV is similar to HSV in that there are two 
covalently linked segments L and S flanked by inverted 
terminal repeats (Fig. 1.1). The repeats flanking UL are 
only 88 bp long compared with the 9200 bp repeats of HSV 
(Dumas et al ., 1981; Ecker and Hyman, 1982; Straus et a l ., 
1982; Davison, 1984 ). VZV DNA preparations do contain four 
sequence orientation isomers but the two isomers 
representing one orientation of constitute 80% of the 
total arrangements (Davison, 1984).
EBV strain B95-8 was the first herpesvirus sequence 
to be published (Baer et al ., 1984). The genome consists of 
approximately 172 kbp, but as this strain of EBV was shown 
to contain' a deletion of 13.6 kbp, a truer estimate of the 
genome length is 186 kbp (Raab-Traub et a l ., 1980). The 
overall structure of EBV differs greatly from HSV (Fig.
1.1). The termini of the genome contain several directly 
repeated copies of a 5 40 bp sequence. Another set of large 
direct repeats, each of 30 72 bp are found internally towards 
one end of the genome. This major internal repeat separates 
a short unique region (Ug) from a larger long unique region 
(U^). Towards either end of UL are found two identical 1 
kbp regions named DT and D0 , both lying in the same
-Li K
orientation. Next to these identical repeats are found 
families of tandem repeat sequences which are related rather 
than identical (Raab-Traub et al., 1980; Laux et al., 1985).
c
The DNA of HCMV has a molecular weight of 147 x 10 
(Geelen et al ., 1978) and has the largest genome of the 
human herpesviruses containing approximately 230 kbp. 
Structurally the genome is similar to that of HSV whereby 
two unique segments L and S are bounded by inverted repeat 
sequences (Kilpatrick and Huang, 1977; Westrate et a l .,
1980; Fig. 1.1) and the DNA contains four equimolar 
populations differing in the relative orientation of the 
unique sequences (Kilpatrick et al., 1976). HCMV also 
possesses an equivalent of the HSV 'a' sequence at the ends 
of the terminal repeats and at the L-S joint region (Spaete 
and Mocarski, 1985). The 230 kbp sequence of the DNA of 
HCMV strain AD169 is now known (Chee et a l ., 1990).
Preliminary analysis of HHV-6 DNA has revealed a 
base composition of 41% G+C and a genome size of 
approximately 160 kbp. The DNA is thought to consist of a 
single unique sequence flanked by a set of large direct 
repeats (McGeoch, 1989). Recent sequence analysis of 21 kbp 
of the HHV-6 genome indicates that the virus is more closely 
related to HCMV than to the other human herpesviruses 
(Lawrence et al., 1990).
4. Genetic content of HSV-1
The acquisition of the complete sequence of the 
HSV-1 genome has allowed the assignment of open reading 
frames (ORFs), corresponding to proposed HSV-1 genes. It 
now appears that most of the HSV-1 sequence is capable of 
encoding proteins, with 8 9% of UT and 97% of Uc occupied by
X j O
ORFs (Rixon and McGeoch, 1985; McGeoch et a l ., 1985; McGeoch 
et a l ., 1986; Perry and McGeoch, 1988; McGeoch et al.,
1988). The UT region contains 56 genes, Uc contains 12
1 j  O
genes and one gene is contained in each repeat element 
yielding a total of 72 genes which encode 70 distinct 
polypeptides (McGeoch, 1989; see Fig.1.3). Of the 70 
polypeptides there are presently 26 genes whose functions 
remain unknown. Genes whose functions are known have roles 
in transcriptional control, DNA replication, virion 
structure and assembly. Most of the genes located in Uc 
are not essential for growth of virus in tissue culture 
(Umene, 1986; Weber et a l ., 1987; Longnecker and Roizman,
1987) whereas presently nine genes in U have been
Li
identified as nonessential.
The present list of genes encoded by HSV-1 may not 
be complete. Published reports suggest the possible 
presence of other genes. These include a transcribed open 
reading frame containing the short region origin of viral 
DNA replication, ori^, (Hubenthal-Voss et al., 1987), and a
O  ”
gene upstream of immediate-early (IE) gene 1 in R^ (Ackerman 
et al ., 1986a; Chou and Roizman, 1986). However in both 
cases the data is not yet conclusive. The region downstream 
of, and partly overlapping, the IE-1 gene has been shown to 
specify transcripts found in latently infected neuronal 
cells. Whether this transcript actually encodes a protein 
is presently uncertain (Stevens et al ., 1987; Wagner et al .,
1988) .
The overall base composition of the genome is 68.3% 
G+C residues although in some regions , such as the IE-1 and 
IE-3 coding sequences, G+C content is as high as 75.4% and 
81.5% respectively (Perry et al ., 1986; McGeoch et a l .,
1986). The prevalence of G+C residues has two main 
consequences; a low number of nonsense codons in 
untranslated reading frames and a high content of amino 
acids encoded by GC-rich codons in HSV-1 proteins, namely, 
alanine, proline, glycine and arginine.
9SECTION IB: Herpes simplex v i m s  lytic cycle
1. Initial stages of infection
An HSV infection begins with the initial binding of 
virus particles to the host cell membrane, subsequent 
penetration of the cell by fusion of the viral envelope with 
the plasma membrane and release of the viral DNA from the 
capsid into the cell nucleus. HSV appears to bind initially 
to heparin sulphate on the cell surface, as agents that can 
block this interaction effectively block HSV adsorption and 
infection (WuDunn and Spear, 1989). Following attachment of 
the virion to the cell surface, the viral envelope fuses 
with the plasma membrane (Morgan et a l ., 1968) and the viral 
capsid is released into the cytoplasm (Fuller and Spear, 
1985). Adsorption is thought to be mediated via attachment 
of the viral surface glycoproteins to specific receptors on 
the cell surface, although these receptors have yet to be 
identified. Four glycoproteins gB, gC, gD and gE have been 
implicated in this event (Para et al., 1982; Johnson et a l ., 
1984; Fuller and Spear, 1985). Experiments with t_s mutants 
have identified two genes (gB and UL25) which play important 
roles in the penetration process (Sarmiento et al, 1979; 
Addison et a l ., 1984; Cai et al., 1988).
On entering the cell, the capsid is transported to 
the nuclear pore where viral DNA is released into the 
nucleus (Knipe et a l ., 1981; Batterson and Roizman, 1983). 
Again, this activity may require a virion function as 
studies on an HSV-1 mutant, tsB7 (UL36), revealed an 
accumulation of viral capsids at nuclear pores at NPT 
(Batterson et a l .,1983).
2. Effect on host cell macromolecular synthesis
Infection of cultured cells with HSV results in the 
rapid inhibition of host cell polypeptide synthesis (Roizman 
et_al., 1965) and cellular DNA synthesis, disaggregation of
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polyribosomes and a reduction in the level of host mRNA 
(Nishioka and Silverstein, 1977; Fenwick, 1984; Schek and 
Bachenheimer, 1985). These processes have been divided into 
two distinct phases: 'early' shutoff, which involves the
rapid degradation of host polyribosomes and reduction in 
host mRNAs and is mediated by a virion component (Nishioka 
and Silverstein, 1977) and a delayed 'late' shutoff which 
involves enhanced degradation of host mRNA and requires the 
expression of viral genes (Nishioka and Silverstein, 1978; 
Isom et a l ., 1983; Fenwick, 1984). The mechanism of host 
shut-off may differ between HSV-1 and HSV-2 as some strains 
of HSV-2 appear to induce a more rapid inhibition of host 
protein synthesis (Pereira et al ., 1977; Schek and 
Bachenheimer, 1985). HSV-2 strain G seems to encode a very 
efficient virion associated host shut-off (vhs) function 
which also destabilises viral IE mRNAs in the absence of de 
novo viral protein synthesis (Fenwick and Owen, 1988) .
The virion-associated primary inhibition of host 
protein synthesis is non-essential for virus replication as 
viable mutants (vhs mutants) have been isolated which fail 
to degrade pre-exiting mRNAs in the absence of viral gene 
expression but are not deficient in the delayed 'late' 
shut-off activity (Read and Frenkel, 1983; Kwong and 
Frenkel, 1987; Strom and Frenkel, 1987). The vhs factor 
appears to be responsible for degradation of both host and 
viral mRNA. Both host and viral mRNA are significantly more 
stable in cells infected with vhs mutants and the failure of 
these mutants to shut-off IE polypeptide expression 
indicates the importance of the shut-off for rapid 
regulation of viral gene expression (Kwong and Frenkel,
1987) . The vhs mutation has been mapped to within the UL41 
open reading frame (Kwong et a l ., 1988). Based on studies 
with the vhs mutant , it has been proposed that the wild 
type (wt) vhs protein interacts with a cellular factor which 
controls the half-life of cellular mRNA, resulting in the 
destabilisation of both host and viral mRNA (Kwong and 
Frenkel, 1989).
In contrast to the inhibition of host protein 
synthesis described above, certain cellular genes, notably 
stress and heat shock proteins, are induced during HSV 
infection (LaThangue et a l ., 1984; Patel et a l ., 1986; Kemp
et al., 1986 ) .
11
3. Transcription and regulatory features of HSV-1
Transcription of HSV-1 genes takes place in the 
nucleus of infected cells using the cellular RNA polymerase 
II (Alwine, 1974; Preston and Newton, 1976) in conjunction 
with cellular and viral trans-activating factors. The HSV 
mRNAs are similar to cellular mRNAs in that they possess 5' 
and 3' non-coding sequences and a 3' poly(A) tract 
(Silverstein et a l ., 1976).
Within the HSV-1 genome, genes are transcribed in 
both orientations and each gene has its own promoter. Hence 
there is no long range ordering of genes where many genes 
are served by a small number of promoters as is the case for 
adenoviruses (Fig. 1.3; McGeoch et a l ., 1988a; McGeoch,
1989). However, the occurence of 3' co-terminal families of 
transcripts is common. For example in Ug, 11 of the 13 
mRNAs (encoding 12 proteins) are arranged in four nested 
families with unique 5' ends and common 3' ends (Rixon and 
McGeoch, 1984, 1985; McGeoch et a l ., 1986). Other features 
of transcriptional organisation include transcripts with 
overlapping reading frames such as US10 and 11 (Rixon and 
McGeoch, 1984), overlapping 5' ends on opposite strands 
(Wilkie et a l .,1980) and spliced transcripts, which although 
not common, notably encode the IE proteins VmwllO (Perry et 
al., 1986), Vmw68 and Vmwl2 (Watson et a l ., 1981; Rixon and 
Clements, 1982) and also the UL15 polypeptide (Costa et al ., 
1985; McGeoch et a l ., 1988a)
HSV transcription is divided into three temporally 
distinct phases : immediate-early (IE), early (E) and late 
(L). The first viral genes to be transcribed from the 
parental genome are designated IE or alpha (o<) genes. The 
IE mRNAs are produced in the absence of viral protein 
synthesis (Kozak and Roizman, 1974; Clements et al ., 1977; 
Jones and Roizman, 1979) and functional IE gene products are 
required for subsequent expression of early or beta (^  ) 
genes from unreplicated genomes. The IE and E gene products 
are in turn required for efficient expression of the late or 
gamma (tf) genes (Honess and Roizman, 1974, 1975; Preston,

Figure 1.3 The location of genes in the HSV-1 genome
(reproduced from McGeoch, 1989)
The HSV-1 genome is shown on four successive lines (40 
kbp per line) with unique regions represented by solid lines 
and major repeat sequences as open boxes. The sizes and 
orientation of proposed functional open reading frames are 
shown by arrows. In the top four lines, genes UL1-UL56 are 
numbered 1-56 and in the bottom line genes US1-US12, as 
1-12. The location of introns in the coding regions of gene 
UL15 and the two copies (TR_ and IR_) of the IE-1 gene areL -u
indicated. Reports concerning the functions of the HSV-1 
genes are referenced in McGeoch (1989) and in relevant 
sections of the thesis.
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1979a,b; Everett, 1984a,b; O'Hare and Hayward, 1988a). The 
late genes have been further divided into two subclasses : 
early-late (fo) and 'true' lates with the distinction
being that true late gene expression is barely detectable in 
the absence of viral DNA replication (Jones and Roizman, 
1979; Holland et a l ., 1980; Hall et al ., 1982; Godowski and 
Knipe, 1985; Johnson et a l ., 1986).
The expression of HSV genes is controlled primarily 
at the level of transcription initiation and certain HSV 
gene products play important regulatory roles in this 
process. The following sections describe the control of HSV 
gene transcription in more detail.
4. Transcription and regulation of immediate-early
genes
There are five IE genes of HSV-1 named IE-1, IE-2 
(UL54), IE-3, IE-4 (USl) and IE-5 (US12). These genes 
encode polypeptides VmwllO, 63, 175, 68 and 12 respectively. 
The IE mRNAs are synthesised in the absence of viral protein 
synthesis and in vivo labelled IE mRNAs have been used to 
locate the position of the IE genes on the HSV-1 genome 
(Watson et a l ., 1979; see Fig. 1.3). The genes for IE-4 and 
IE-5 have identical promoters located in the repeat 
sequences of Ug while their coding sequences differ due to 
their location in the UQ region itself. Both genes are 
spliced with exon sequences lying in the repeat regions 
(Watson et al ., 1981; Rixon and Clements, 1982). The IE-1 
gene is also spliced and is located within the TR^/IR^ 
regions whereas IE-3 gene is unspliced and lies wholly 
within IRg/TRg; both genes are therefore diploid (Perry et 
al., 1986; Rixon et al ., 1982). The unspliced mRNA 
specified by IE-2 lies within the UT region and is therefore
L i
the only IE gene not associated with the major repeat 
regions (Whitton et al ., 1983).
The IE upstream promoter regions have been 
sequenced (Mackem and Roizman, 1980, 1981; Murchie and 
McGeoch, 1982; Whitton et a l ., 1983; Whitton and Clements,
1984a) and are now known to contain a number of cis-acting 
elements which are recognised by both viral and cellular
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Figure 1.4 Cis-acting signals for the regulation of HSV
transcription (reproduced from Johnson and 
Everett, 1986a)
IE promoter regions contain a cap site, a TATA box, 
distal promoter elements, including CAAT and GA- and GC-rich 
motifs and a far upstream element required for activation by 
the virion component Vmw6 5, which includes the consensus 
sequence, TAATGARAT. E promoters include only the distal 
and proximal promoter regions. Late promoters consist of 
only a TATA box and cap site, although an active origin of 
DNA replication (ORI) is also required in cis for efficient 
gene expression.
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trans-activating factors. Deletion analysis of the promoter 
and upstream regions of IE genes has identified essentially 
two distinct domains; a promoter region and a regulatory 
domain (Mackem and Roizman, 198 2a,b,c; Cordingley et al., 
1983, Preston et a l ., 1984; Fig 1.4).
The promoter region lies proximal to the mRNA 
initiation site and allows expression of downstream coding 
sequences but not regulation as an IE gene (Mackem and 
Roizman, 1982a,c; Cordingley et a l ., 1983). Not 
surprisingly, a TATA box, which is known to play an 
important role in the precise initiation and efficiency of 
transcription of eukaryotic genes, is located 20 to 30 bp 
upstream of the start site (Benoist et al ., 1980; Benoist 
and Chambon, 1981).
The far upstream regulatory region can itself be 
divided into two distinct domains; one element which allows 
the downstream coding sequences to be regulated as an IE 
gene and an enhancer-like sequence which allows high level 
expression (Post et al ., 1981; Mackem and Roizman, 1982a,c; 
Cordingley et a l ., 1983; Lang et al ., 1984; Preston and 
Tannahill, 1984).
Evidence that IE gene expression was positively 
regulated by a virion component came from observations that 
expression from IE upstream regions could be stimulated by 
infection with HSV ts mutants which could penetrate cells 
but did not express IE genes or by infection with UV 
light-irradiated virus (Post et al ., 1981; Mackem and 
Roizman, 1982a; Batterson and Roizman, 1983; Batterson et 
al ., 1983; Cordingley et a l .,1983; Preston and Tannahill,
1984). The UL48 gene encoding the virion polypeptide 
responsible for IE stimulation was identified, sequenced and 
shown to encode a phosphorylated protein of apparent M^ of
65,000 (Dalrymple et a l ., 1985; Pellet et al ., 1985;
Campbell et a l ., 1984). The virion stimulatory polypeptide, 
Vmw65 (or VP16) is a major structural component of the 
virion tegument (Marsden et a l ., 1976; Hall et al., 1982). 
Recently, an HSV-1 Vmw65 insertion mutant has been 
constructed in which the ability of Vmw65 to trans-activate 
IE gene expression was abolished. The accumulation of IE 
mRNAs 1,2 and 4 were reduced 2 to 5-fold but IE mRNA 3 was 
unaffected. The mutant has a high particle/PFU ratio and at
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high moi, many of the particles are capable of trans 
-activation in the early stages of infection. Activation of 
IE transcription by Vmw65 is therefore important at low moi 
and in vivo, but at high moi, this function is not required 
(Ace et a l ., 1989).
The trans-inducing activity of Vmw65 is mediated 
essentially through interaction with cellular factors at an 
AT-rich element located in the IE upstream regulatory region 
which has the consensus sequence 5 1-TAATGARAT-31 (R=purine; 
Mackem and Roizman, 1982a,c; Cordingley et a l ., 1983;
Whitton and Clements, 1984a; Preston et a l ., 1984; Campbell 
et a l ., 1984; Kristie and Roizman, 1984; Gaffney^ 19*85; Bzik 
and Preston, 1986; Fig.1.4).
Although the action of Vmw65 is mediated through a 
sequence specific element, the protein itself is unable to 
bind directly to this element or indeed non-specifically to 
double-stranded (ds) DNA (Marsden et al ., 1987). However, 
Vmw6 5 forms a complex (IEC) with at least two cellular 
proteins on the TAATGARAT element (McKnight et al ., 1987; 
Preston et a l ., 1988; O'Hare and Goding, 1988; Gerster and 
Roeder, 1988). The formation of this complex correlates 
with stimulation of IE gene expression (O'Hare and Goding, 
1988; Ace et a l ., 1988). Evidence that OCT-1, a ubiquitous 
cellular protein which binds to the octamer sequence, 
ATGCAAT, interacts with Vmw6 5 was given by Gerster and 
Roeder (1988) who showed that, in the presence of Vmw65, the 
addition of OCT-1 protein to OCT-1 depleted extracts 
stimulated the formation of IEC complex.
The amino-terminal 411 amino acids of Vmw65 are 
required for binding to cellular factors (McKee et a l . 
submitted for publication) and the acidic carboxy-terminal 
domain contains the trans-inducing activity (Triezenberg et 
al., 1988) .
Other regulatory elements in IE genes include 
multiple GC-rich sequences, located in the enhancer region 
of the upstream regulatory domain, which act as binding 
sites for the eukaryotic cellular transcription factor Spl 
(Jones and Tjian, 1985; Briggs et a l ., 1986) and GA-rich 
elements which may possibly enhance the TAAGARAT element 
(O'Hare and Hayward, 1987).
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5. Properties and functions of IE polypeptides
The IE polypeptides have been the subject of 
intensive study due to early observations that in the 
absence of their polypeptide products there was no 
expression of E and late genes (Honess and Roizman, 1974; 
Swanstrom et a l ., 1974; Clements et a l ., 1977; Anderson et 
al., 1980). The main features and characteristics of these 
proteins are described below:
Vmwl7 5
The IE-3 gene product, Vmwl75, accumulates in the 
nucleus of infected cells and is post-translationally 
modified by phosphorylation and also by poly-ADP 
ribosylation in vitro, such that three forms of the protein 
can be separated by differences in electrophoretic mobility 
(Pereira et a l ., 1977; Preston and Notarianni, 1983). Ts 
mutants have been particularly useful in the study of the 
role of Vmwl75. At NPT, a mutant, tsK, with a lesion in 
IE-3, overproduces the IE-1,2,4,5 products and an aberrant 
form of the IE-3 gene product which is found largely in the 
cytoplasm. Early or late genes are not expressed (with the 
exception of the large subunit of ribonucleotide reductase 
encoded by UL39). A functional Vmwl75 is therefore required 
for the transcription of E and late classes of viral genes 
and also for the repression of IE gene expression (Preston, 
1979a; Watson and Clements, 1980). Further evidence for the 
role of Vmwl75 in coordinating the transition from IE to E 
gene expression has been obtained from transient 
transfection assays where transcription from early gene 
(e.g. glycoprotein D; thymidine kinase) promoters linked to 
the gene for chloramphenicol acetyltransferase (CAT) was 
monitored following co-transfection with plasmids containing 
a copy of IE-3 (Everett, 1984a, 1986; Quinlan and Knipe,
1985; O'Hare and Hayward, 1985a; Gelman and Silverstein, 
1986). Vmwl75 was shown to trans-activate an E gene 
promoter but a greatly enhanced level of transcription was 
observed when a plasmid containing a copy of IE-1 was also 
present (DeLuca and Schaffer, 1985; Everett, 1986; O'Hare 
and Hayward, 1985a).
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The role of Vmwl75 in autoregulation and repression 
has been studied by assaying the level of expression from IE 
promoter-CAT constructs in cells containing plasmids 
expressing Vmwl75. Vmwl75 was shown to repress basal levels 
of transcription from IE promoters and to reduce 
transcription from IE promoters stimulated by Vmw65 (O'Hare 
and Hayward, 1985b) although at low doses of Vmwl75, the 
IE-3 and IE-4/5 promoters were both stimulated (DeLuca and 
Schaffer, 1985, Gelman and Silverstein, 1986).
While most of the IE polypeptides bind DNA to some 
extent in vitro (Hay and Hay, 1980; Metzler and Wilcox,
1985) Vmwl75 is the only IE protein known to interact 
specifically with a conserved binding sequence, ATCGTC, 
which is found in the promoter/regulatory region of the 
IE-1, IE-2 and IE-3 genes and of some early and late genes 
(Faber and Wilcox, 1988; Kristie and Roizman, 1986; Paterson 
and Everett, 1986). Whether this sequence is involved in 
trans-activation remains to be resolved as most early gene 
promoters lack sequences closely related to the consensus 
sequence. There is also no evidence for any 
trans-activation specific sequences in early promoters being 
required for the action of either Vmwl75 (Everett, 1984a; 
Coen et al ., 1986) or indeed any other viral or cellular 
encoded proteins (Michael et a l ., 1988. Kattar-Cooley and 
Wilcox, 1989) .
VmwllO
The HSV IE-1 gene product is a phosphorylated 
protein found mainly in the nucleus of infected cells 
(Pereira et a l ., 1977, Hay and Hay, 1980; Ackerman et al .,
1984) . Studies on the role of VmwllO have been limited due 
to the failure to isolate any jts mutants. However, variants 
of HSV-1 and 2 have been isolated that contain only one copy 
of the gene (Poffenberger et al., 1983; Harland and Brown,
1985) and more recently, mutant viruses have been 
constructed which contain large deletions in both copies of 
IE-1 (Stow and Stow, 1986; Sacks and Schaffer, 1987). At low 
multiplicities of infection (moi) the mutant dll403 (Stow 
and Stow, 1986) grows poorly in tissue culture cells and has 
a 50 to 100-fold lower yield than wt HSV-1. At high moi the 
virus expresses similar amounts of viral proteins and
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replicates as well as wt HSV, although virus stocks have 
significantly higher particle to pfu ratios than wt HSV-1.
It appears that VmwllO is not absolutely essential for virus 
growth in tissue culture but rather ensures that there is 
sufficient viral gene expression at low moi for a productive 
infection (Stow and Stow, 1986; Everett, 1989).
As in the case of Vmwl75, the use of individually 
cloned plasmid copies of IE-1 has allowed the study of the 
effect of VinwllO on HSV promoter activation in 
co-transfection experiments. The experiments demonstrated 
that VmwllO is a strong trans-activator of IE, E and late 
classes of genes (Everett, 1984a; Quinlan and Knipe, 1985; 
Mavromara-Nazos et al ., 1986) which can act synergistically 
with Vmwl75 to increase activation from a number of viral 
promoters (DeLuca and Schaffer, 1985; Everett, 1986; O'Hare 
and Hayward, 1985a) as well as some cellular promoters 
(Everett, 1985) .
A large number of in-frame insertion and deletion 
mutants within the coding region of IE-1 have been 
constructed, recombined into virus and used to define 
regions of the polypeptide sequence that are important for 
its function in transfection assays and virus infection 
(Everett, 1987b, 1988, 1989) . Two regions most sensitive to 
mutation lie in the second exon (region 1 ) and at the 
carboxy terminus (region 5). Region 1 contains a potential 
zinc-finger DNA binding motif which is crucial for 
trans-activation of the E gene (gD) promoter in the absence 
of Vmwl75 but is not required to the same extent when Vmwl75 
is supplied. The converse situation applies to region 5.
It is possible that in transfection assays VmwllO modulates 
transcription by two different mechanisms, one of which 
requires Vmwl75. The VmwllO synthesised in ts>K infected 
cells, which express a mutated Vmwl75, is not of itself 
sufficient for activation of E promoters suggesting that in 
vivo, transcriptional activation by VmwllO proceeds by a 
mechanism which also requires Vmwl75.
VmwllO is the only HSV gene product required for 
reactivation of HSV-2 from in vitro latently infected cells. 
Interestingly, a deletion in region 1 prevents the 
reactivation event which suggests that events leading to 
reactivation are initiated by the activation of gene
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expression by VmwllO alone (Harris et a l ., 1989).
Vmw63
The IE-2 gene product is a phosphoprotein located 
in the nucleus of the infected cells (Pereira et al ., 1977; 
Hay and Hay, 1980; Wilcox et a l ., 1980). Mutant viruses 
containing ts lesions have been isolated and found to 
overproduce Vmwl75 and Vmw63 at NPT. Synthesis of early 
proteins and DNA was not affected but production of many 
late proteins was restricted (Sacks et a l ., 1985). Further
studies using deletion mutants which do not express Vmw63
demonstrated that these viruses overexpressed early genes, 
displayed reduced levels of late (gamma^) polypeptides and 
were replication incompetent on non-complementing cell 
lines. Vmw63 therefore has an essential role in regulating
early and late gene expression and possibly also in
regulating IE gene expression (McCarthy et al ., 1989).
The use of transient expression assays for analysis 
of the ability of Vmw63 to regulate HSV-1 genes has produced 
conflicting reports. While some studies have produced 
evidence for the trans-activation of an HSV early gene (gB) 
by Vmw63 alone (Rice and Knipe, 1988) it would appear that 
Vmw63 alone does not invariably exhibit such activity. 
However, in concert with Vmwl75 and VmwllO, Vmw63 can 
further stimulate the expression of genes under late 
promoter control (Everett, 1986; Sekulovich et al., 1988; 
Rice and Knipe, 1988) .
Vmw68
IE gene 4 encodes Vmw68, a nuclear phosphorylated 
protein (Pereira et a l ., 1977; Hay and Hay, 1980; Ackerman 
et a l . , 1984). A deletion mutant which lacks the carboxy 
terminal third of Vmw68 has been constructed (Post and 
Roizman, 1981; Sears et al., 1985) and shown to exhibit 
growth properties dependent on the cell line used. This 
implies that host factors in some cell lines can complement 
the function of Vmw68 . In mutant infected resting cells, a 
reduction in viral growth has been attributed to a 
reduction in late (gamn^) gene expression (Sears et al., 
1988) .
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Vmwl2
Unlike the other IE polypeptides, Vmwl2, encoded by 
IE gene 5, is not phosphorylated and is located in the 
cytoplasm (Preston, 1979b; Marsden et a l ., 1982). IE-5 is 
not an essential gene for viral growth in tissue culture as 
viable deletion mutants lacking the entire IE-5 gene have 
been isolated (Longnecker and Roizman, 1986; Umene, 1986; 
Brown and Harland, 1987).
6 . Regulation of early gene expression
Following the synthesis of IE gene products, 
expression of early genes can occur (Honess and Roizman, 
1974; Clements et al., 1977). Early genes are sometimes 
sub-divided due to the variation in kinetics of gene 
expression amongst this group. Thus, the large sub-unit of 
ribonucleotide reductase (RR^), has traditionally been 
classed as a beta^ gene product (Roizman and Batterson,
1983) but is in fact expressed very early in infection and 
can be detected in the absence of activation by IE proteins 
(Roizman and Batterson, 1985; Wymer et al ., 1989). Other 
early genes e.g. gB, are transcribed at early times but are 
not fully expressed until after the onset of DNA replication 
(Gibson and Spear,1983; Johnson and Everett, 1986a).
Early experiments to evaluate the promoter sequence 
requirements for the trans-activation of E gene promoters by 
viral gene products used deletion mutagenesis of E promoter 
sequences (of the TK and gD genes) linked to indicator genes 
which were assayed by microinjection into xenopus oocytes 
(McKnight et a l ., 1981; Jones et a l ., 1985). Later 
experiments by McKnight and Kingsbury (1982) used linker 
scanning mutations in which small sections of promoter 
sequence were replaced by synthetic linker DNA. By assaying 
these mutants in xenopus oocytes, and therefore in the 
absence of IE gene products, only promoter elements 
recognised by the cellular transcription machinery could be 
detected. Several functional elements were present and 
included a TATA box, upstream GA- and GC-rich (Spl binding 
site) regions and an inverted CCAAT motif present in the TK 
promoter (McKnight and Kingsbury, 1982; Everett, 1983,
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1984b; Eisenberg et al ., 1985; El Karah et__al., 1985; see 
Fig. 1.4). When the TK linker-scanning mutants were 
introduced into the HSV-1 genome at the normal TK promoter 
location (Coen et a l ., 1986) the upstream elements in the 
promoter region were less crucial for gene expression while 
greater importance was placed on the requirement for a TATA 
box and cap site region. Analysis of deletion and insertion 
mutants within the gD promoter region, induced by HSV-1 
infection, or activated by an SV40 enhancer linked upstream 
of the promoter, showed that mutations which resulted in a 
reduced response to viral trans-activation also incurred a 
reduction in cis-activation by the SV40 enhancer. It would 
therefore appear that there are no promoter elements 
upstream of the gD and TK gene that are specific for 
trans-activation by HSV products (Everett, 1984b). This 
implies that IE gene products activate E gene transcription 
by their interaction with, or alteration of, the activity of 
cellular transcription factors (Eisenberg et a l ., 1985; Coen 
et a l ., 1986)
7. Regulation of late gene expression
Late gene expression is first detected at 2-3 h 
post infection although maximal expression is not reached 
until 10-16 h post infection (Munk and Sauer, 1964; Roizman, 
1969). Late gene expression requires HSV DNA replication 
for maximum activity as noted by analysis of the polypeptide 
profiles of DNA negative ts mutants or under conditions 
where DNA synthesis is inhibited (Honess and Roizman, 1974; 
Powell et al ., 1975; Holland et al ., 1980; Conley et a l ., 
1981; Pederson et a l ., 1981).
Late genes have been divided into two groups;
’leaky late' (Y-j_) whose expression is reduced but still 
detectable in the absence of DNA replication and ’true 
lates' (3*2  ^ whose expression is barely detectable (<1%) 
before DNA synthesis (Wagner, 1985; Roizman and Batterson,
1985). The prototype of the (Y^) genes is UL19 encoding the 
major capsid protein, Vmwl55. The promoter of this gene 
extends no more than 125 bp upstream of the RNA cap site and 
can be activated by IE gene products (Costa et al., 1985).
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Detailed analysis of the promoter region of a ( f gene has 
been carried out using transient transfection assays in 
which US11 promoter deletions were carried on a plasmid 
containing an HSV-1 origin of replication, oric, which 
enables replication of the plasmid DNA in the presence of 
infecting HSV-1 (Johnson and Everett, 1986a; Stow and 
McMonagle, 1983). Surprisingly, DNA promoter elements 
required for regulation of gene expression were contained 
within a 31 bp sequence upstream of the RNA cap site 
containing only a TATA box and the cap site region 
(Fig.1.4). When sequences upstream of the early gD promoter 
TATA box were deleted, the gene was regulated as a true late 
gene and required the activity of an origin of replication
(Johnson and Everett, 1986b).
The requirement for viral DNA synthesis in late 
gene regulation is not yet understood. An actively 
replicating template will undoubtedly result in structural 
changes in the DNA which may provide a switch for L gene 
expression, or the replication machinery itself may play 
some role in situ.
8 . Herpes simplex virus DNA replication
This section summarises the general features of HSV 
DNA replication. A more detailed account of the enzymology 
and cis-acting sequences required is presented in section 
ID.
(a) in vivo studies
On the basis of velocity sedimentation
characteristics of newly synthesised viral DNA, and EM and
restriction endonuclease analysis of replicative 
intermediates, the replication of HSV can broadly be divided 
into three phases:
(i ) Initial phase of replication
Upon entering the cell nucleus, the HSV genome is 
thought to circularise by direct ligation of the termini 
forming a joint fragment in which the two terminal 'a'
sequences share a DR^ element {section IB part 10; Davison
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and Wilkie, 1983; Poffenberger et a l ., 1983). Although 
circularisation was originally thought to occur by exposure 
of complementary cohesive termini digested by exonuclease 
(Roizman, 1979), it now appears more likely that it takes 
place by ligation of the termini via the complementary 
3 '-single base extensions on the L and S termini (Mocarski 
and Roizman, 1982a,b; Davison and Rixon, 1985). HSV genomes 
containing heterotypic 'a’ sequences (Davison and Wilkie, 
1983) and VZV, which lacks a terminal redundancy, are both 
assumed to carry out this process (Davison, 1984). Studies 
using an HSV-1 deletion mutant showed that the covalent 
head-to-tail linkage of infecting viral DNA reached maximum 
levels less than 30 min after exposing the cells to virus 
and took place in the absence of protein synthesis 
(Ben-Porat and Veach, 1980; Poffenberger and Roizman, 1985).
(ii) Early phase of replication
Newly synthesized herpesvirus DNA, pulse-labelled 
3m  vivo with H-thymidine, has been analysed by velocity 
sedimentation in neutral sucrose gradients (Jacob and 
Roizman, 1977; Ben-Porat and Tokazewski, 1977). Viral DNA 
synthesised 2-3 h after infection sediments heterogenously 
at approximately twice the rate of unit-length viral DNA 
(Ben-Porat and Tokazewski, 1977). During the early phase, 
the genome continues to remain 'endless' (Jongeneel and 
Bachenheimer, 1981) and it has been suggested that viral 
genomes therefore undergo an initial template amplification 
stage as circular monomers (Ben-Porat and Tokazewski, 1977).
(iii) Late phase of replication
Herpesvirus DNA synthesised at late times (4-6 h 
after infection) sediments at approximately 100 times the 
rate of unit length viral DNA (Jacob and Roizman, 1977) and 
has been described as being in the form of "a large tangled 
mass" (Ben-Porat and Rixon, 1979). Restriction endonuclease 
analysis shows a decrease in the concentration of end 
fragments consistent with the hypothesis that the viral DNA 
accumulating in the cell consists of head-to-tail 
concatemers arising from the replication of the DNA by a 
rolling circle mechanism (Jacob et al ., 1979).
It is also possible that the rapidly sedimenting
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DNA synthesised late in infection is generated by a 'Cairns1 
type mechanism of replication where the daughter molecules 
remain topologically linked at the end of a round of 
replication (Jongeneel and Bachenheimer, 1981) or perhaps 
from homologous recombination between nascent DNA circles. 
This latter possibility cannot be ruled out as HSV is known 
to exhibit a high rate of recombination which, furthermore, 
appears to be dependent on the viral replication machinery 
(Schaffer et a l ., 1974, Smiley et a l ., 1980; Weber et a l .,
1988) .
HSV DNA fragments upon denaturation with alkali 
(Kieff et al ., 1971; Wilkie, 1973). Although HSV DNA does 
contain short stretches of ribonucleotides (Biswal et al .,
1974) , it is unlikely that these are entirely responsible 
for the fragmentation in alkali since similar amounts of 
fragmentation have been reported on formamide gradients 
(Roizman, 1979). It has been suggested that fragmentation 
is due to the presence of single-strand nicks or gaps in HSV 
DNA which appear to be randomly distributed on both strands. 
The functional significance of these nicks is presently 
unknown (Frenkel and Roizman, 1972; Wilkie, 1973; Wadsworth 
et a l ., 1976).
(b) in vitro studies
Another approach to the analysis of the mode of 
replication of HSV DNA has been the development of 
sub-cellular systems that support the synthesis of HSV DNA. 
These have included nuclear monolayers (Bell, 1974), 
isolated nuclei (Becker and Asher, 1975; Bolden et al .,
1975), nucleoplasmic extracts (Pignatti et a l ., 1979; Muller 
et a l ., 1981) and permeabilised infected cells (Jongeneel 
and Bachenheimer, 1980). In general these systems have been 
unable to faithfully reproduce in vivo patterns of viral DNA 
synthesis and fail to synthesise unit-length DNA or support 
semi-conservative replication. However, permeabilised 
infected cells were capable of incorporating labelled 
triphosphates into rapidly sedimenting DNA (Jongeneel and 
Bachenheimer, 1980).
(c) inversion/recombination of the HSV genome
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Following circularisation of the infecting viral 
genome, it is thought that limited synthesis of circular 
intermediates occurs and that inversion of the L and S 
segments may take place by recombination within the 'aT 
sequences. Whether inversion is merely a consequence of the 
genome structure or has some biological role is unknown.
All four isomers are functionally equivalent in tissue 
culture since variants have been isolated which are frozen 
in the P, I„ and ITn configurations (Preston et al., 1978;O JjO — _
Poffenberger et a l ., 1983; Jenkins and Roizman, 1986). In 
addition, single plaque isolates of wt HSV-1 yield equimolar 
amounts of the four isomers; hence each isomer can be 
rapidly converted to the other three forms. Pairs of the 
four isomers can be generated without an inversion event 
through utilisation of different cleavage sites in the 
concatemeric or circular DNA e.g. P and I can be generatedIjD
by alternative cleavage of the same concatemeric molecule 
and similarily so can I and IT . Although many studiesO J-i
indicate that the 'a* sequence is sufficient for inversion, 
it is clear that inversion events can also occur between 
inverted copies of other sequences present in an HSV genome 
(Pogue-Geile et a l ., 1985; Jenkins et al ., 1985; Varmuza and 
Smiley, 1985; Weber et a l ., 1987). Experiments by Weber et 
al. (1988) have demonstrated that the DNA replication 
process is intrinsically recombinogenic and argues against a 
specific inversion mechanism operating on the 'a' sequence.
9. Herpes simplex virus structural proteins
Many early genes encode enzymes and proteins 
involved in HSV DNA replication and are dealt with in more 
detail in section 1C. The rest of this section deals with 
HSV-1 encoded structural proteins and events following the 
synthesis of HSV DNA.
There appear to be at least 30 different virion 
structural polypeptides, the majority of which are encoded 
by the HSV late genes. These proteins have been grouped
into three main classes; glycoproteins, tegument proteins 
and capsid proteins. HSV encodes seven known glycoproteins;
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gB (encoded by UL27), gC (UL44), gD (US6 ), (Spear, 1976), gE 
(US8 ) (Bauke and Spear, 1979), gG (US4) (Ackerman et al ., 
1986b; Richman, 1986), gH (UL22) (Marsden et al ., 1978;
Frame et al ., 1986; McGeoch et a l ., 1987,1988a) and gl (US7) 
(Longnecker et a l ., 1987). In addition, an ORF in the U
O
region, US5, specifies an amino acid sequence characteristic 
of a glycoprotein although the protein has yet to be 
identified. The glycoproteins gB, gD and gH are essential 
for growth in tissue culture (Little et al ., 1981; Weller et 
al ., 1983a; Buckmaster et a l ., 1984; Fuller and Spear 1985; 
Gompels and Minson, 1986) whereas gC, gE, gG, gl and US5 
appear to be non-essential (Longnecker and Roizman, 1986; 
Longnecker et a l ., 1987; Harland and Brown, 1988).
The number of virus encoded proteins that 
constitute the tegument layer is uncertain. HSV-1 tegument 
polypeptides are normally recognised as proteins not 
belonging to the capsid or envelope that are released by 
solubilisation of the virus with non-ionic detergent 
(Lemaster and Roizman, 1980; Roizman and Furlong, 1974).
The IE transcription activator, Vmw65 (UL48) is a major 
constituent of the tegument as is the UL36 gene product, 
Vmw273 (Batterson et a l ., 1983; McGeoch et al., 1988a). The 
UL47 gene is also now thought to be located in this layer 
(McLean et al . submitted for publication).
The HSV capsid is composed of at least 6 
polypeptides including the major capsid protein of
155,000 (ICP5, VP5, Vmwl55) which is encoded by UL19 
(Marsden et al., 1978; Morse et a l ., 1978; McGeoch et al ., 
1988a). The family of polypeptides encoded by UL26 of 
approximate Mr 40,000 (p40) are also associated with 
different forms of the HSV-1 capsid (Addison, 1986; Rixon et 
al., 1988). Recent studies by Rixon et al. (submitted for 
publication) have identified UL18 and UL38 as encoding two 
capsid proteins.
10. Packaging, encapsidation and assembly of virions
Herpes simplex virus infected cells contain large 
concatemeric DNA molecules arising from replication of the 
viral genome. For the assembly of mature virions
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site-specific cleavage events take place to generate 
unit-length genomic molecules that are packaged into virus 
particles. Studies using ts mutants have demonstrated that 
the cleavage and packaging processes are tightly linked as 
mutants which fail to encapsidate replicated DNA are also 
unable to cleave it into unit lengths (Ladin et al.y 1980; 
Preston et a l .f 1983; Addison et a l ., 1984; Deiss and 
Frenkel, 1986).
The presence of the 'a sequence at both genomic 
temini suggests that this sequence may be involved in the 
cleavage of the DNA. Insertion of an additional 'a' 
sequence into the viral genome results in the generation of 
novel termini corresponding to the position of the inserted 
'a sequence (Smiley et a l ., 1981; Mocarski and Roizman, 
1982; Varmuza and Smiley, 1985). Replicated plasmid DNA 
containing a functional viral origin of replication can only 
become packaged and propagated in virus stocks as defective 
genomes if the plasmid contains an 'a sequence (Stow et 
a l ., 1983, 1986; Deiss and Frenkel, 1986) indicating that 
cis-acting maturation and packaging signals reside in the 
'a* sequence.
The structure of the 'a' sequence is shown in Fig 
1.5). Short (17-21 bp) direct repeat sequences, DR^, are 
located at each end of the 'a1 sequence. However DR^ 
elements located at the end of the L and S termini are 
incomplete. For example, the L terminus of HSV-1 strain 17 
possesses 20.5 bp of a 21 bp DRl sequence (i.e. 20 bp plus a 
single nucleotide 3' extension) and the remaining 0.5 bp is 
at the end of the S terminus. Hence in concatemeric DNA 
molecules, adjacent 'a1 sequences share an intervening DR^ 
element (Mocarski and Roizman, 1981) . Adjacent to the DR^ 
repeats are two unique regions called and Uc according to 
their location nearest to the flanking b and c sequences 
respectively. Separating and Uc are two additional 
repeat elements, DR2 , a 12 bp repeat unit present in 1 to 22 
copies and DR^, a 37 bp sequence present in 0 to 3 copies 
(Davison and Wilkie, 1981; Mocarski and Roizman, 1981). 
Although there is variation in the nucleotide composition of 
the 'a* sequence depending on the virus strain, two highly 
conserved sequences are located in and Uc termed pac-1 
and pac-2 respectively (see Fig. 1.5).

Figure 1.5 Structure of the HSV-1 'a1 sequence
The viral genome is shown with an expanded region below 
showing the structure of the 1 a f sequence in the orientation 
found in the L-S junction.
- a unique sequence located toward the b' sequence 
U - a unique sequence located toward the c 1 sequence
DRl - a 17-21 bp element present as a direct repeat
at the ends of the 'a' sequence 
DR2 - a 12 bp repeat element present in 1 to 22 copies
DR4 - a 37 bp element present in 0-3 copies
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The structure of the 'a ' sequence at the L and S 
termini suggest that cleavage of concatemeric DNA occurs 
through the shared DR^ element of two adjacent 'a' 
sequences. However, certain defective genomes capable of 
undergoing cleavage and packaging were shown to contain only 
4 bp of the DR^ element, suggesting that the recognition 
signal for cleavage is not identical to the cleavage site 
(Mocarski et a l ., 1985). Several studies using deletion 
analysis or generation of novel termini using sub-fragments 
of the 'a* sequence have demonstrated that sequences within 
Ub and Uc are required for cleavage and packaging.
Based on these findings, a simple model for 
cleavage and packaging of HSV DNA can be proposed. 
Circularisation of linear genomes containing an 'a' sequence 
at each end results in the generation of a novel joint 
fragment containing tandem 'a1 sequences sharing a DR^ 
element, when such molecules are replicated by a rolling 
circle mechanism the novel joint fragment is reiterated at 
intervals corresponding to a unit length genome in the 
concatemers. A putative cleavage/packaging protein complex 
recognises the packaging signal at this joint and produces a 
staggered cleavage through the shared DR^. Packaging of the 
resulting molecule continues until the next paired 'a' 
sequence in the same orientation is encountered (i.e. one 
genome length away). Repetition of the cleavage event 
completes the packaging of one genome with an 'a' sequence 
at each terminus and enables that of the next to be 
initiated. More elaborate models have been proposed to 
explain the cleavage/packaging and amplification of the 'a1 
sequence in the case of artifically constructed defective 
molecules which contain a single 'a' sequence. Following 
replication and propagation, these molecules are found to 
contain an 'a' sequence at each terminus (Varmuza and 
Smiley, 1985; Deiss et a l ., 1986).
Some evidence for the above model has come from gel 
retardation analysis of protein-DNA interactions using probe 
DNA containing various elements from the 'a1 sequence. 
Sequence— specific complexes were obtained using pac—2-DR^ 
sequence but not with DNA containing either element alone or
pac-1 and DR^ (Chou and Roizman, 1989). Purification of 
proteins which formed complexes revealed a previously
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reported DNase activity (Hoffman, 1981), probably the viral 
exonuclease encoded by UL12; the VPl tegument protein 
(Lemaster and Roizman, 1980) encoded by UL36 and a third 
unidentified protein of apparent Mr 140,000. Although the 
action of the viral DNase is normally exonuclear and 
non-specific, its DNA binding and cleavage activity could be 
directed by its interaction with a cellular or viral 
protein. A host cell protein has also been identified as 
binding to the conserved pac-2 sequence in HCMV (Kemble and 
Mocarski, 1989).
Further studies using ts mutants tsl204 and ts!2Ql 
(Preston et a l ., 1983; Addison, 1986) which are defective in 
both cleavage and packaging events have suggested a role for 
the p40 proteins encoded by UL26 (Preston et al ., 1984; 
McGeoch et a l ., 1988a). At NPT ^ts^Ol is unable to process 
p40; the unprocessed proteins become associated with empty 
capsids which accumulate in the cell nucleus. Tsl233 (whose 
mutation maps to UL33) is similarily unable to package viral 
DNA at NPT and assembles partially cored capsids but is able 
to process p40 normally (Al-Kobaisi, 1990). The p40 protein 
is found in empty capsids but appears to be present only as 
a minor component of full capsids or mature virions. It has 
been suggested therefore that p40 is only briefly associated 
with capsids at an early stage in assembly and is lost 
during packaging of the viral DNA (Rixon et a l ., 1988).
Nucleocapsids are enveloped at the inner lamella of 
the nuclear membrane; only capsids containing an approximate 
genome length are enveloped and transported to the cytoplasm 
forming mature virions (Roizman and Furlong, 1974, Vlazny et 
al., 1982; Stow et a l ., 1986). Virions are proposed to 
leave the cell via the Golgi apparatus following a pathway 
similar to that taken by secreted soluble proteins (Johnson 
and Spear, 1983).
SECTION 1C: Cis- and trans-acting requirements for HSV DNA
replication
1. cis—acting signals required for HSV DNA replication
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The existence of specific regions within the HSV 
genome which allow the initiation of DNA synthesis was first 
suggested by EM studies of replicating DNA molecules and 
analysis of the structures of defective genomes which arose 
during serial passage of HSV at high m o i .
Friedmann et a l . (1977) observed, using EM, DNA 
molecules that contained replicative loops or Y-shaped 
structures, indicative of replicative intermediates. The 
position of these structures suggested that the genome 
contained probably three specific origins of DNA 
replication.
Extension of these observations came from the study 
of defective virus genomes. These genomes do not contain 
the complete genetic information of the virus and as a 
consequence are only replicated when helper functions are 
supplied by non-defective genomes (Schroder et a l ., 1975/6). 
That defective genomes could be maintained in virus stocks 
indicated that they contained cis-acting sequences required 
for initiation of DNA synthesis and for cleavage and 
packaging of the viral DNA (Frenkel et a l ., 1975). 
Characterisation of defective genomes by restriction 
digestion and Southern blot analysis revealed that they 
consist of repeated identical copies of small segments of 
viral DNA (Wagner et a l ., 1974; Frenkel et a l ., 1976, 1980; 
Schroder et a l ., 1975/76; Graham et a l ., 1978; Locker and 
Frenkel, 1979; Kaerner et al., 1979, 1981; Denniston et al ., 
1981) . On the basis of the origin of DNA sequences within 
the repeating units, defective genomes were divided into two 
classes: class I defective genomes, containing DNA sequences 
from the short segment of the genome including the 'a' 
sequence (Denniston et a l ., 1981; Frenkel et a l ., 1980,
1981; Vlazny and Frenkel, 1981) and class II defective 
genomes, containing sequences derived from the middle of the 
long unique region as well as the 'a' sequence (Schroder et 
al., 1975/76; Kaerner et al., 1979, 1981; Frenkel et a l ., 
1980). This suggested that the HSV genome might contain two 
distinct origins of replication, one in L and the other in
S. Vlazny and Frenkel (1981) provided direct evidence that 
repeat units of class I and II defective DNAs contain 
origins of replication by demonstrating that individual 
units generated by restriction enzyme cleavage could
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replicate and regenerate tandemly repeated structures in the 
presence of helper virus.
To identify the precise sequences required for DNA 
replication, an assay was developed whereby plasmids 
containing inserts of viral DNA were transfected into tissue 
culture cells which were subsequently infected with wt HSV-1 
to provide any necessary trans-acting helper functions. The 
presence of a viral origin of replication within the plasmid 
molecule allows replication of the linked vector sequences. 
Amplification of non-HSV sequence in the plasmid could be 
detected by hybridisation of extracted DNA with labelled 
parent vector DNA. In this manner, an origin of replication 
was located within a 995 bp fragment containing only 
sequences from within Rg (Stow, 1982) . Furthermore, the 
products of plasmid replication were high molecular weight 
molecules containing tandem duplications of the plasmid DNA, 
indicative of a rolling circle mechanism of replication.
This origin has been designated ori due to its locationO
within the inverted repeats of the S component; therefore
there are two copies of oriG in the HSV genome.
The origin within class II defective genomes,
designated ori , has similiarly been mapped and originates 
Li
from near the middle of the UT component of the HSV genome
Li
(Frenkel et al., 1980; Locker et a l ., 1982). Hence, in 
total, the HSV genome contains three origins of replication.
(a) the short region origin of replication
Using a systematic deletion analysis of 
orig-containing plasmids, Stow and McMonagle (1983) 
identified a 90 bp region within the above 995 bp fragment 
from the TRg/IRg region that contained the minimum signals 
necessary for ori activity (Fig. 1.6). The minimal 
sequence lies within an untranscribed region located between 
the 5' ends of two divergently transcribed IE genes. The 
oric sequence contains several distinguishing features 
including an almost perfect palindromic sequence 45 bp long 
containing 18 consecutive A and T residues at its centre. 
Intra-strand base pairing could potentially generate a 
cruciform structure. The removal of 23 bp from the centre 
of the palindrome followed by the insertion of an 8 bp
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Figure 1.6 DNA sequence of the 90 bp HSV-1 ori„ region
&
as defined by Stow and McMonagle (1983)
The 45 bp palindrome is indicated by arrows and the 18
bp region protected from DNase I digestion by an origin
binding protein is shown as a hatched box at the left hand
end of the palindrome (Elias et al., 1986). This region
includes an 11 bp sequence (underlined) which is conserved
in HSV ori and VZV ori (Fig. 1.7 and 1.8). The limits of 
Li O
the minimal HSV-2 ori sequence as defined by Lockshon and
O
Galloway (1988) are marked on the HSV-1 orig sequence, as 
are the limits of the minimal orig sequence as defined by 
Deb and Doelberg (1988).
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Hindlll linker, resulted in the loss of ori activity,
to
demonstrating an essential role for sequences within the
palindrome for initiation of DNA replication (Stow, 1985).
An 11 bp sequence located at the left hand end of
the palindrome is conserved in HSV ori and VZV ori_ (Weller
Li S
et a l ., 1985; Stow and Davison, 1986; see Fig. 1.9 section 
ID). Interestingly, this conserved sequence lies within an 
18 bp region covering the left hand end of the palindrome 
which is protected from DNase I digestion by an HSV encoded 
origin binding protein {Elias et al ., 1986; see section 1C 
part 2 (a)}.
More recent studies carrying out deletion analysis
of orig-containing plasmids in order to define the limits of
sequence required for origin activity have presented
conflicting results. Using plasmids containing an HSV-2
ori sequence, which is highly homologous to HSV-1 orin ^ s
(Whitton and Clements, 1984b), Lockshon and Galloway (1988) 
identified a 75 bp core origin sequence containing a 
palindromic region. The limits of this core origin on the 
corresponding HSV-1 sequence are shown in Fig. 1.6. Within 
this region, HSV-1 and HSV-2 are identical in 70 out of 75 
residues. Deletion of the central AT-rich region of the 
Dalindrome abolished ori^ activity, as did replacement of AT 
bp with GC bp. When additional copies of an AT-dinucleotide 
were introduced progressively into the centre of the 
palindrome, ori activity oscillated with a periodicity of
to
approximately 10 bp (one helical turn ). In marked contrast
to these observations, Deb and Doelberg (1988) have reported
that a plasmid lacking the right arm of the palindrome was
unimpaired in its replication (Fig. 1.6).
The reason for HSV-1 possessing two copies of orig
is not known. Viable deletion mutants lacking one copy of
ori have been isolated, but attempts to generate viable 
to
deletion mutants lacking both copies of orig have so far 
proved unsuccessful (Longnecker and Roizman, 1986; Smith e_t 
al., 1989). This suggests that at least one copy of orig 
may be essential for viral replication. In the case of HSV-2 
strain HG52, the genome contains four copies of orig due to 
a tandem duplication of a 137 bp element in the TRg and IRg
regions (Whitton and Clements, 1984b).
Despite the location of orig between divergently
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transcribed genes, there is no direct evidence for the 
promoter or regulatory elements of these genes having any 
effect on o r i a c t i v i t y  or vice versa. In identifying the 
minimal otig functional region, sequences outwith the core 
origin sequence appeared to have some enhancing effect on 
origin activity but determination of the actual sequences 
involved has yet to be carried out (Stow, 1982; Stow and 
McMonagle, 1983; Lockshon and Galloway, 1988). A transcript 
in HSV-infected cells has been identified that extends 
through the ori^, sequence (Hubenthal-Voss et al., 1987; 
Hubenthal-Voss and Roizman, 1988) although the 5 1 and 3 1 
ends of the transcript are not located within sequences 
which affect orig function. The role of this transcript (if 
any) in regulation of DNA replication has yet to be 
determined.
(b) the long region origin of replication
Early attempts to analyse the HSV origin of 
replication in class II defective genomes were hampered due 
to the tendency of this region to suffer deletions when 
cloned into E.coli vectors (Spaete and Frenkel, 1982; Weller 
et a l ., 1985). Plasmids containing such deletions could 
produce defective genomes when transfected into cells along 
with HSV-1 DNA, but only following restoration of the 
deleted region by recombination with the helper HSV-1 DNA 
(Spaete and Frenkel, 1982). This suggested that the deleted 
region contained the origin of replication, designated ori .ij
The first ori sequence to be determined was from a 
Li
class II defective DNA of HSV-I strain Angelotti. Gray and 
Kaerner (1984) sequenced a 296 bp fragment of virion DNA 
which was prone to deletions when cloned in E.coli.
Subsequent studies by Weller et a l . (1985) and Quinn and
McGeoch (1985) reoorted the sequence of an undeleted ori
+ L 
from strains KOS and 17syn . Weller et a l . (1985)
successfully cloned the 425 bp deletion-prone region of the
non-defective HSV-1 strain KOS into a yeast vector in an
undeleted form. Using the plasmid amplification assay
developed by Stow and McMonagle (1983) this sequence was
shown to exhibit origin activity.
The ori sequence of HSV-1 lies between two 
Li
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divergently transcribed genes encoding the major DNA binding 
protein (LJL29) and the DNA polymerase (UL30), notably both 
components of the DNA replication machinery, suggesting a 
possible relationship between ori activity andJ-j
transcriptional activity.
The ori^ region of KOS and 17syn+ contains a 144
bp perfect palindrome, the probable reason for the cloning
instability. As with orig, the oriL sequence contains an
AT-rich region at the centre of the palindrome (Fig. 1.7).
The entire orig palindrome is highly homologous to the
central region of the ori palindrome (85% identical
Li
residues) and sequence homology extends about 40 bp to the
left of the oric palindrome. The oriT of HSV-2 has been O Li
functionally localised to a 241 bp fragment from a region
homologous to that containing HSV-1 ori_. Sequencing of the
Lj
HSV-2 ori has identified a 136 bp, almost perfect,
Li
palindrome which shows 88% identity to HSV-1 oriT (Lockshon
Li
and Galloway, 1986). The original ori sequence determined
Li
by Gray and Kaerner (1984) consisted of two large tandemly
repeated palindromic regions and is not therefore the
simplest form of sequence associated with ori .
Li
The limits of the minimal ori^ sequence required
for origin activity have not been determined. By comparison
with studies carried out with ori„ and from the striking
sequence similarity between both origins, it is likely that
the limits lie within the 72 bp arms of the palindrome. Due
to the nature of the palindrome, the 11 bp conserved
sequence, located at the left hand end of the orig
palindrome, is present twice within the ori^ palindrome.
The isolation of a viable deletion mutant lacking
150 bp of ori demonstrates that this origin is dispensible 
Li
for virus replication and moreover, the closely related 
alphaherpesvirus, VZV, which contains two copies of orig, 
does not appear to have an equivalent of ori^ (Davison and 
Scott, 1986; Stow and Davison, 1986; Polvino-Bodnar et a l .,
1987) .
2. Genetics of HSV DNA replication
Three complementary approaches have been used to
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Figure 1.7 Comparsion of the DNA sequence of HSV-1 ori„
O
and HSV-1 oriT .
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The location of the HSV-1 ori0 and oriT are marked onb -Li
the schematic diagram of the HSV-1 genome and the sequence 
from these regions is shown below. Solid bars represent 
conserved bases. Arrowed dashed lines above the ori^ 
sequence represent the limits of the 144 bp perfect 
palindrome and the arrowed dotted lines below the orig 
sequence represent the limits of the minimal orig region as 
defined by Stow and McMonagle (1983). The limits of the 
oric palindrome are marked by dots.
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identify the trans-acting viral gene products involved in 
the replication of HSV DNA.
Approximately 10 complementation groups of ts 
mutants have been characterised and designated defective for 
DNA synthesis at NPT. Some of these mutations map to genes 
encoding IE regulatory proteins (Preston, 1979; Dixon and 
Schaffer, 1980). Since the transcription of early genes 
depends on prior expression of one or more IE genes, IE 
polypeptides are likely to have an indirect role in DNA 
replication. However, complementation groups of mutants 
have been identified with lesions in each of the seven genes 
encoding products directly involved in DNA replication (see 
below).
The second approach has involved the biochemical 
analysis of cell-free extracts from infected cells for 
enzyme activities, which, by analogy with more extensively 
characterised replication systems, may have a role in DNA 
replication. The biochemical activities presently 
identified include a viral DNA polymerase (Keir and Gold, 
1963; Hay et a l ., 1971), a single-stranded major DNA binding 
protein (Bayliss et al ., 1975; Purifoy and Powell, 1976), an 
origin-specific DNA binding protein (Elias et a l ., 1986), 
helicase-primase activity (Crute et a l ., 1989), thymidine 
kinase (Kit and Dubbs, 1963), ribonucleotide reductase 
(Cohen, 1972), an exonuclease (Hay et al., 1971; Morrison 
and Keir, 1968) , uracil-DNA glycosylase (Caradonna and 
Cheng, 1981), deoxyuridine triphosphate nucleotidyl 
hydrolase (Wohlrab et al ., 1982) and protein kinase 
activities (Blue and Stobbs, 1981; Purves et al ., 1987).
Some DNA negative ts mutants have been shown to specify 
thermolabile forms of some of these enzymes e.g. DNA 
polymerase (Purifoy and Powell, 1981), single-stranded major 
DNA binding protein (Lee and Knipe,1983; Ruyechan et a l .,
1986), ribonucleotide reductase (Preston et al., 1984) and 
the exonuclease (Moss, 1986).
The complete set of viral genes required for DNA 
replication has now apparently been identified using a third 
approach based on the transient replication of transfected 
plasmid DNA containing an HSV origin of replication. When 
purified HSV DNA is transfected into tissue culture cells, 
viral genes are expressed which provide nec essary
35
trans-acting functions required to amplify an 
orig-containing plasmid concurrently transfected into the 
cells. Challberg (1986) constructed a set of five plasmids 
containing Xbal fragments, which between them contained most 
of the HSV-1 genome, and found that these plasmids behaved 
similarly to intact viral DNA in supporting amplification of 
an orig-containing plasmid.
Following systematic subcloning, deletion analysis 
and inactivation by restriction enzyme digestion, and in 
conjunction with the HSV-1 sequence data, a set of seven 
genes was identified, which were necessary and sufficient 
for plasmid amplification (Wu et a l ., 1988). In addition, 
three other genes were identified which stimulated 
amplification, namely the IE proteins Vmwl75, 110 and 63 and 
these were therefore proposed to have an indirect role in 
DNA replication. The identification of seven genes, 
essential for DNA synthesis (UL5, UL8 , UL9, UL29, UL30, UL42 
and UL52) correlates well with the mapping data of the DNA 
negative t_s mutants. Ts defects in these seven genes all 
lead to a DNA negative phenotype (Purifoy et a l ., 1977;
Dixon and Schaffer, 1980; Chartrand et a l ., 1980; Purifoy 
and Powell, 1981; Conley et a l ., 1981; Weller et al ., 1983; 
Littler et a l ., 1983; Coen et a l ., 1984; Weller et al.,
1987; Zhu and Weller, 1988; Marchetti et a l ., 1988). The 
location of the genes are shown in Fig. 1.3 and the 
predicted molecular weights of the products are shown in 
Table 1.1. In addition, deletion and insertion mutants have 
been characterised which map to the UL8 , UL9 and UL52 genes 
and verify their essential nature. These host range (hr) 
mutants only replicate in cell lines expressing the 
corresponding wt gene product (Carmichael et al., 1988; 
Goldstein and Weller, 1988a; Carmichael and Weller, 1989).
Our knowledge of the functions of the products of 
these seven genes varies considerably. Three of the genes 
encode the previously well-characterised viral DNA 
polymerase (UL30), the single-stranded major DNA binding 
protein (mDBP; UL29) and the 65-kD double-stranded DNA 
binding protein (65-kD DBP) whereas the products of the 
other four genes were, until recently, unknown.
The high degree of correlation between genes 
required for DNA synthesis in the transient system and genes
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identified by genetic studies to be essential for viral DNA 
replication would indicate that the major genetic 
requirements have now been identified. However, it remains 
possible that certain functions important for replication of 
intact viral genomes may not have been detected using the 
transient plasmid replication assay (e.g. circularisation, 
sealing of nicks). The remainder of this section will 
outline the information that is available on the functions 
of the genes whose products are essential or may play an 
indirect role in HSV DNA synthesis.
(a) genes essential for HSV DNA replication
UL30 - viral DNA polymerase
The induction of a novel DNA polymerase in extracts 
of HSV-infected cells was first described by Keir and Gold 
(1963). This activity is distinguishable from cellular DNA 
polymerases on the basis of biochemical characteristies such 
as sensitivity to inhibitors, salt concentration required 
for maximal activity and also by immunological criteria 
(Keir et a l ., 1966; Weissbach et al., 1973; Powell and 
Purifoy, 1977; O'Donnell et al . , 1987a). Studies of HSV t_s 
mutants and drug-resistant mutants have demonstrated that 
this enzyme is virally encoded. Several jfcs mutants with 
lesions in the polymerase gene (pol) have been characterised 
and fail to synthesis viral DNA at NPT (Purifoy et al .,
1977; Dixon and Schaffer, 1980; Chartrand et al ., 1980; Coen 
et a l ., 1984). The protein has been purified and has an 
apparent molecular weight around 140,000 (Powell and 
Purifoy, 1977; Knopf, 1979; O'Donnell et al ., 1987a) which 
is in close agreement with the predicted molecular weight of 
136,000 based on sequence analysis of the pol gene (Gibbs et 
al., 1985; Quinn and McGeoch, 1985). In common with other 
DNA polymerases, the HSV polymerase has an intrinsic 3'-5' 
exonuclease activity that would appear to provide a 
proofreading function to increase fidelity of replication 
(Knopf, 1979; Powell and Purifoy, 1977; O'Donnell et_al., 
1987a). Crute and Lehman (1989) have recently demonstrated 
that the pol gene product also contains an intrinsic 
ribonuclease H activity that specifically degrades RNA/DNA 
heteroduplexes or duplex DNA substrates in the 5'-3'
direction. This activity is analogous to the 5 1—3 1 
exonuclease associated with E.coli DNA polymerase I which is 
required for DNA repair and removal of RNA primers 
(Kornberg, 1980 ) .
A purified preparation of the HSV DNA polymerase is 
catalytically active on simple primer-templates and is 
highly processive in the absence of accessory factors, 
although the addition of single-stranded DNA binding protein 
of E.coli greatly stimulates the rate of synthesis on primed 
single-stranded DNA templates (O'Donnell et al., 1987a).
The polymerase has also been expressed in yeast (Haffey et 
a l ., 1988) and by in vitro transcription/translation (Dorsky 
and Crumpacker, 1988). In both cases, the enzyme is 
catalytically active and is therefore functional in the 
absence of any accessory factors. However, other virus 
encoded polypeptides may be required to increase the
efficiency or modify the activity of the polymerase. The
polymerase of HSV-2 has been shown to co-purify with a 55-kD 
polypeptide, known to be encoded by the UL42 gene and it is
now generally considered that the holoenzyme is a
heterodimer containing UL30 and UL42 subunits (Vaughan et 
a l ., 1984; Parris et a l ., 1988; see below).
The HSV DNA polymerase activity can be blocked by 
the action of several antiviral drugs, namely 
deoxyribonucleotide and pyrophosphate analogues . 
Drug-resistant mutants have been isolated (Hay and 
Subak-Sharpe, 1976; Crumpacker et a l ., 1980; Coen et a l ., 
1982; Honess et a l ., 1984) which, through characterisation 
of their mutations have identified a region within the 
carboxy terminal portion of the enzyme involved in 
interactions with deoxyribonucleotide triphosphates. This 
region is highly conserved in other herpesvirus polymerases 
as well as some eukaryotic and prokaryotic enzymes (Gibbs et 
al., 1985; Larder et al., 1987; Gibbs et a l ., 1988; Wong et 
al., 1988).
UL29 - the major single-stranded DNA binding protein
Next to the polymerase, the best characterised 
protein required for HSV DNA replication is the major 
single-stranded DNA binding protein (mDBP; ICP8 ). This 
species was identified as an abundant HSV induced protein
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with a molecular weight of around 130,000, which was present 
in HSV-infected cells but not virions (Honess and Roizman, 
1973; Powell and Courtney, 1975). Ts mutants with amino 
acid substitutions in the gene for the DNA binding protein 
(dbp) fail to synthesise viral DNA at NPT indicating that 
the protein is essential for HSV DNA replication (Conley et 
al., 1981; Weller et a l ., 1983; Littler et a l ., 1983).
Mapping of the ts lesions and analysis of the
properties of mutated polypeptides has allowed the 
identification of distinct functional domains within the 
polypeptide. Some mutants produce proteins that are 
defective in nuclear localisation while others are unable to 
bind DNA (Lee and Knipe, 1983; Leinbach et al ., 1984;
Quinlan et a l ., 1984; de Bruyn-Kops and Knipe, 1988; Gao et
al ., 1988; Gao and Knipe, 1989). The DNA binding domain 
appears to be located within the carboxy terminal region 
(Leinbach and Heath, 1988) although some of the amino acid 
residues between positions 346 and 450 also play some role 
in DNA binding, perhaps by stabilizing the single-stranded 
DNA (ssDNA) binding site in the carboxy terminus or by 
forming intermolecular contacts required for cooperative DNA 
binding (Gao et al ., 1988).
Other dbp mutants have also been shown to display 
altered sensitivity to drugs that inhibit the viral DNA 
polymerase suggesting some interaction between the 
polymerase and the mDBP (Chiou et a l ., 1985). In addition, 
some dbp ts mutants over-express certain late genes at NPT 
suggesting a role for the protein in transcriptional 
regulation (Godowski and Knipe, 1985, 1986). Interestingly, 
the mDBP has moderate affinity for binding to 
polyriboadenylic acid suggesting that the protein may 
possibly influence gene expression at the post 
transcriptional level by binding to the poly(A) tail of mRNA 
transcripts (Ruyechan and Weir, 1984). As the mDBP protein 
binds tightly to single-stranded DNA cellulose columns 
(Bayliss et a l . , 1975 ; Purifoy and Powell, 1976; Powell et 
al ., 1981; Knipe et al., 1982; Ruyechan, 1983) it has been 
postulated that the protein is analogous to the gene 32 
protein of bacteriophage T4 and the single-stranded oinding
protein (SSB) of E .coli. These proteins bind to 
single-stranded DNA at the replication fork and stabilise
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the strands for use as templates by the DNA polymerase. In 
support of this, mDBP binds more tightly to single-stranded 
than double-stranded DNA (Ruyechan, 1983; O'Donnell et al., 
1987b) and binding activity is cooperative and 
sequence-independent (Ruyechan, 1983). The mDBP has a small 
stimulatory effect on HSV polymerase activity (Ruyechan and 
Weir, 1984) , and can reduce the melting temperature of 
duplex DNA in vitro (Powell et al ., 1981).
Using monoclonal antibodies against mDBP, the 
location of the protein throughout the viral replicative 
cycle has been examined (Showalter et a l ., 1981; Knipe and 
Spang, 1982; Quinlan and Knipe, 1983; Quinlan et a l ., 1984; 
de Bruyn-Kops and Knipe, 1988). The intracellular 
distribution of mDBP in infected cells is dependent on the 
status of viral DNA replication (Quinlan et al ., 1984).
When replication occurs, the protein accumulates in large, 
globular replication compartments in association with viral 
DNA. When replication is blocked either chemically, or by 
the use of pol ts mutants, mDBP is found at numerous foci 
called pre-replicative sites in association with a nuclear 
protein framework. On lifting the replicative block, the 
protein redistributes itself back to replicative 
compartments (Quinlan et a l ., 1984). Hence, the protein may 
possibly play some role in organising cellular and viral 
components into structures related to HSV DNA replication 
(de Bruyn-Kops and Knipe, 1988). Finally, Matsumoto et al.
(1987) noted that the amino terminal 1/5 of mDBP shares some 
sequence similarity with rat proliferating cell nuclear 
antigen (PCNA). PCNA (also called cyclin or DNA polymerase 
delta auxiliary protein) is a highly conserved protein whose 
intranuclear distribution is regulated by cellular DNA 
replication and which is also required for stimulation of 
DNA polymerase delta (Bravo and MacDonald-Bravo, 1985).
UL42 - double-stranded DNA binding protein
The HSV-1 double-stranded DNA binding protein 
(dsDBP), of apparent molecular weight 65,000, is the 
counterpart of the HSV-2 55-kD polypeptide (described above) 
which co—purifies with the product of the polymerase gene 
(Vaughan et a l ., 1984). This polypeptide is encoded by the 
UL42 gene (Parris et al., 1988) and is therefore distinct
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from the 65-kD virion trans-inducing factor (Marsden et al.,
1987). Immunoaffinity purification of the UL42 protein has 
shown that there is a close association between it and the 
polymerase but the strong non-sequence specific DNA binding 
activity is an intrinsic property of the UL42 gene and is 
not due to its interaction with polymerase (Gallo et al.,
1988) .
The role of dsDBP in DNA synthesis is not 
completely resolved. As stated earlier, the protein is not 
required for HSV DNA polymerase activity. Gallo et al. 
(1989) have however demonstrated that purified dsDBP can 
specifically stimulate the activity of purified HSV DNA 
polymerase up to 10-fold. The ability of a monoclonal 
antibody to dsDBP to remove the stimulatory activity from a 
dsDBP preparation indicates this protein does act as a 
polymerase accessory factor although the mechanism for 
stimulation remains to be determined. Under appropriate 
assay conditions, the processivity of purified polymerase on 
ss primer-template molecules is enhanced by addition of 
purified UL42 product (M. Challberg, personal 
communication). It thus seems probable that the in vivo 
polymerase is a heterodimer consisting of the UL30 and UL42 
subunits.
UL5, UL8 , UL9 and UL52
The products of the four remaining DNA replication 
genes, UL5, UL8, UL9 and UL52 had (until 1988) not been 
identified amongst the proteins of infected cells suggesting 
that they were present at low abundance. Identification of 
these products depended upon their cloning into expression 
vectors (Olivo et a l ., 1988, 1989; Calder and Stow, 
maunscript submitted for publication).
By analogy with other replication systems, a 
number of possible functions for these proteins can be 
postulated, such as origin recognition, primer synthesis and 
degradation, unwinding of duplex DNA, polymerase accessory 
factors and topoisomerases. A recent report by Olivo et a l .
(1988) and the results presented in this thesis have 
identified the UL9 gene as encoding the origin binding 
activity initially detected by Elias et a l . (1986). This 
work will be described and discussed in detail in sections 3
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and 4. Analysis of the predicted amino acid sequence of the 
four proteins has suggested that UL5 and UL9 contain purine 
NTP-binding sites of the type found in many helicases 
(Hodgeman, 1988; McGeoch et al ., 1988; Gorbalenya et a l ., 
1989; Gorbalenya and Koonin, 1989).
Infection of cells with HSV has been shown to 
induce novel helicase and primase activities (Crute et al ., 
1988; Holmes et a l ., 1988; Crute et a l ., 1989). The primase 
activity detected by Holmes et a l . (19 88) now however 
appears to be an RNA polymerase activity released from Vero 
cell mitochondria upon infection by HSV-1 (Tsurumi and 
Lehman, 1990). The helicase activity (Crute et al., 1988) 
has been purified to homogeneity (Crute et a l ., 1989) and 
additionally contains a tightly associated DNA primase. Both 
activities are components of a three-subunit enzyme composed 
of the products of UL5, UL8 and UL52. The helicase can use 
either ATP or GTP as a cofactor in displacing an 
oligonucleotide annealed to Ml3 single-stranded DNA. 
Experiments with model substrates suggest that the polarity 
of unwinding is 5'-3' relative to the Ml3 DNA, thus, the 
enzyme may prime lagging strand synthesis as it unwinds DNA 
at the replication fork. As yet, the helicase and primase 
activities have not been assigned to individual gene 
products although recent studies in our laboratory have 
shown that helicase activity can be obtained with a 
combination of the UL5 and UL52 proteins (Calder and Stow, 
manuscript submitted for publication).
(b) genes indirectly involved in HSV DNA replication
Apart from the trans-activating roles of the IE 
gene products, several HSV encoded enzymes may also 
indirectly influence viral DNA replication by modifying 
nucleic acid metabolism. There are two HSV-specified 
enzymes which catalyse reactions in the biosynthesis of DNA 
precursors : thymidine kinase (TK) and ribonucleotide 
reductase (RR). TK, first described by Kit and Dubbs 
(1963), phosphorylates, in addition to thymidine, 
deoxycytidine (Jamieson and Subak-Sharpe, 1974) and 
thymidylate (Chen and Prusoff, 1978), and uses nucleoside 
triphosphates, usually ATP, as a phosphate donor. Thus., the
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enzyme possesses both pyrimidine deoxyribonucleoside kinase 
and thymidylate kinase activity. However, exogenously added 
deoxycytidine fails to be incorporated into DNA suggesting 
that reduction of CDP, rather than phosphorylation of dCMP 
is the major route of dCDP and therefore dCTP synthesis 
(Jamieson and Subak-Sharpe, 1976). Studies of TK negative 
mutants have shown that TK (encoded by UL2 3) is not 
essential for virus growth in dividing cells but is required 
in serum-starved cells (Jamieson et a l ., 1974). TK is not 
essential for the establishment of a latent infection in 
mice, but may have some role in either reactivation or virus 
replication following reactivation (Efstathiou et al.,
1989) .
Ribonucleotide reductase catalyses the reduction of 
ribonucleoside diphosphates to their corresponding 
deoxyribonucleoside diphosphates and is essential for the 
replication of DNA in prokaryotic and eukaryotic cells. HSV 
RR differs from its cellular counterpart in that it is 
insensitive to inhibition by TTP (Cohen, 1972; Dutia, 1983). 
The enzyme is composed of large, (RR^), and small, (RR^), 
subunits encoded by contiguous genes, UL39 and UL40 
respectively (Preston et al., 1984; Bacchetti et al., 1984; 
Frame et a l ., 1985; McLauchlan and Clements, 1983). 
Interaction of the subunits is essential for enzyme 
activity. A synthetic oligopeptide corresponding to the 
carboxy terminus of RR2 specifically inhibits the viral 
enzyme by interfering with the subunit interaction (Frame et 
al., 1985; Cohen et al., 1986; Dutia et a l ., 1986). 
Contrasting evidence has been presented for the requirement 
of HSV RR for growth in tissue culture cells. Goldstein and 
Weller (1988b) have shown, using an insertion mutant in RR^, 
that the enzyme is dispensible for growth in actively 
dividing cells whereas a ts mutant, t_sl207, which contains a 
lesion in RR^, exhibited decreased virus yields at NPT 
(Preston et al ., 1984). However, characterisation of another 
mutant, ts!222 has indicated that, as with TK, RR is 
essential for the replication of HSV in tissue culture cells 
under certain conditions. These conditions include 
non-dividing, serum-starved cells and actively dividing 
cells at 39.5°C (Preston et al., 1988). The dependence of 
these mutants on the state of the cell for their replication
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probably reflects the requirement for cellular RR to 
compensate for the loss of the virus encoded enzyme.
HSV also encodes a deoxyuridine-51-triphosphate 
nucleotidyl hydrolase, or dUTPase, which catalyses the 
conversion of dUTP to dUMP and pyrophosphate (Wohlrab and 
Francke, 1980; Preston and Fisher, 1984). The enzyme 
(encoded by UL50) more likely functions to minimise the 
incorporation of uracil into nascent DNA rather than provide 
dUMP for TTP synthesis. The gene is dispensible for growth 
in tissue culture (Fisher and Preston, 1986).
Caradonna and Cheng (1981) reported the induction 
of a uracil-DNA glycosylase activity in HSV-infected cells. 
It seems likely that the role of this enzyme is the removal 
of uracil residues created by deamination of cytosine in DNA 
rather than uracil residues directly incorporated into the 
DNA. This enzyme is encoded by UL2 and is dispensible for 
growth in tissue culture (Mullaney et a l ., 1989).
The HSV exonuclease was first described by Keir and 
Gold (1963) as an increased alkaline nuclease activity in 
infected cells. The enzyme, encoded by UL12, has 5 1 and 3' 
exonuclease activities and an endonuclease function 
(Morrison and Keir, 1968; Hoffman and Cheng, 1979; Hoffman, 
1981). Studies with _ts mutants have produced conflicting 
results with regard to the requirement of the exonuclease 
for virus growth and DNA synthesis (Moss et a l ., 1979; 
Francke and Garret, 1982; Moss, 1986). More definitive 
experiments using an insertion mutant in the UL12 gene, have 
confirmed that the alkaline nuclease is required for virus 
replication in tissue culture. This mutant is unimpaired in 
viral DNA synthesis but exhibits a defect in the production 
of infectious virus particles. This suggests a possible 
role for the exonuclease post DNA replication (Weller et al. 
unpublished data).
A novel HSV-induced topoisomerase activity has been 
detected in HSV-infected cells and virions (Biswal et al ., 
1983; Leary and Francke, 1984; Muller et a l ., 1985). Muller 
et a l . (1985) suggested that the topoisomerase was of type I 
activity i.e. produces transient single-strand breaks in the 
DNA, and was a component of the viral envelope or tegument 
structure, whereas Biswal et a l . (1983) have reported their 
activity as copurifying with the DNA polymerase. Whether
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this enzyme is virus encoded remains to be determined.
Finally, a protein kinase (PK) activity is induced 
after HSV-1 infection of cultured cells (Blue and Stobbs, 
1981) which could possibly be involved in the modification 
of replication proteins. The HSV US3 gene was first 
identified as a putative PK gene based on amino acid 
sequence similarity to known eukaryotic PKs (McGeoch and 
Davison, 1986). Biochemical and genetic studies have 
demonstrated that a virus-induced PK is encoded by US3 and 
that the activity is not essential for virus growth in 
tissue culture (Frame et a l ., 1987; Purves et a l ., 1987). 
Recently, a second protein kinase function has been 
suggested for UL13 (Smith and Smith, 1989). The substrates 
for these enzymes are not yet known.
SECTION ID: DNA replication in other human herpesviruses
1. VZV DNA replication
Comparisons of the VZV DNA sequence with that of 
the closely related herpes simplex virus type 1 have 
significantly extended our knowledge of the proteins 
involved and possible mechanism adopted by VZV in 
replicating its DNA. The relative scarcity of information 
on the molecular biology of VZV is due primarily to the 
growth characteristics of the virus. VZV has a restricted 
host range in vitro and is highly cell-associated. It is 
difficult to obtain a cell-free virus of reasonable titre 
and few VZV mutants have been isolated. Despite the 
considerable difference in G+C content between VZV and HSV 
(46% and 68% respectively) molecular hybridisation and DNA 
sequence studies have shown that these two viruses exhibit 
similar gene arrangements and hence have allowed functions 
to be provisionally assigned to VZV genes products which are 
homologous to HSV-1 counterparts (Davison and Wilkie, 1983; 
McGeoch, 1984; Davison and McGeoch, 1986; Table 1.1).
The model for VZV DNA replication is basically 
identical to that proposed for HSV. The virus circularises 
after entry into the cell by ligation of the termini. VZV
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does not possess a terminal direct repeat equivalent to the 
'a' sequence of HSV-1 therefore circularisation of the viral 
genome on entering the cell is most likely to take place via 
direct ligation of the termini to produce a novel L-S joint 
identical in sequence to the normal L-S joint. Due to the 
low frequency of inversion of UT compared to Uc , replicated
li O
viral DNA predominantly contains two isomers representing a
single orientation of UT .
Li
From DNA sequence studies, an origin of replication 
was predicted in the TR^/IR^ region (Davison and Scott,
1985) which contained a 46 bp palindrome similar in size and 
location to ori^ of HSV (Stow and McMonagle, 1983). A 259 
bp fragment of VZV DNA containing the palindrome was 
subsequently shown to function as an origin of replication 
and deletions within the palindrome affected replicative 
ability (Stow and Davison, 1986).
A comparison of HSV-1 ori and VZV ori^ sequence is
O *3
shown in Fig. 1.8. The palindromes are of similar length
although the AT-rich region of VZV is approximately twice as
long as HSV. To the left of the VZV palindrome is an 11 bp
sequence identical to a sequence found in ori and ori of
O -Li
HSV-1 and HSV-2 and which is part of the 18 bp sequence
protected from DNase I digestion by an HSV-1 induced
origin-binding protein (Elias et a l ., 1986). Unlike HSV, in
which the 11 bp sequence lies partly inside the palindrome,
in VZV the sequence lies completely outwith this region.
The observation by Stow and Davison (1986), that plasmids
containing VZV oriQ were able to replicate in the presence
of superinfecting HSV-1 with approximately 5% the efficiency
of an HSV-1 ori^-containing plasmid, is consistent with the 
o
conserved 11 bp region forming part of a sequence involved 
in origin recognition. Results and discussion presented in 
this thesis will expand upon this point.
Although VZV contains an origin of replication 
equivalent in position to that of HSV-1 °rig/ no origin is 
present in the region corresponding to HSV-1 ori^. The 
cloned VZV Kpnl s fragment which includes the intergenic 
region between the pol and dbp genes and which is inactive 
in replication assays was shown not to have undergone any 
deletion, thereby excluding the possibility that the viral 
genome contains a deletion prone origin (like HSV-1 oriL ) at
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Figure 1.8 Comparison of the DNA sequences within HSV 
and VZV ori .^
The sequences shown are: HSV-1 ori , nucleotides 568 toO
642 of the sequence of Stow and McMonagle (1983) and VZV 
oric, nucleotides 5590 to 5662 of the sequence of Davison 
and Scott (1985).
The limits of the palindromes are shown by arrows and 
conserved regions are marked by solid bars.
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this locus (Stow and Davison, 1986).
The ability of HSV to stimulate replication of a 
VZV orig-containing plasmid suggests similarities in the 
function of viral encoded polypeptides in initiation of DNA 
replication. VZV homologues of all seven HSV genes 
essential for DNA synthesis have been recognised (Table 
1.1) .
VZV also encodes a thymidylate synthetase (TS), not 
found in HSV, whose existence was predicted from DNA 
sequence analysis (Thompson et a l ., 1987). TS catalyses the 
reductive methylation of deoxyuridylate to thymidylate and 
is encoded by VZV gene 13. The function of TS was confirmed 
by expressing the polypeptide in an E.coli mutant from which 
the bacterial TS gene had been deleted. The only VZV 
replicative activities so far described are the polymerase, 
exonuclease and several DNA binding proteins.
2. EBV DNA replication
The 172kbp genome of the gammaherpesvirus, 
Epstein-Barr virus is maintained as an extrachromosomal 
multicopy (usually 1 to 10 copies per cell) supercoiled 
plasmid in tumour cells from Burkitt's lymphoma and 
nasopharyngeal carcinoma biopsies. These multiple copies 
arise soon after infection by amplification of the viral DNA 
relative to cell DNA (Sudgen et a l ., 1979). Latent 
infections, characterised by limited viral gene expression 
and faithful replication of the EBV episome once (and only 
once) per cell cycle, can be established in primary 
lymphocytes immortalised in vitro. Such transformed cell 
lines have been extensively used to identify EBV functions 
involved in DNA replication. In addition to the latent 
(maintenance) phase during which viral genome replication is 
tightly coupled to that of the cell, lytic replication of 
EBV can occur under certain conditions and is characterised 
by multiple rounds of DNA synthesis within the infected 
cell. Recent experiments have shown tnat separate origins 
of DNA reolication are utilised during the latent and lytic 
phases.
To mao the sequences required for maintenance,

Figure 1.9 Structure of the EBV origin of replication,
oriP, and location of EBNA-1 binding sites
A schematic diagram of the EBV genome is shown with an 
expanded region below showing oriP and three distinct loci 
(regions 1, 2 and 3) which contain EBNA-1 binding sites.
At the left of oriP (region 1) is a 20 member family of 
tandemly repeated sequences. This family consists of 17 
imperfect copies and three truncated copies of a 30 bp 
sequence. The 30 bp EBNA-1 consensus sequence, shown below 
this region, contains a central 12 bp palindrome 
(underlined) followed by a 12 bp region containing a 4 bp 
direct repeat, AGAT. separated by two bp (shaded block).
At the right of oriP (region 2) are four truncated 
copies of the 30 bp sequence described above (located in 
marked boxes). Two of the blocks of repeats plus additional 
flanking sequences make up a 6 5 bp region of dyad symmetry 
(marked by arrows above the sequence). Region 3 contains 
two EBNA-1 binding sites which lie in the EBNA-1 coding 
region. The base pair coordinates are from Baer et al.
(1984).
47
plasmids containing fragments of the EBV genome and a 
selectable marker were transfected into EBV transformed 
cells to determine the region of the genome which 
facilitates autonomous replication of the input plasmid. In 
this manner, Yates et al. (1984) identified a cis-acting 1.8 
kbp element, oriP (origin of plasmid replication), within 
the Ug region of the genome which confers stable plasmid 
maintenance during latent infections and did not allow 
runaway replication under conditions where lytic EBV DNA 
synthesis was induced (Yates and Camiolo, 1988). Further 
analysis of this region identified two non-contiguous 
sequences which were essential for activity; a region of 
approximately 20 tandem, imperfect copies of a 30 bp 
sequence (region 1; Fig. 1.9) and a second sequence of 114 
bp approximately 1 kbp downstream, which contains a 65 bp 
region of dyad symmetry composed of 4 related copies of the 
30 bp sequence (Reisman et al ., 1985; region 2 Fig. 1.9 ). 
Since oriP dependent replication required the presence of 
the EBV genome in tranfected cells, it was postulated that 
replication from oriP required trans-acting products encoded 
by the EBV genome (Yates et al ., 1984).
To map the gene(s) encoding the trans-acting 
function(s), cells containing individual overlapping 
segments of the EBV genome were transfected with plasmids 
containing oriP and a selectable marker. The EBV 
BamHI-Z/Sall-P fragment encoding the 80-kD viral nuclear 
antigen, EBNA-1, was the sole requirement for plasmid 
maintenance; the DNA polymerase and other components of the 
replicative machinery are presumably supplied by the cell 
(Yates et a l . , 1985; Lupton and Levine, 1985). Not 
surprisingly, EBNA-1 is a member of a family of genes 
(EBNA-1 to 6 ) which are normally expressed during latent 
infection. No counterparts to these genes have been 
identified in HSV or VZV (Sample et al . , 1986; Speck and 
Strominger, 1985; McGeoch, 1989).
Using filter binding and DNase I footprinting 
assays, Rawlins et al. (1985) demonstrated that the carboxy
terminal domain of the EBNA-1 protein could specifically 
bind to three loci in the EBV genome. Two of these loci 
corresponded to essential elements within oriP. The third 
site within the BamHI-Q fragment (region 3; Fig. 1.9)
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contained two tandem copies homologous to the tandem repeat 
units found in regions 1 and 2. The EBNA-1 protein bound to 
each of the 20 tandem repeats in regions 1 and 2 protecting 
a 25 bp region containing a 12 bp palindromic consensus 
sequence, TAGCATATGCTA (Kimball et a l ., 1989; Fig. 1.9). A 
later report demonstrated that tandem copies of the dyad 
symmetry region alone (region 2 ) could cooperatively 
activate replication suggesting that region 2 contains the 
actual minimal origin of replication in latently infected 
cells (Wysokenski and Yates, 1989). Indeed, experiments 
using a gel electrophoresis technique developed by Brewer 
and Fangman (1987) to study replicative intermediates, 
indicated that the site of initiation of DNA replication 
within oriP is at, or very near the dyad symmetry element in 
region 2 while the direct repeats in region 1 contain a 
replication fork barrier and termination site. Hence, 
replication from oriP appears to proceed in a predominantly 
unidirectional manner (Gahn and Schildkraut, 1989).
Studies using purified EBNA-1 and either monomeric 
or multimeric region 1 consensus binding sites have 
indicated that cooperative interactions between binding 
sites have little impact on EBNA-1 binding to region 1 
(Kimball et a l ., 1989). Conflictingly, another report 
suggests that a minimum of seven EBNA-1 binding sites are 
required to activate oriP efficiently through a highly 
cooperative process (Wysokenski and Yates, 1989).
EBNA-1 has different affinities for binding to the 
three naturally occurring loci, with region 1 having the 
highest affinity and region 3 the lowest. The increased 
affinity of region 1 over region 2 is greater than would be 
predicted from the number of individual binding sites in 
each locus (Jones et al., 1989). Based on these findings, a 
'sink and origin' model has been proposed in which the 
initiation of plasmid replication is controlled by the 
interaction of EBNA-1 with region 2 in oriP (Rawlins et a l ., 
1985) . The amount of EBNA-1 available for initiation of DNA 
replication might then be regulated by sequestration of 
protein at region 1 (the sink). iMoreover, since 
overproduction of EBNA-1 could potentially result in 
increased initiation of plasmid DNA replication and loss of 
synchrony with cell division, it seems likely that EBNA-1
49
synthesis is itself strictly controlled. The EBNA-1 primary 
transcript passes through region 3 and it is possible that 
EBNA-1 binding to this site might negatively regulate its 
own transcription. Occupation of region 3 (the weakest 
binding region) would occur when EBNA-1 protein 
concentration increased beyond that necessary to saturate 
regions 1 and 2 (Jones et al., 1989).
In addition, it appears that EBNA-1 can positively 
regulate its own expression. Reisman and Sugden (1986) 
demonstrated that region 1 of oriP acts as an EBNA-1- 
dependent enhancer. Analysis of cQNA clones has shown that 
the EBNA-1 gene is transcribed as a highly spliced mRNA from 
promoters within the BamHl c fragment although the open 
reading frame encoding the gene lies approximately 90 kbp 
downstream in the BamHl k fragment (Summers et a l ., 1982; 
Hennessy and Kieff, 1983; Sample et al ., 1986; Bodescot et 
al., 1987). Although the region 1 enhancer is approximately 
3 kbp from the EBNA promoter, in the presence of EBNA-1 this 
promoter depends on region 1 in cis for efficient expression 
(Sudgen and Warren, 1989). Such negative and positive 
feedback controls of EBNA-1 expression would be expected to 
tightly regulate the protein present in the cells, and hence 
the amplification of episomal EBV genomes.
A significant advance has been made in the study of 
lytic phase replication of EBV DNA with the identification 
of a portion of the genome, termed oriLyt, that enables 
enhanced replication of plasmids in cells in which EBV is in 
the lytic phase (Hammerschmidt and Sudgen, 1988). The EBV 
lytic phase can be induced in some latently infected cell 
lines by chemical treatments (ZurHausen et al., 1978) or by 
introduction of a vector expressing the BZLF-1 gene of EBV, 
whose product is a transcriptional activator (Countryman and 
Miller, 1985; Takada et a l ., 1986). Fragments from 
throughout the EBV genome were co-transfected into latently 
infected cells along with the BZLF-1 gene and assayed for 
their capacity to allow replication of linked plasmid DNA 
sequences. Sequences containing the minimal oriLyt were 
mapped to within a set of directly repeating elements, D^ 
and D , which themselves contain multiple repeat sequences 
and are situated at the ends of the UL region (see Fig.1.1; 
section 1.1). Most naturally occurring strains of EBV have
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two copies of oriLyt although some strains (e.g. B95-8) can 
replicate in the lytic phase with only one copy. Unlike the 
lytic origins of HSV and VZV, oriLyt is a complex sequence 
consisting of two essential regions of approximately 300 bp 
separated by at least 260 bp of non-essential sequence. The 
second 300 bp region can be functionally substituted by a 
transcriptional promoter/enhancer.
OriLyt differs functionally in at least three ways 
from oriP. Firstly, replication from oriLyt yields a 100 to 
1000 fold amplification of the plasmid content per cell 
whereas replication from oriP yields a stable number of 
plasmid molecules per cell in a dividing population. 
Secondly, the products of oriLyt replication are 
concatemeric DNA molecules whereas replication via oriP 
produces circular episomal molecules. Thirdly, the only 
viral gene product that oriP requires to function is EBNA-1; 
oriLyt requires at least one viral gene, the DNA polymerase, 
which is not expressed in latently infected cells (Leinbach 
et a l ., 1976). The EBV genome possesses clear counterparts 
to four of the HSV-1 DNA replication genes, namely UL5,
UL29, UL30 and UL52 (Table 1.1; McGeoch, 1987) and it would 
be expected that these also play important roles in the 
lytic phase.
OriLyt does not contain an AT-rich sequence within 
a palindromic sequence analogous to the human 
alphaherpesviruses. Its complex structure and association 
with potential binding sites for transcription factors 
distinguish it from the origins of HSV-1 and HSV-2. 
Interestingly, there is no clear counterpart for the HSV UL9 
origin binding protein in EBV. Despite probable differences 
in the initiation of DNA replication, both viruses, during 
the lytic phase appear to amplify plasmid containing origins 
in a similar manner as the products of replication in both 
cases consist of concatemeric DNA. No latent origin of 
replication has been identified in HSV. Based on the lack 
of detectable viral gene expression in HSV latently infected 
neuronal cells, and the fact that these cells are 
non-dividing, it would appear that an equivalent of oriP is 
not required for HSV to be maintained in the latent phase.
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3. HCMV DNA replication
By DNA sequence comparisons of HCMV with HSV-1, 
homologues to four of the seven HSV-1 genes known to be 
essential for DNA replication have been identified (Chee et 
al., 1990). These are the DNA polymerase (Kouzarides et
al., 1987), the major DBP, UL5 and UL52 (Table 1.1). HCMV
origins of DNA replication have yet to be identified. HCMV, 
like HSV, possesses a terminal 'a' sequence. The HCMV 'a‘ 
sequence can provide the cleavage/packaging signals for 
defective HSV genomes (Spaete and Mocarski, 1985).
SECTION IE; The role of sequence-specific DNA binding
proteins in the initiation of DNA replication
The subject of this thesis concerns the 
identification and characterisation of an HSV origin-binding 
protein which, by analogy with other well-characterised 
prokaryotic and eukaryotic origin-binding proteins is 
believed to play a critical role in directing the formation 
of a replication complex at the HSV origins of DNA 
replication. Initiation of DNA synthesis has been 
investigated in many systems and several other examples in 
which initiation takes place at internal origins following 
interactions with sequence-specific DNA binding proteins are 
known. The following section briefly describes the role of 
sequence-specific DNA binding proteins in three of the best 
studied systems (E.coli, bacteriophage lambda, and simian 
virus 40 [SV40]) and attempts to identify some common 
features.
In prokaryotic and eukaryotic cells, the initiation 
of DNA replication is a tightly controlled event such that 
the chromosomes are replicated once per cell cycle. In 
contrast, many DNA viruses have evolved replicative 
mechanisms to escape such stringent controls and allow 
autonomous replication of the viral genome. This can be 
achieved by specifying a replicative machinery that is 
distinct from the host cell (e.g. adenoviruses), or by 
synthesising proteins that preferentially recognise and
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direct replication of the viral DNA from a specific origin 
sequence using host-cell enzymes (e.g. SV40).
The development of origin-dependent in vitro DNA 
replication in several systems e.g. E.coli (Fuller et a l ., 
1981), bacteriophage lambda (Wold et a l ., 1982) and SV40 (Li 
and Kelly, 1984) has demonstrated that, whether prokaryotic 
or eukaryotic, these systems have a common pathway for 
initiating DNA replication. This pathway can be envisaged 
as a three step process:
(1 ) a protein recognises and binds to a specific 
sequence within the origin of replication 
(initial complex)
(2 ) this complex leads to the melting of a small 
stretch of duplex DNA within the origin 
(open complex)
(3) a helicase activity extends the primary replication 
bubble (pre-priming complex) which marks the site 
at which the synthesis of daughter strands is 
initiated.
Examples of well-characterized proteins that are 
required to mediate steps 1 and 2 are the E.coli dnaA 
protein, the bacteriophage lambda 0 protein and SV40 T 
antigen.
1. E.coli dnaA initiation protein
DNA replication of the E .coli chromosome initiates 
at a unique site called oriC. The minimal oriC consists of 
a 245 bp DNA sequence which contains all the cis-acting 
information required for autonomous replication (Fig.
1.10(a); Oka et a l ., 1980). Mutational analysis of this 
sequence has revealed two essential sequence elements; 
protein recognition elements and spacer elements that 
maintain a required distance between the protein recognition 
elements (Oka et a l ., 1984). The boundary at the right end 
of oriC coincides with the end of the rightmost of four 9 bp 
elements (dnaA boxes) bound by the E .coli dnaA protein {Fig. 
1.10(a)}. The leftmost 60 bp of oriC contains three tandem 
repeats of a 13 bp motif ( L-left, M-middle, R-right) which 
are highly conserved among the Enterobacteriaceae.
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Figure 1.10 Features of the replication origins of E.coli, 
bacteriphage lambda and simian virus 40
(a) The E.coli minimal oriC region. The 13 mers of the 
AT-rich region (left [L], middle [M], right [R]) are 
shown by large solid arrows, with the consensus sequence 
shown below. The dnaA protein binding sites are shown 
by shaded boxes (dnaA A boxes) with the consensus 
sequence shown below.
(b) Part of the sequence of the bacteriophage lambda origin 
of replication. Overlined and capitalised regions I to 
IV signify the location and sequence of the 
bacteriophage lambda 0 protein binding sites located at 
the left hand side of the AT-rich region of the origin. 
Stippled underlined dA runs, four of which are located 
in the 0 protein binding sites, are proposed to be 
responsible for DNA bending (Zahn and Blattner, 1984).
(c) The SV40 core origin. The T antigen binding sites I and 
II, the early palindrome and AT-rich tract are marked.
The orientation and approximate position of the GAGGC 
motifs in binding sites I and II are indicated by short 
arrows within the boxed regions.
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Studies on the activity of the dnaA protein have 
established that it performs three crucial roles in 
initiating DNA replication. Firstly, the dnaA protein binds 
tightly to each of the four dnaA boxes in oriC (initial 
complex; Fuller and Kornberg, 1983; Fuller et al., 1984). A 
dnaA-oriC complex is then formed which consists of 
negatively supercoiled oriC DNA wrapped around a central 
core of 20-40 dnaA protein monomers (Funnell et al., 1987; 
Baker and Kornberg, 1988).
Secondly, in the presence of the protein HU (a 
nistone-like DNA binding protein; Dixon and Kornberg, 1983) 
the dnaA protein bound to oriC, successively melts the three 
AT-rich 13 mer repeats to form an open complex, as evidenced 
by this region becoming susceptible to single-stranded 
nuclease digestion. Formation of this open complex requires 
bound ATP. The dnaA protein can stably bind to both ATP and 
ADP, slowly hydrolysing the former to the latter, but the 
ATP bound form alone has been shown to be active in oriC 
replication (Sekimizu et a l ., 1987).
Thirdly, the dnaA protein guides the dnaB-dnaC 
complex into this melted region to form a pre-priming 
complex. The origin DNA must unwind prior to actual 
initiation of DNA synthesis to allow the replication 
machinery access to this region in order to copy the 
individual DNA strands. The dnaB helicase is required to 
unwind DNA ahead of the replication fork (Baker et al., 
1986,1987; Dodson et al ., 1986). This protein is unable to 
initiate unwinding of a closed duplex molecule (LeBowitz and 
McMacken, 1986) hence the requirement for an open complex 
formed through the action of dnaA protein.
The mechanism by which the dnaA protein forms the 
open complex is not totally clear. The repeated 13 mer 
region which, following binding of dnaA to oriC, becomes 
hypersensitive to nuclease activity, has a nucleotide 
composition that naturally confers a low free energy cost 
for DNA unwinding i.e. reduced helical stability over this 
region in the absence of replication proteins. However, the 
AT—rich nature of this region alone is not responsible for 
the formation of an open complex as other extended AT—rich 
regions in oriC are not sensitive to single-strand-specific 
nucleases. Thus, the energetic requirement for unwinding
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this sequence is dependent on base sequence as well as 
composition (Kowalski and Eddy, 1989). It has been 
postulated that dnaA therefore recognises part of the R-13 
mer which could then concentrate unwinding of the 
supercoiled template to the remaining non-contacted 13 mers 
by virtue of the reduced helical stability of the region. 
This model accounts for the specific duplex opening of oriC 
without requiring dnaA interaction with all of the 13 mers 
and is consistent with mutational studies of oriC which 
showed that the R-13 mer but not the L and M-13 mers are 
required for dnaA/HU induced opening of oriC (Bramhill and 
Kornberg, 1988). In addition, the R-13 mer sequence and 
spacing from the leftmost dnaA box is completely conserved 
amongst all known Enterobacteriaceae origins whereas the L 
and M-13 mers have tolerated base substitutions. The L-13 
mer can be replaced by a dissimilar DNA sequence with 
reduced helical stability (Asada et a l ., 1982; Kowalski and 
Eddy. 1989). Hence, the 13 mer repeat region is a complex 
genetic element that plays at least two essential 
overlapping roles; protein recognition by dnaA and confering 
helical instability.
In addition to its key role in initiating 
replication at oriC, dnaA may play some role in modulating 
its own transcription. Schaefer and Messer (1989) 
demonstrated that the presence of a dnaA box site in the 
middle of the open reading frame of the dnaA gene can lead 
to a transcriptional block of the dnaA gene as well as 
downstream gene expression. The alteration of a single base 
within the box reduces its ability to terminate 
transcription as seen by the corresponding overproduction of 
the dnaA protein. A dnaA box and 13 mer sequence are also 
found in the dnaA gene promoter region leading to 
autoregulation of the gene by dnaA.
2. Bacteriophage lambda 0 protein
Bacteriophage lambda initiates Qidirectional 
replication at a unique site in the phage genome. The lambda 
origin contains two essential domains. The left domain 
consists of four 13 bp repeating units (iterons) of
hyphenated dyad symmetry and the right domain adjacent to
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the iterons contains a 49 bp region of high AT-content (71%) 
with almost all purines lying on the same strand {Schnos and 
Inman, 1970; Fig. 1.10(b)}.
Replication of phage is dependent on two 
phage-encoded proteins 0 and P and, except for dnaA and dnaC 
proteins, all of the replicative proteins of E.coli (Eisen 
et a l ., 1966; Friedman et al ., 1984).
The 0 protein is regarded as the functional 
analogue of the dnaA protein. It binds, most likely as a 
dimer, to each iteron forming a characteristic DNA protein 
structure termed the 'O-some' which consists of 0 protein 
molecules with the DNA wrapped around (initial complex).
Due to the tracts of adenosine residues between and within 
each iteron, the origin DNA is naturally bent in solution. 
Binding of the 0 protein induces further bending of this 
region (Zahn and Blattner, 1985a,b). The lambda origin/O 
protein complex differs from the dnaA/oriC complex in that 
it does not require bound ATP for helix destabilisation of 
the AT-rich region (Schnos et a l ., 1988). Binding of the 0 
protein renders the AT-rich region sensitive to 
single-strand-specific nuclease digestion indicating the 
formation of an open complex. The modification of the DNA 
is absolutely dependent on supercoiled tension at the 
origin. The mechanism by which the free energy stored in 
the supercoiled DNA and/or statically bent origin is 
transferred into a localised and asymmetric strand 
separation remains to be investigated (Schnos et a l ., 1988; 
Dodson et al ., 1989).
The 0 protein at the lambda origin interacts with P 
protein (analogous to dnaC; Furth et al ., 1978) via its 
carboxy terminus (Wicker and Zahn, 1986) and the P protein 
in turn interacts with the dnaB helicase, dnaJ and dnaK 
proteins of E.coli (Friedman et a l ., 1984). In the presence 
of single-stranded DNA binding proteins and ATP, the origin 
is unwound by dnaB helicase. Similarily to oriC of E .coli, 
the binding of the 0 protein is the catalyst for this 
reaction as the dnaB helicase can only function on 
pre-formed open complexes (LeBowitz and McMacken, 1986). 
Functional studies have demonstrated that the AT-rich domain 
of the origin is indeed the target for entry and initial 
action of dnaB (Dodson et al., 1986).
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3. SV40 T antigen
SV40 has proved to be an excellent model system for 
the study of eukaryotic mechanisms of DNA replication. The 
viral genome consists of a 5.2 kbp circular double-stranded 
DNA molecule that is complexed with hi stones to form a 
minichromosome, indistinguishable from cellular chromatin. 
Since SV40 encodes a single replication protein, T antigen, 
the virus uses much of the cellular replicative machinery 
(Tegtmeyer, 1972).
The primary step in initiation of SV40 DNA 
replication is the binding of T-ag to sequence elements 
within the origin. The SV40 T antigen (T-ag) is a 
multifunctional 82-kD phosphoprotein that catalyses 
pre-synthesis reactions at the SV40 origin and contains an 
ATP-dependent DNA helicase activity (Stahl et a l ., 1986).
The protein binds strongly to two sites, I and II, shown in 
Fig. l'.lO(c). Site II is located within the 64 bp sequence 
which marks the core origin. The pentameric motif 
5 1-G(A/G)GGC-31 which serves as the recognition site for 
T-ag is found in sites I and II although the number and 
orientation of the motifs and their spacing differ at each 
site. Site II contains four motifs arranged in a 27 bp 
perfect inverted repeat with two motifs on each arm of the 
palindrome (Tjian, 1978; DeLucia et a l ., 1983). At least 
one T-ag monomer can bind to each pentamer (Mastrangelo et. 
al., 1985).
Through detailed analysis of base substitution 
mutations, three domains within the core origin have been 
identified as crucial for replication; the central GAGGC 
elements, a 10 bp region overlapping an imperfect inverted 
repeat (early palindrome) and a 17 bp AT-rich region 
(Fig.1.10(c) Deb et a l ., 1986a). Fragments containing the 
AT-rich region exhibit naturally occurring stable bends in 
the DNA (Deb et a l ., 1986b).
DNase I footprinting assays show that in the 
presence of ATP, T-ag covers the entire core origin sequence 
on all faces of the DNA helix (Deb and Tegtmeyer, 1987; 
Borowiec and Hurwitz, 1988a). EM studies have shown that 
the protein is arranged as a two-lobed structure at the core
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origin which contains twelve monomers of protein. In the 
absence of DNA, ATP can cause T-ag to aggregate in hexameric 
clusters (Mastrangelo et a l ., 1989) which suggests that each 
lobe of T-ag bound to DNA contains six T-ag monomers.
The ATP-dependent binding of T-ag to core origin 
induces structural changes in the early palindrome region 
and the AT-rich element (Borowiec and Hurwitz, 1988b). 
Surprisingly, the early palindrome, rather than the AT-rich 
element appears to be the initial site of DNA melting. 
Parsons et a l . (1990) demonstrated that high levels of T-ag
can cause significant melting at this element in the absence 
of the other two elements. The sequence of the early 
palindrome is strongly biased toward purines on one strand 
and pyrimidines on the other. As these sequences are 
inherently unstable (Wells, 1988) this may facilitate 
melting in this region. Melting of the early palindrome 
does not require energy as ADP and nonhydrolysable analogues 
can effectively sustitute for ATP. This T-ag activity is 
distinct from its pentanucleotide binding, as the early 
palindrome does not contain GACCG motifs, and also its 
helicase activity which is energy dependent (Borowiec and 
Hurwitz, 1988b; Stahl et al, 1986; Parsons et al ., 1990).
After formation of this open complex, the origin 
becomes completely denatured and the T-ag helicase function 
unwinds the duplex DNA in a bidirectional manner. In vitro, 
this unwinding reaction requires a cellular single-stranded 
DNA binding protein to maintain extensive regions of 
single-stranded DNA (Wobbe et a l ., 1987; Fairman and 
Stillman, 1988 ) .
The requirement for a third factor, identical to 
the catalytic subunit of cellular protein phosphatase 2A 
(PP2Ac ) has recently been demonstrated when using T-ag 
isolated from cells infected with a recombinant adenovirus 
vector expressing T-ag (Virship et a l ., 1989). The purified 
PP2A dephosphorylates specific phosphoserine residues, 
consistent with the hypothesis that SV40 DNA replication is 
regulated by modulating the phosphorylation state of T-ag 
(McVey et al., 1989).
To summarise the key requirements for initiation of 
DNA replication in these three systems; each origin sequence 
has a lengthy AT-rich tract and multiple sequence repeats
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that bind multiple units of an origin-binding protein 
forming an initial multimeric complex. The binding of the 
proteins causes structural changes in the origin region 
forming an open complex. These complexes, in conjunction 
with other replication proteins e.g. helicases and 
single-stranded DNA binding proteins, lead to regions of 
highly underwound DNA ultimately allowing entry and activity 
of the polymerising enzyme.
There are of course notable differences between the 
three systems. Firstly, while the dnaA and lambda 0 
proteins are wrapped by DNA, in SV40, the DNA is surrounded 
by T-ag. Secondly, origin-binding and helicase functions 
are encoded by separate genes in E.coli and lambda whereas 
SV40 T-ag can carry out both functions. Thirdly, the 
AT-rich region in E.coli and lambda serves as the initial 
melting site. In SV40, a polypurine-polypyrimidine tract is 
the first region to be separated. SV40 T-ag does not 
require supercoiled DNA to form a pre-priming complex but 
can function effectively on linear DNA templates.
Although our knowledge of the initiation of HSV DNA 
synthesis has not reached the levels of sophistication 
exemplified by the above systems, several analogies can be 
drawn. For example, HSV has internal origins of DNA 
replication and these contain DNA palindromes, lengthy 
AT-rich tracts and sequence-specific recognition sites (Stow 
and McMonagle, 1983; Weller et a l ., 1985; Stow and Davison, 
1986; Elias et a l ., 1986). The work described in this 
thesis aimed to provide further relevant information by 
identifying the HSV-1 encoded origin binding protein and 
investigating the role of its interaction with the origin in 
HSV DNA synthesis.
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CHAPTER 2; MATERIALS AND METHODS
SECTION 2A:_____Materials
1. Chemicals
Chemicals were obtained from either BDH Ltd. or 
Sigma Chemical Co. Ltd. except for the following:
Beecham Research Labs. Ltd.: ampicillin (penbritin);
Bio-Rad Labs. Ltd.: ammonium persulphate, TEMED [N,N,N'N' 
tetramethylethylenediamine], Bio-Rad protein assay dye 
reagent concentrate; Boehringer Mannheim: proteinase K, 
tris-[tris(hydroxymethyl-aminomethane)]; Du Pont UK Ltd.:
3
En hance autoradiography enhancer; Fluka Chemicals Ltd.: 
HPLC grade dimethyl-sulphoxide, formamide, piperidine;
James Burrough (FAD) Ltd.: absolute alcohol 100; Koch-Light 
Labs.: boric acid, caesium chloride; May and Baker Ltd.: 
acetic acid (glacial), chloroform, glycerol, hydrochloric 
acid; Pharmacia LKB Ltd.: DEAE-sephacel, ficoll 400,
2 1-deoxyribonucleoside 5'-triphosphates, ribonucleoside 
5 1-triphosphates, gene 32 protein, ultra-pure dNTP set, 
'universal' and T7 promoter sequencing primers, diguanosine 
triphosphate sodium salt [G(5')ppp(5 1)G].
2. Miscellaneous Materials
dialysis membrane Medicell International Ltd
nitrocellulose BA85 Schleicher and Schuell
rabbit reticulocyte
lysate (N90) Amersham International pic.
RNasin Promega
SDS-7B pre-stained
molecular weight markers Sigma Chemicals Co. Ltd.
tissue culture plastics Gibco Ltd. and Sterilin Ltd.
Trypsin (0.25% w/v) Gibco Ltd.
wacker silane GF 38 Wacker Chemicals
X-ray film for
autoradiography (XSl) Kodak Ltd.
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3. Enzymes
Restriction enzymes were manufactured by Bethesda 
Research Labs, and Northumbria Biologicals Ltd. Calf 
intestinal phosphatase was manufactured by Boehringer 
Mannheim, T4 kinase by New England Biolabs and T7 DNA 
polymerase by Pharmacia LKB Ltd.
4. Radiochemicals
Radiolabelled compounds were supplied by Amersham 
International pic.
specific activity
3 5(a) [ -S]-L-methionine around 8 00 mCi/mmol
32(b) 5 ' [o<- P]-deoxyribonucleoside
triphosphates 3000 Ci/mmol (10 uCi/ul)
32(c) 5 ' [©C- P]-adenosine
triphosphate 5000 Ci/mmol (10 uCi/ul)
35(d) 5 1 [c<- S]- deoxyadenosine
thiotriphosphate >1000 Ci/mmol (10 uCi/ul)
5. Synthetic oligonucleotides
These were synthesised using a model 8600 biosearch 
DNA synthesiser by Dr. J. McLauchlan. A list of the 
oligonucleotides used during the course of this study are 
given in Table 2.1.
6 . Plasmids
(a) Cloning vectors
The pTZ range of phagemid expression vectors pTZ 
19U, pTZl9R, pTZl8U and pTZlSR (Mead et a l ., 1986) were 
obtained from Dr. R. M. Elliott and are shown in Fig. 2.1. 
These plasmids were used for cloning, production of 
single-stranded DNA for site-directed mutagenesis and in 
vitro transcription.
Table 2.1 Double-stranded oligonucleotides used 
in this study
Oligonucleotide I :
5' GATCCGCGAAGCGTTCGCACTTCGTCCCA
GCGCTTCGCAAGCGTGAAGCAGGGTCTAG 5
Oligonucleotide II :
5 1 GATCTGGGGCGAAGTGCGAGCACTTCGCG
ACCCCGCTTCACGCTCGTGAAGCGCCTAG 5
Oligonucleotide III :
5' GATCTAAAAGAAGTCAGAACGCGA
ATTTTCTTCAGTCTTGCGCTCTAG 5 1
Oligonucleotide pml :
5 1 GATCCGCGAAGCGTTCTCACTTCGTCCCA
GCGCTTCGCAAGAGTGAAGCAGGGTCTAG 5
Oligonucleotide X :
5 1 GATCGGATATGCTAATTAAATACAT
GCCTATACGATTAATTTATGTA 5 1
pTZ18R and pTZ19R Multifunctional Phagemids
PrimorpUC 18/19 MCS T7 Promoter
Bgl I
Nas I
pTZ18R
pTZ19R
2880 bp
Xmn I
Aha II
Sea I
Figure 2.1 Diagram of the pTZ range of phagemid expression
vectors
The key features of these plasmids include a multiple 
cloning site from pUCl8/19, an ampicillin resistance gene, a 
lacZ gene, an fl origin of replication for the production of 
single-stranded DNA and a T7 RNA polymerase promoter.
Vectors pTZl8R and pTZl9R are identical except for the 
multiple cloning site (MCS) being in the reverse orientation 
in pTZl9R. Vectors pTZl8U and pTZl9U (not shown) are 
identical to pTZ18R and pTZl9R respectively, except the fl 
origin is in the reverse orientation.
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(b) Plasmids containing HSV-1 replication genes and IE-3 and
IE-1 genes
Four plasmids containing HSV-1 (Glasgow strain 17) 
replication genes were obtained from Institute stocks and 
are as follows:
pGX25 - BamHI c fragment containing UL5 + UL8 cloned 
into pATl53 (Twigg and Sherratt, 1980) 
pGXl25 - Kpnl £_ fragment containing UL8 + UL9 cloned 
into pMKl6 (Kahn et a l ., 1979) 
p9-4 - (derived from pGX184) Hindlll 1 fragment
containing the UL42 gene cloned into 
pUC9 (Vieira and Messing, 1982) was obtained from 
Dr. C. MacLean 
pGX94 - Xhol b fragment containing the UL52 gene 
cloned into pATl53
Plasmid pGX58 consists of the HSV-1 Xhol c fragment 
containing the IE-3 gene cloned into pMK16. Plasmid pJR3 
(obtained from Dr. J. Russell) consists of a PstI + SstI 
fragment containing the IE-1 gene cloned into a pUC9 
derivative.
Plasmids pNNl and pNN3 were kindly provided by Dr. 
M. D. Challberg (Challberg, 1986). Both plasmids were 
constructed from a starting plasmid, p M C H 9 ,  which consists 
of the Hpal b fragment of HSV-1 DNA cloned into pUCl9. pNNl 
contains the UL29 gene encoding the major single-stranded 
DNA binding protein and pNN3 the UL3 0 gene, encoding the 
viral DNA polymerase.
(c ) Plasmids containing HSV-1 and VZV ori^ sequence
Plasmid pSl consists of a 535 bp DNA fragment from 
the HSV-1 BamHI x fragment which contains a functional copy 
of orig, cloned into pATl53 (Stow and McMonagle, 1983).
Plasmid pSl9 was generated by deletion of pSl and 
consists of a 100 bp fragment which retains orig activity 
(Stow and McMonagle, 1983).
Plasmid pV02 consists of a 259 bp fragment produced 
by Rsal plus Clal cleavage of pVKr (nucleotides 5502 to 5760
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of the TRg/IRg sequence of Davison and Scott, 1985) cloned 
between the EcoRI and Clal sites of pATl53 following the 
ligation of an EcoRI linker to the Rsal terminus. This 
plasmid contains a functional copy of VZV ori (Stow and
O
Davison, 1986).
(d) Plasmids containing segments of the UL9 gene
To express parts of the UL9 gene as fusion proteins 
in Escherichia coli, three plasmids containing in-frame 
segments of the UL9 gene were constructed by Dr. N. D. Stow, 
and are shown in Fig. 2.2. The parental vector, pRIT2T, was 
supplied by Pharmacia LKB Ltd. (Nilsson et al ., 1980). An 
additional plasmid was constructed, pRIT2T-4, in which the 
EcoRI site in the multiple cloning region of pRIT2T was 
replaced by an Apal site and a 4 bp deletion introduced. 
Plasmid pX8 encodes the N-terminal 10-524 amino acids of the 
UL9 gene cloned into DRIT2T-4, pBl encodes the C-terminal 
317 amino acids cloned into pRIT2T-4 and pP31 encodes the 
C-terminal 591 amino acids cloned into pRIT2T.
7. Cells
BHK 21 clone 13 (BHK) cells, a continous line 
derived from baby hamster kidney (MacPherson and Stoker,
1962) were routinely used for the growth of virus, 
preparation of nuclear extracts and plasmid amplification 
assays.
8 . Viruses
HSV-1 Glasgow strain 17syn+ , HSV-1 strain KOS and 
HSV-2 strain HG52 were obtained from Institute stocks.
HSV-1 strain 1 7syn+ was the wild type virus used in most 
experiments. Seed stocks of HSV-1 DNA negative ts mutants 
were obtained from Mrs. M. Murphy and Dr. V. G. Preston 
(Table 2.2).
HSV-1 recombinant viruses tsK/UL5, tsK/UL8 , tsK/UL9 
and tsK/UL52 were obtained from Janice Calder in our 
laboratory. These viruses contain additional copies of the 
early genes UL5, UL8 , UL9, and UL52 inserted under the 
control of the IE 3 promoter within the TK gene of tsK 
(Calder and Stow, unpulished results).
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Figure 2.2 Construction of plasmids containing fragments of
the UL9 gene for expression in E.coli
(a) Structure of plasmid pRIT2T. pRIT2T-4 is essentially 
similar except the EcoRI site in pRIT2T is replaced by an 
Apal site (Weir et al ., 1989). The positions of the phage 
lambda promoter, P , and coding sequences for the N-terminal 
region of the Staphylococcus aureus A protein are indicated.
(b) Fragments inserted into vectors. The upper line shows 
the SstI fragment containing the UL9 gene which was 
initially cloned into the EcoRI site of pUC8 . The N- and C- 
terminal regions of the coding sequences (black bar) are 
indicated. Plasmids pX8 , pBl and pP31 contain the indicated 
fragment inserted in frame and in the appropriate 
orientation into pRIT2T-4, pRIT2T-4 and pRIT2T respectively. 
The C-terminal ends of the pBl and pP31 inserts lie within 
the pUC8 polylinker. The nucleotide numbering is from 
McGeoch et al. (19 88).
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9 . Tissue culture media
BHK cells were grown in Glasgow modified Eagle's 
medium (GMEM; Busby et a l ., 1964) supplemented with 10% new 
born calf serum, 10% tryptose phosphate broth, 100 units/ml 
penicillin and 100 ug/ml streptomycin (ETC10).
The following modified tissue culture media were 
also used:
GMEM wash GMEM containing antibiotics only
ECx GMEM containing x% calf serum
ECxHuy GMEM containing x% calf serum
y% human serum
10. Bacterial strains and bacteriophage
Three bacterial strains of E.coli were used: DH-1 
(recAl, nalA, r„ , m„ , endol , B , relAl ; Hanahan, 1983), 
Kl2AHIAtrp (Bernard et a l ., 1979) and BW313 (dut , ung , 
thi , relAl, spoTl, HfrKLl6 ; Kunkel, 1985). The bacterial 
strain BW313 and the bacteriophage M13 R408 (Russel et al., 
1986) were provided by Dr. R. Thompson.
11. Bacterial culture media
The following solutions were used:
10 g/1 NaCl, 10 g/1 Bactopeptone 
5 g/1 yeast extract 
L-Broth plus 1.5% w/v agar 
5 g/1 NaCl, 16 g/1 Bactopeptone 
10 g/1 yeast extract
Ampicillin, where appropriate, was added to L-Broth 
and L-Broth agar at 50 ug/ml.
12. Anti sera
L-Broth
L-Broth agar 
2 x YT broth
Rabbit antisera raised against decapeptides from
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the C-termini of the UL5, UL8 , UL9 and UL52 gene products 
and reactive with the corresponding polypeptides were kindly 
provided by Dr. M. D. Challberg (Olivo et a l ., 1988).
13. Commonly used solutions
50 x Denhardt's 
solution
Giemsa stain
Gel soak I 
Gel soak II
Hybridisation
buffer
Loening's buffer
PBS A
PBS
Prehybridisation
buffer
STET buffer
20 x SSC 
TBE
TE
TEN
versene
1% polyvinylpyrrolidone, 1% BSA 
1% Ficoll
1.5% Giemsa in glycerol, heated to 
50°C for 2 h and diluted with an 
equal volume of methanol 
200 mM NaOH, 600 mM NaCl 
1 M Tris, 600 mM NaCl, pH adjusted 
to 8.0 with HCl
6 x SSC, 5 x Denhardt's solution, 
0.05% SDS, 5 0 ug/ml denatured calf 
thymus DNA, 2 0 mM Tris.HCl (pH 7.5), 
1 mM EDTA
36 mM Tris, 36 mM NaH2PC>4 .2H20,
1 mM EDTA
170 mM NaCl, 3.4 mM KCl, 10 mM 
Na2HP04 , 1.8 mM KH2PC>4 (pH 7.2)
PBS A supplemented with 6.8 mM CaCl2 
and 4.9 mM MgCl2
6 x SSC, 5 x Denhardt's solution, 
0.1% SDS, 2 0 ug/ml denatured calf 
thymus DNA
8% (w/v) sucrose, 0.5% (v/v) 
TritonX-100, 50 mM Tris.HCl (pH 8.0) 
50 mM EDTA
3 M NaCl, 3 M trisodium citrate 
90 mM Tris.HCl, 89 mM boric acid,
1 mM EDTA
10 mM Tris (pH 8.0), 1 mM EDTA 
TE plus 100 mM NaCl 
0.6 mM EDTA in PBS A plus
0.02% (w/v) phenol red
SECTION 2B: Methods
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1. Cell culture
BHK cells were grown in ETC10 medium at 3 7°C in an
atmosphere of 5% CO2 (MacPherson and Stoker, 1962).
Cultures were passaged every two to three days. Cells from
2
confluent monolayers (850 cm roller bottles) were harvested 
in 20 ml ETC10 after two versene washes and brief 
trypsinisation (0.25% trypsin) and remained viable for up to 
5 days at 4°C.
2. Virus stocks
(a) production of virus stocks
Stocks of wt HSV-1 and HSV-1 _ts mutants were 
propagated in BHK cells. Cell monolayers in glass roller 
bottles were infected with virus at a moi of 0.01 pfu per 
cell in 50 ml EC5. Infected cultures were maintained at 
31°C for 3-4 days until the appearance of extensive 
cytopathic effect. The bottles were shaken vigorously to 
dislodge the cells into the medium. Cells were spun from 
the medium at 2,000 rpm (Sorval GS3 rotor) for 5 min, 
resuspended in 5 ml of EC5, sonicated in a Cole Palmer 
ultrasonic bath to release the virus and centrifuged at
2,000 rpm (Sorval RT6000B in universals) for 5 min at 4°C to 
remove cell debris. Cell-associated virus (CAV) in the 
supernatant was stored in aliquots at -70°C. The medium 
from infected cells was centrifuged at 12,000 rpm (Sorval 
GSA rotor) for 2.5 h at 4°C and the pellet of cell-released 
virus (CRV) resuspended in a small volume of EC5, sonicated 
and stored at -70°C. Sterility checks were performed on CAV 
and CRV stocks using blood agar plates.
(b ) titration of virus
All virus stocks were titrated on BHK cell 
monolayers in 50 mm or 35 mm tissue culture dishes. Serial 
10—fold dilutions of virus were made in GMEM wash and 0.1 ml 
samples of each dilution were inoculated onto cell 
monolayers from which the growth medium had been removed.
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Following an absorption period of 1 h at permissive 
temperature (PT; 31°C for ts mutants; 31°C or 3 7°C for wt 
HSV), the cells were overlaid with EC2Hu5 to neutralise 
unadsorbed virus and prevent the formation of secondary HSV 
plaques. Incubation was continued at the appropriate 
temperature (2 days at 3 7°C, 3 days at 31°C). An equal 
volume of Giemsa stain was added to the medium for several 
minutes. The stain was washed off and the viral plaques, 
clearly visible under a dissecting microscope were counted.
3. Preparation of HSV-1 DNA
HSV-1 DNA was prepared essentially as described by 
Wilkie (1973). Infected cells were pelleted as described in 
2(a). and resuspended in RSB buffer (10 mM Tris.HCl (pH 
' 7.5), 10 mM KC1, 10 mM MgC^) containing 0.5% Nonidet P40 
and placed on ice for 10 min. Nuclei were removed by 
centrifugation at 2,000 rpm (Sorval GSA rotor) for 5 min at 
4°C and the viral particles in the resulting supernatant 
(CAV) were pelleted at 12,000 rpm (Sorval GSA rotor) for 2.5 
h at 4°C. CRV was pelleted from the growth medium as 
described in 2(a). The virus pellets from CAV and CRV were 
resuspended in TE and 1/25 vol of 250 mM EDTA and 1/40 vol 
of 20% SDS added to disrupt the particles. DNA was then 
sequentially extracted by gentle mixing, twice with phenol, 
once with phenol/chloroform (1 :1 ) and once with chloroform. 
DNA was precipitated by the addition of 1/20 vol of 5 M NaCl 
and 2.5 vols of ethanol, pelleted, washed twice with ethanol 
lyophilised and resuspended overnight in TE.
Viral DNA was further purified by caesium chloride 
(CsCl) equilibrium gradient centrifugation. 1.25 g of CsCl 
was added for each ml of solution, to give a final density 
of 1.72 g/ml, dissolved by gentle inversion and the sample 
centrifuged in sealed plastic tubes at 40,000 rpm (Beckman 
Type 65 rotor) 48 h at 15°C. The bottom of each tube was 
punctured with a syringe needle and fractions collected in 
Linbro wells. 2 ul of each fraction were analysed on a 
mini-gel and fractions containing viral DNA were pooled and 
dialysed against TE for 3-4 h at 4 C. The viral DNA was 
subsequently stored at -20°C.
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4. Gel electrophoresis
(a) non-denaturing agarose gel electrophoresis
Analysis and preparation of DNA restriction 
fragments used horizontal, 0.8% agarose gels in TBE or 
Loening's buffer containing 0.5 ug/ml of ethidium bromide. 
DNA samples were mixed with a solution of 5 x SB dyes {5 x 
TBE or Loenings buffer, depending on the electrophoresis 
buffer used, 50% sucrose and 0.2% bromophenol blue(BPB)}. 
After loading samples, gels were electrophoresed at 100 V 
for 3 h (TBE gels) or 30 V overnight (Loening's buffer 
gels).
For a rapid assessment of small amounts of DNA, 
mini-gels, consisting of 20 ml of 1% agarose were run in TBE 
at 50 V for approximately 30 min. In both cases, DNA bands 
were visualised by exposure to U.V. light and photographed 
on type 667 Polaroid film.
(b) non-denaturing polyacrylamide gel electrophoresis
To analyse or purify labelled DNA fragments, 
vertical slab gels were poured without a stacking gel using 
appropriate concentrations of acrylamide in TBE. The 
acrylamide stock solution used was normally 29:1 
acrylamide:N,N'-methylene bisacrylamide and final solutions 
(50 ml) containing 8% polyacrylamide in TBE were polymerised 
with 200 ul of 25% (w/v) ammonium persulphate solution (APS) 
and 2 0 ul of TEMED.
(c ) non-denaturing polyacrylamide gels for size estimation 
of protein-DNA complexes
Gels were set up exactly as described by van 
Huijsdnen et a l . (1937). 20 ml of 25% and 5% acrylamide
solutions were prepared using stock 30% acrylamide (28.5:1.5 
acrylamide:bisacrylamide) in 0.5 x TBE with the 25% 
polyacrylamide solution also containing 3% sucrose. Linear 
5-25% gels were poured using a gradient maker. The gels 
were run at 150 V for 36-48 h at 4°C. After the run, the 
gel was fixed in 3 .5% perchloric acid, dried and exposed to 
autoradiography film (Kodak XS1) at -70°C.
(d) denaturing polyacrylamide gels
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Sequencing gel mix (6% acrylamide, 8.3 M urea in
0.5 x TBE) was prepared as follows: 460 g of urea were
dissolved in 150 ml of 40% acrylamide stock 
(acrylamide:N,N1-methylene bisacrylamide 19:1, previously 
deionised by stirring with 10 g of amberlite for 30 min and
filtered) and 50 ml of 10 x TBE and adjusted to 1 I with
f^O. This solution was then stored at 4°C in the dark for
up to one month. To polymerise the gel, 72 ul each of 25%
APS and TEMED were added to 6 0 ml of sequencing gel mix.
Gels were poured between sealed plates separated by 0.35 mm
spacers, using a 25 ml syringe. Once set, the wells were 
rinsed throughly in 0.5 x TBE using a 10 ml syringe with 
needle. DNA samples were boiled for 2-3 min in 95% 
deionised formamide, 0.05% BPB and 0.05% xylene cy anol, 20 
mM EDTA (pH 7.5) and 2-3 ul immediately loaded using a 
Hamilton syringe. Gels were electrophoresed at 40 W until 
the BPB reached the bottom of the gel (approximately 1.5-2 
h) and the siliconised notched front plate removed. Gels 
were then soaked in 10% acetic acid for 30 min to remove 
urea, before drying onto the 'wackered' back glass plate at 
80°C. Dried gels were exposed to autoradiography film at 
-7 0°C.
(e) SDS-PAGE polyacrylamide gel electrophoresis
SDS-PAGE polyacrylamide gel electrophoresis was 
carried out essentially as described in Marsden et al . 
(1976). Stocks of 30% acrylamide were prepared in water, 
with a ratio of acrylamide to N,N1-methylene bisacrylamide 
(cross-linking reagent) of 28.5:1.5 and 29.25:0.75. For the 
resolving gel mix (40 ml) solutions containing the 
appropriate percentage of acrylamide (normally 8% of 
29.25:0.75) were prepared in a buffer of final concentration 
375 mM Tris.HCl (pH 8.9), 0.1% SDS. To polymerise the gel 
solution, 0.6 ml of 10% APS and 40 ul of TEMED were added 
and the mixture was then poured into a sandwich of glass 
plates (including one notched plate) to within 3-4 cm from 
the top of the notched plate. Butan-2-ol was gently layered 
on top of the acrylamide solution and the gel allowed to 
polymerise. Following polymerisation, the butanol was 
rinsed off using unpolymerised stacking gel solution. Once 
removed, a 25 ml stacking gel solution consisting of 5%
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acrylamide (28.5:1.5) in 122 mM Tris.HCl (pH 6.7), 0.1% SDS, 
to which had been added 2 00 ul of 10% APS and 10 ul TEMED, 
was prepared and layered on top of the resolving gel. Wells 
were formed using a teflon comb. Protein samples were 
boiled for 5 min in sample buffer at a final concentration 
of 50 mM Tris.HCl (pH 6.7), 2% SDS, 700 mM 2-mercaptoethanol 
and 10% glycerol with sufficient BPB to enable visualisation 
of a dye front. Electrophoresis was carried out in tank 
buffer (52 mM Tris, 53 mM glycine and 0.1% SDS) at 10-12 mA 
overnight.
Following electrophoresis, gels were fixed for 45
min in methanol:acetic acid:water (50:7:50), before gently
3shaking for 45 min m  3 vols En hance and then washed for 5 
min in 5 vols of i^O. The gel was then heat-dried under 
vacuum onto Whatman filter paper and exposed to 
autoradiography film at -7 0°C.
5. Preparation of plasmid DNA
(a) growth of bacterial cultures
Overnight cultures of bacteria were set up using 
either 20 ul of a bacterial stock (stored in 50% glycerol or 
7% DMSO) or from a single colony picked from an agar plate, 
and allowed to stand or shake overnight at 3 7°C in 5 ml of 
L-broth containing 50 ug ampicillin, where appropriate.
(b) large scale preparation and purification of plasmid DNA
The propagation and purification of supercoiled 
plasmid DNA on caesium chloride/ethidium bromide gradients 
were essentially as described by Davison and Wilkie (1981). 
An overnight culture was transferred to a 1 L flask 
containing 400 ml of L-broth (containing 50 ug/ml of 
ampicillin where appropriate) and shaken at 37°C until the 
optical density (O.D) had reached approximately 0.6 at 630 
nm. Plasmid DNA was amplified by adding 1 ml of a 
chloramphenicol solution (34 mg/ml in absolute alcohol) to 
the culture and continuing shaking overnight before 
harvesting.
Bacterial cells were pelleted by centrifugation at
8,000 rpm (Sorval GS3 rotor) for 10 min, washed once by
resuspending the pellet in 10 ml of TE and then pelleted
70
again at 5,000 rpm (Sorval SM24 rotor) for 5 min. The 
pellet was resuspended in 2 ml of 25% sucrose, 50 mM 
Tris. HCl (pH 8 ) and 2 mM M g C ^  before adding 400 ul of 20 
mg/ml lysozyme. The mixture was left at room temperature 
(RT) for 30 min before the addition of 800 ul of 250 mM EDTA 
and 3.2 ml of 50 mM Tris.HCl (pH 8 ), 62.5 mM EDTA, 0.5% 
TritonX-100. Following a further 15 min incubation, the 
mixture was centrifuged at 3 5,000 (Beckman Type 65 rotor in 
Oakridge tubes) for 30 min at 4°C. The supernatant, 
containing the extracted plasmid DNA, was decanted into a 15 
ml Falcon tube and after adjusting the volume to 7.5 ml with 
H2O, 7.5 g of caesium chloride were added to the DNA to give 
a final density of 1.55 to 1.60 g/ml. The caesium chloride 
was thoroughly mixed until dissolved and following the 
addition of 200 ul of 10 mg/ml ethidium bromide, samples 
were centrifuged in sealed plastic tubes at 44,000 rpm 
(Beckman Type 65 rotor) for 40 h at 15°C. Ethidium bromide 
bands were visualised under long wave U.V. light and the 
lower band containing the supercoiled plasmid DNA was 
collected from immediately below with a syringe.
The ethidium bromide was removed by successive 
extractions (usually x 4) with an equal volume of isoamyl 
alcohol until no ethidium bromide was detected under long 
wave U.V. light. The DNA was then dialysed against TE at 
4°C for 2-3 h with one change of buffer and finally stored 
at -20°C.
(c) quantitation of plasmid DNA preparations
A small quantity of plasmid DNA was linearised with 
an appropriate restriction enzyme and resolved on an agarose 
gel along with a digested DNA sample of standard DNA of 
known concentration (previously quantified by UV 
absorbance). DNA bands were visualised under U.V. light and 
photographed using type 665 Polaroid film. DNA 
concentrations were obtained by densitometric analysis of 
the resulting band on the negative polaroid 665 film using 
the data system for the Hoefer GS-360 scanning densitometer. 
Within the ranges used, there was a linear relationship 
between the amount of DNA present and the area under the 
peak corresponding to the DNA band on the negative.
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(d) small scale preparations of plasmid DNA
Transformed E .coli DH-1 colonies were picked and 
resuspended in 2 ml of L-broth and 50 ug/ml of ampicillin 
and shaken overnight at 3 7°C. 1.2 ml samples were pelleted
in 1.5 ml Eppendorf tubes in a high speed SE microfuge (MSE 
microcentaur at 13,000 rpm) for 20-30 sec and the 
supernatant aspirated off. The pellet was dispersed by 
vortexing briefly before adding 100 ul of STET buffer and 16 
ul of 10 mg/ml lysozyme. After vortexing, the mixture was 
heated at 100°C for 2 min, with caps off, and then 
centrifuged in a high speed microfuge for 15 min. The 
gelatinous pellet was removed with a sterile tooth-pick and 
100 ul of isopropanol added to the supernatant. The mixture 
was briefly vortexed and incubated at RT for 10 min before 
spinning in a high speed microfuge for 3 min. The 
supernatant was poured off and the pellet lyophilised and 
resuspended in 5 0 ul of 3 mM EGTA.
6 . Restriction enzyme digestion of DNA
DNAs were digested in f^O containing the 
appropriate concentration of commercial restriction enzyme 
buffer (BRL) and the restriction enzyme (normally 1 unit/ug 
DNA). For the preparation and analysis of DNA fragments, 
the digestion was normally carried out in a 30 ul volume and 
incubated at 37°C for 3-4 h.
For the analysis of small scale plasmid DNA 
preparations, 3 ul of the sample were digested in a 10 ul 
volume also containing 10 ug/ml RNase A for 1 h at 3 7°C and 
electrophoresed on a mini-gel. For the digestion of high 
molecular weight cellular DNA and HSV DNA, digestion was 
carried out for a minimum of 6-8 h at 3 7°C.
7. Purification of DNA fragments from plasmids
(a ) by agarose gel electrophoresis
Plasmids were cleaved with appropriate restriction 
enzymes and fragments separated by electrophoresis on a 1% 
agarose gel. The DNA was visualised under long wave U.V. 
light and the required band excised from the gel. The gel 
slice was placed in a bag prepared from boiled dialysis
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tubing with 0.5 ml of 0.5 x TBE and immersed in a shallow 
layer of 0.5 x TBE in an electrophoresis tank. After 
electroelution at 200 V for 2-3 h, the current was briefly 
reversed to remove the DNA from the side of the bag. The 
DNA in solution was purified over a DEAE-sephacel column. A 
0.5 ml DEAE-sephacel column was washed with TE + 0.1 M NaCl 
before applying the DNA in solution. The flow through was 
collected and re-applied to the column. The bound DNA was 
washed with 5 ml of TE + 0.1 M NaCl and eluted with two 
aliquots of 0.2 5 ml of TE + 1 M NaCl. The eluate was 
divided between two Eppendorf tubes and DNA precipitated 
with 2 vols of ethanol overnight at -20°C, spun down in a 
high speed microfuge for 10 min, washed in 70% ethanol, 
lyophilised and resuspended in TE.
(b) by low melting point (LMP) agarose gel electrophoesis
Digested DNA was electrophoresed in a 1% LMP 
agarose mini-gel in TBE at 4°C. DNA fragments were 
visualised under long wave U.V. light and the required gel 
slice was excised and placed in a 1.5 ml Eppendorf tube.
Two volumes of TEN (w/v gel slice:TEN) were added to the gel 
slice and heated at 70°C for 10 min to melt the agarose. An 
equal volume of phenol, heated to 7 0°C, was added to the 
melted agarose and vortexed thoroughly for 2 min. After 
centrifugation in a high speed microfuge for 5 min, the 
aqueous phase was re-extracted with an equal volume of 
phenol at RT. Samples were then extracted once with 
chloroform, ethanol precipitated, lyophilised and 
resuspended in TE.
(c ) by polyacrylamide gel electrophoresis
Small (100 bp) end-labelled fragments were resolved 
on 8% polyacrylamide gels. After electrophoresis, one glass 
plate was removed and the wet gel covered with cling film 
before exposure to autoradiography film at RT for 2-3 min. 
Alignment of the autoradiograph with the wet gel enabled the 
relevant band to be excised and placed in an Eppendorf tube. 
The gel slice was submerged in 0.5 ml of elution buffer (500 
mM NH4OAc, 10 mM MgCl2 , 0.1% SDS and 1 mM EDTA) and eluted 
overnight at 37°C with constant agitation. The buffer 
containing DNA was extracted sequentially with
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phenol:chloroform (1 :1 ) and chloroform, and precipitated in 
two volumes of ethanol in a dry ice bath for 10 mins. After 
pelleting the DNA for 15 min in a high speed microfuge, the 
pellet was washed in 100% ethanol, lyophilised and 
resuspended in
8 . Radioactive labelling of DNA fragments and 
oligonucleotides
(a) 3 1 end-labelling
Plasmid DNA (approximately 2 ug) was cleaved at the 
relevant restriction enzyme site to produce a 5' overhang, 
sequentially extracted with phenol and chloroform, ethanol 
precipitated and resuspended in an appropriate volume of 
H2O. Synthetic oligonucleotides were synthesised such that 
on annealing complementary strands, a 5' overhang was 
formed. The DNA to be labelled was added to a reaction mix 
containing NTP buffer (500 mM Tris.HCl pH (7.8), 50 mM 
M g C^/ 10 mM DTT) , 20 uCi of the appropriate radiolabelled 
deoxyribonucleoside triphosphate, 40 nM of the other three 
unlabelled dNTPs and 2 units of the large fragment of E.coli 
DNA pol I, and left at RT for 30-45 min. Finally, 
unlabelled dNTP corresponding to the initial label was added 
to 40 nM and incubation continued for 15 mins to produce 
labelled fragments with blunt ends. End-labelled DNA was 
purified from unincorporated dNTPs by polyacrlyamide gel 
electrophoresis {7(c)}.
(b) 5 1 end-labelling of oligonucleotides
Oligonucleotides (200 ng) were resuspended in
kinase buffer (50 mM Tris. HCl pH (7.6), 10 mM M g C ^  r 0*1 mM
EDTA, 0.1 mM spermidine, 5 mM DTT) containing 20 uCi of [Y  
3 2- P]-ATP and 5 units T4 polynucleotide kinase and incubated 
at 3 7°C for 30 min. The DNA was sequentially extracted with 
phenol and chloroform and precipitated with ethanol in a 
dry/ice ethanol bath. After pelleting the DNA for 15 min in 
a high speed microfuge, the pellet was lyophilised and 
resuspended in E^O.
(c) internal labelling of plasmid DNA by nick translation
200 ng of plasmid DNA were radiolabelled (Rigby et
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al. , 1977) by the addition of 20 uCi of [<*-32P ]dATP, 1 unit
—7
of E.coli DNA polymerase holoenzyme and 5 x 10 ug/ml of 
DNase I in a final volume of 20 ul of NTP buffer containing 
40 nM each of dGTP, dCTP and dTTP. After a brief incubation 
at 37°C, the reaction mix was left at RT for 2-3 h. The 
reaction was stopped by the addition of 100 ul of TEN (pH
8.3), 10 ul of 5 x SB. To purify the labelled plasmid DNA 
from unincorporated dNTPs, the reaction was loaded on a 
Sephadex G-5 0 column. Sephadex beads were pre-swollen 
overnight in TE. Columns were prepared in plastic 5 ml 
pipettes with siliconised glass wool plugs and pre-run with 
20 ml of TE. The column was loaded with the stopped 
reaction and the fastest eluting fraction, detected by 
monitering flow through with a Geiger counter, collected.
9. DNA cloning
(a) preparation of competent bacteria
The method used was based on that of Maniatis et 
al. (1982). A 1 ml aliquot from an overnight standing 
culture of bacteria was used to inoculate 40 ml of L-broth. 
The culture was then grown at 37°C to an O.D. of 0.2 at 630 
nm. Bacteria were pelleted at 9,000 rpm (Sorval SS34 rotor) 
for 1 min and resuspended in 2 0 ml of 10 mM CaC^. After a 
brief vortex, cells were again pelleted before resuspension 
in 20 ml of 75 mM C a C ^ *  Cells were incubated on ice for 20 
min and pelleted. The cell pellet was resuspended in 1-2 ml 
of 75 mM CaCl2 an<3 divided into 200 ul aliquots. 50 ul of 
80% glycerol was added to each aliquot, mixed and stored at 
-7 0°C.
(b ) preparation of ampicillin plates
L-broth agar was melted and then allowed to cool 
until hand hot. Ampicillin was added to a concentration of 
50 ug/ml and the agar poured into 90 mm sterile Petri dishes 
and allowed to set. The plates were dried overnight in an 
inverted position at 37°C before being stored at 4°C.
Plates were normally used within three weeks.
(c ) cloning of DNA fragments
DNA was cloned into the appropriate restriction
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sites (normally BamHI-Sall) in the polylinker of pTZl9U.
The vector was digested in the presence of 1 unit of calf 
intestinal phosphatase to minimise re-ligation of plasmid 
molecules. The DNA to be inserted was either purified from 
a starting plasmid by agarose gel electrophoresis {4 (a)} or 
the plasmid was additionally digested with an enzyme which 
cleaves the ampicillin resistance gene. Prior to ligation 
reactions, the DNA was extracted sequentially with phenol 
and chloroform, precipitated with ethanol, lyophilised and 
resuspended in ^ O .
For ligation, DNA was incubated with BamHI-Sall 
digested pTZl9U (2 ug in 50 ul reaction) at a ratio of 5:2 
insert:vector in ligase buffer (50 mM Tris.HCl pH (7.5), 10 
mM M g C ^ f  1 mM ATP, 2 0 mM DTT, 5 0 ug/ml bovine serum 
albumin) containing 0.5 units of T4 DNA ligase and left 
overnight at RT.
(d) transformation of bacteria
A 200 ul aliquot of competent bacterial cells was
thawed and placed on ice for 10 min. 10 ul of ligation mix
were added to the cells, gently mixed and incubated on ice
for a further 30 min. The cells were then heat-shocked at
42°C for 90 sec, placed back on ice for 6 0 sec before adding
400 ul of L-broth. The cells were further incubated at 37°C
for 1 h. 100 ul of cells were spread onto ampicillin plates
-1 -2at various dilutions (usually 0 , 10 , 1 0  ) and incubated
overnight at 3 7°C. Small scale DNA preparations were made 
from individual colonies transformed to ampicillin 
resistance {5(d)} and analysed on a mini-gel. Cultures were 
grown from positive clones and stored in 7% DMSO at -70°C.
10. Synthesis, purification and annealing of 
complementary oligonucleotides
Synthetic oligonucleotides were synthesised on a 
Biosearch 8600 DNA synthesiser using the macroscale 
synthesis procedure. The DNA was eluted from the column by 
resuspending the beads in 1 ml of ammonia. The ammonia 
solution was incubated at 55°C for 5 hr and removed by 
lyophilisation. The samples were resuspended in 40 ul H^O,
20 ul of which was stored at -7 0°C and the remainder
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lyophilised before resuspending in TBE containing 90% 
formamide. The sample was purified by denaturing 
polyacrylamide gel electrophoresis using a 15% 
polyacrylamide gel (29:1) containing 8 M urea in TBE. 2 ul 
of a formamide-dye mix {4(d)} was loaded in a separate well 
to act as a migration marker. The gels were electrophoresed 
at 250 V until the BPB had migrated 2/3 through the gel.
To visualise the DNA, the gel was removed from the 
glass plate onto cling film and viewed against a thin layer 
chromotography plate with an angled short wave U.V. lamp.
The DNA in the gel absorbs the U.V. radiation and appears as 
a dark band against a uniform fluorescent background 
contributed by the chromotographic plate. The top band was 
excised and eluted as described in 7(c). Finally, the 
recovered DNA was resuspended in ^ 0  and the O.D. at 260 nm 
and 280 nm, determined. For synthetic oligonucleotides, the 
conversion factor is taken as 1 O.D. unit at 260 nm =20 
ug/ml.
Based on O.D. calculations, approximately equal 
amounts of oligonucleotides were run on an agarose gel and 
photographed using Polaroid 665 film under U.V. 
illumination. The relative concentrations were calculated 
using the data program for the Hoefer GS-360 scanning 
densitometer. DNA solution volumes were re-adjusted (if 
necessary) to equalise the oligonucleotide concentrations of 
complementary strands.
Equal amounts of complementary strands (normally 2 
ug of each) were mixed together in a 100 ul final volume 
with H^O, heated in a boiling bath for 2-3 mins and 
incubated at 37°C for 30 min. To check the efficiency of 
annealing, one of the strands was 5' end-labelled before 
annealing to the complementary strand. Aliquots of labelled 
ss and annealed oligonucleotide were analysed on a 
non-denaturing polyacrylamide gel (Fig. 2.3). As the 
annealing efficiency was greater than 95%, 100% efficiency 
was assumed for calculating the final concentration of ds 
oligonucleotides.
11. Expression of Staphylococcus aureus protein A:UL9 
fusion proteins in E.coli
1 2
Figure 2.3 Efficiency of annealing of complementary 
oligonucleotides
A single-stranded oligonucleotide;
[A ]= 5' GATCCGCGAAGCGTTCGCACTTCGTCCCA 
32was 5 1 P-labelled and annealed to an equimolar amount of 
its complementary strand;
[3]= GCGCTTCGCAAGCGTGAAGCAGGGTCTAG 5'
Aliquots of oligonucleotide [A] before (track 1) and after 
(track 2) annealing were resolved on a 8% non-denaturing 
polyacrylamide gel.
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E.coli strain Kl2AHlAtrp cells (Bernard et al.f 
1979) containing the fusion protein constructs (see 
materials) were propagated at 28°C. To induce synthesis of 
the fusion proteins, bacteria were grown to an O.D. of 0.4 
at 630 nm in 50 ml L-broth and rapidly shifted to 42°C for 
75 min. Total cellular extracts were prepared as described 
in 12(b).
12. Preparation of extracts for DNA binding studies
(a) preparation of nuclear extracts from cells infected 
with virus or transfected with viral DNA
BHK cell monolayers were infected with 5 pfu/cell 
of virus and incubated at 37°C or 38.5°C for 8 h or 31°C for 
12-16 h. For transfection experiments, approximately 10 ug 
of HSV-1 digested DNA, or plasmids containing HSV-1 
replication genes (0.5 ug of each), were made up to a total 
of 15 ug of DNA with calf thymus carrier DNA, transfected 
onto BHK cells as described in section 14 and incubated at 
37°C for 24 h. Nuclear extracts were prepared using the 
following methods:
Method A - Extracts were prepared essentially as described 
by Piette et al . (1985). Infected cells from 3 x 90 mm 
plates were harvested by scraping into ice-cold PBS and 
pelleted by centrifugation at 2,000 rpm (Sorval SM24 rotor) 
for 5 min. All subsequent procedures were carried out at 
4°C. The cell pellet was resuspended in 3 ml of buffer A 
(10 mM Hepes (pH 8.0), 50 mM NaCl, 0.5 M sucrose, 1 mM EDTA, 
0.5 mM spermidine, 0.15 mM spermine, 1 mM PMSF, 7 mM
2-mercaptoethanol, 0.5% Triton X-100) and disrupted using 12 
strokes of a Dounce homogeniser with a B-type pestle. After 
centrifugation at 2,000 rpm (Sorval SM24 rotor) for 10 min, 
nuclei were resuspended in 1 ml of buffer B (10 mM Hepes (pH 
8.0), 25% glycerol, 0.1 mM EDTA, 0.5 mM spermidine, 0.15 mM 
spermine, 1 mM PMSF, 7 mM 2-mercaptoethanol) containing 100 
mM NaCl and after 15 min of gentle agitation, centrifuged at 
5,000 rpm for 10 min. The supernatant was removed and the 
nuclei were resuspended in 1 ml of buffer B containing 600 
mM NaCl. After gentle agitation for 30 min, the nuclei were 
pelleted at 15,000 rpm (Sorval SS34 rotor using Eppendorf
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tube adaptors) for 15 min and the supernatant brought to 45% 
saturation using solid (NH4 )2SC>4 . Proteins were 
precipitated by centrifugation at 15,000 rpm (Sorval SS34 
using Eppendorf tube adaptors) for 15 min. The pellet was 
resuspended in 100 ul of buffer B containing 100 mM NaCl. 
Aliquots of the resulting extract were flash frozen in a dry 
ice/ethanol bath and stored immediately at -7 0°C.
Method B - Extracts were prepared essentially as described 
by Dignam et a l . (1983) and modified by Preston et al.
(1988). Cells from 3 x 90 mm plates were harvested as 
described above and washed with PBS. The cell pellet was 
resuspended in 200 ul 90 of lysis buffer A (10 mM Hepes (pH 
7.9), 1.5 mM MgCl2 , 10 mM KCl, 0.5% NP4 0, 0.5 mM DTT and 0.5 
mM PMSF) and gently pipetted at 3 min intervals for 10 min. 
Nuclei were pelleted by successive centrifugation at 2,000 
rpm for 5 min and 12,0 00 rpm (Sorval SS3 4 using Eppendorf 
tube adapters) for 15 min, and resuspended in 100 ul of 
buffer C (20 mM Hepes (pH 7.9), 25% glycerol, 1.5 mM MgCl2 ,
0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTT) containing 600 mM 
NaCl. Proteins were eluted by gentle pipetting at regular 
intervals for 30 min before centrifugation at 15,000 rpm for 
20 min. The supernatant, designated nuclear extract, was 
flash frozen in aliquots using a dry ice/ethanol bath and 
immediately stored at -7 0°C.
(b) preparation of extracts from bacterial cells
Heat-induced bacterial cells were pelleted at 4,000 
rpm (Sorval SS34 rotor) for 7 min, washed twice in 10 ml of 
TE and finally resuspended in 1 ml of TE and spun down in a 
high speed microfuge. The pellet was resuspended in 400 ul 
of buffer C (see method B) containing 600 mM KCl. The 
suspension was sonicated using a probe sonicator at 70 W, 
four times for 1 sec with 30 sec intervals on ice and 
centrifuged in a high speed microfuge for 10 min at 4°C.
The resulting supernatant was aliquoted, flash frozen in a 
dry ice/ethanol bath and stored at -70°C for use in gel 
retardation assays.
13. Estimation of protein concentration
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Estimates of total protein concentration in nuclear 
extracts were obtained using Bio-Rad protein assay dye 
reagent. 5 ul of cell extract was diluted in 1 ml of E^O 
and 800 ul of the diluted protein sample mixed with 200 ul 
of dye reagent and left at RT for 10 min. The absorbance of 
the solution was measured at 5 95 nm and converted to 
milligrams of protein by comparison to a standard curve 
produced by using known quantities of BSA made up in f^O and 
diluted as described for the cell extract.
14. Plasmid amplification assay (Stow, 1982)
(a) transfection of cells with DNA and virus superinfection
Monolayers of BHK cells in 50 mm Petri dishes were 
transfected with supercoiled plasmid containing HSV-1 ori O
fragments in the presence of 10 ug of calf thymus carrier 
DNA using the calcium phosphate technique (Graham and van 
der Eb, 1973). The DNAs were mixed in 1 ml of HeBS buffer 
(13 7 mM NaCl, 5 mM KCl, 0.7 mM Na2H?C>4 , 5.5 mM D-glucose, 21 
mM Hepes, pH adjusted to 7.05 with NaOH). 2 M CaCl2 was
added to the DNA solution to give a final concentration of 
125 mM and 500 ul of the fine suspension which formed were 
added to cell monolayers from which growth medium had been 
removed. The plates were incubated at 3 7°C for 45 min and 
overlaid with 4 ml of ECS. Each monolayer received an 
amount of plasmid DNA calculated to contain the same number 
of plasmid molecules as present in 0.24 ug pATl53 (Stow and 
McMonagle, 1983). The cells were given a dimethyl 
sulphoxide boost (Stow and Wilkie, 1976) 4 h after 
tranfection. The growth medium was removed from the plates 
and cells washed with 4 ml of GMEM wash. 1 ml of a 25% DMSO 
solution (diluted in HeBS) was added to the plates for 4 
min. The DMSO was removed, plates washed and overlaid with 
EC5 and incubated at 37°C. Six h after transfection, the 
cells were either mock-infected or superinfected with wt 
HSV-1 or ts mutants at a moi of 5 pfu/cell and incubated in 
EC5 at the appropriate temperature.
(b ) preparation of total cellular DNA
Growth medium was removed from plates 2 4 h post
transfection and the cells incubated at 37°C for 5 h with 2
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ml of lysis buffer (0.6% SDS, 10 mM EDTA, 10 mM Tris.HCl (pH
7.5) containing 500 ul of proteinase (type XIV from 
Streptomyces griseus) per ml. NaCl was added to a final 
concentration of 200 mM followed by sequential extraction 
with phenol and chloroform. DNA was precipitated in ethanol 
overnight at -20°C, pelleted by centrifugation at 7,000 rpm 
(Sorval SM24 rotor) for 20 min, lyophilised and resuspended 
in TE containing RNase A (10 ug/ml).
1/15 of the total DNA extracted from a 50 mm plate 
was digested with Dpnl and EcoRI. Dpnl cleaves the sequence 
GATC provided the A residue is methylated (Lacks and 
Greenberg, 1977). Plasmid DNA which has been methylated by 
the dam methylation system of E .coli, can be digested into 
several fragments. Following replication of the vector 
sequences in eukaryotic cells, GATC sequences containing 
unmethylated A residues are produced which are resistent to 
Dpnl. EcoRI cleaves the replicated plasmid DNA (in the form 
of long concatemeric molecules; Stow, 1982) into unit length 
plasmid molecules.
(c) Southern transfer of DNA to nitrocellulose
Digested DNA samples for Southern transfer 
(Southern, 1975) were run on a 1% agarose gel in Loening's 
buffer. Following electrophoresis, the gel was gently 
shaken, first in gel soak I for 45 min, then in gel soak II 
for 45 min. The DNA was blotted overnight onto a pre-soaked 
nitrocellulose filter using 6 x SSC, a wick of Whatman 3 mm 
paper and a weighted capillary stack of absorbent paper 
towelling. The filter was then air dried and baked at 80°C 
for 2 h in a vacuum oven prior to hybridisation.
(d) DNA:DNA hybridisation
Nitrocellulose filters were incubated in 20 ml of
prehybridisation buffer for 2-3 h at 65°C with constant 
7 8agitation. 1 0 - 1 0  cpm of nick translated probe DNA was 
denatured by the addition of 1/10 vol of 2 M NaOH for 10 min 
then neutralised with 2 M HCl before adding to 10 ml of 
hybridisation buffer. The prehybridisation buffer was 
removed and replaced by hybridisation mix containing the 
denatured labelled DNA. Hybridisation was carried out at 
65°C overnight with constant agitation. The filter was then
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washed twice for 1 h in 2 x SSC, 0.25% SDS at 65°C. The 
filter was blotted onto tissue paper before exposure to 
autoradiography film at -70°C.
15. In vitro transcription and translation of pTZ plasmids
The pTZ derived plasmids were linearised 3 1 to the 
coding sequence with an appropriate restriction enzyme, 
extracted with phenol and chloroform and ethanol 
precipitated.
In vitro transcription was performed using the 
Riboprobe system (Promega Biotech) following the 
manufacturer's protocol. 1 ug of linearised DNA was mixed 
with 5 ul 5 x SP6 buffer (200 mM Tris.HCl (pH 7.5), 30 mM 
M g C ^ /  10 mM spermidine, 0.01% BSA, 10 mM DTT, 0.4 mM each 
of ATP, LJTP, CTP, GTP, 0.5 mM G ( 5 ' ) ppp( 5 1 ) G , 40 units of 
RNasin and 10 units of T7 RNA polymerase in a total volume 
of 25 ul. The reaction mixture was incubated at 37°C for 1 
h.
In vitro translation was carried out by adding 2.5
ul of the transcription reaction mixture to 20 ul of rabbit
reticulocyte lysate. Duplicate samples were incubated at
31°C for 90 min, either in the absence or presence of 25-50 
35uCi [ S]-methionine in a 25 ul volume. The samples were 
treated with 200 ug/ml RNase A, 2 0 mM EDTA for 15 min at 
31°C. Non-radioactive samples were used immediately in gel 
retardation assays (described below) and radiolabelled 
translation products were analysed by SDS-polyacrylamide gel 
electrophoresis {section 4(e)}.
16. Preparation of sonicated calf thymus DNA
Approximately 5 0 mg of calf thymus DNA were 
resuspended in 5 ml of H2O and sonicated 3 times using a 
probe sonicator at 100 W for 30 sec with 30 sec intervals on 
ice. The sonicated DNA.was sequentially extracted with 
phenol (x 3) and ether (x 3), then dialysed overnight 
against 1 L of H20. The O.D. 260 nm was measured and the 
volume of DNA adjusted to give a final concentration of 1 
mg/ml before storing at -20°C.
17. Gel retardation assay
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The method used was essentially as described by
Schneider et a l ., (1986). Probe fragments, 3 1 end-labelled 
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with IX.- P] deoxyribonucleoside triphosphates were eluted 
from 8% non-denaturing polyacrylamide gels and extracted 
sequentially with phenol and chloroform and precipitated 
with ethanol. Either 1 ng of labelled oligonucleotide (44 
fmoles) or 5 ng of labelled 100 bp fragment (75 fmoles) were 
incubated at 25°C with 2 ug of sonicated calf thymus DNA and 
5 ug of extract in a 20 ul reaction mix containing buffer C 
plus 100 mM NaCl. After 20 min, 5 ul of loading buffer (25% 
glycerol, 10 mM DTT and 0.01% BPB in TBE) were added and the 
samples loaded onto 5% polyacrylamide gels (55:1 
acrylamide:N,N'-methylene bisacrylamide) containing TBE.
Gels were run in TBE at 25 mA for 1.5-2 h, fixed in 10% 
acetic acid, dried and exposed to autoradiography film at 
-7 0°C.
For assays containing proteinase or antisera, the 
reagents were added 10 min after the extract and incubation 
continued for a further 10 min. 1 ul of antiserum was added 
to the 20 ul binding reactions.
18. Plasmid DNA sequencing
Plasmid DNA was sequenced following a dideoxy 
sequencing protocol using denatured plasmid templates 
described by Hattori and Sakaki (1986).
(a) preparation of denatured plasmid templates
15 ml overnight cultures from single transformed 
colonies were pelleted at 10,000 rpm (Sorval SS34 rotor) for 
15 min and resuspended in 1 ml of lysozyme solution (0.4% 
lysozyme, 2 5 mM Tris.HCl (pH 7.5), 10 0 mM EDTA, 5 0 mM 
glucose) and after 5 min at RT, mixed with 2 ml of 0.2 M
NaOH, 1% SDS, vortexed and incubated on ice for 5 min. 1.5 
ml of potassium acetate solution (3 M KOAc, 11.5% glacial 
acetic acid) was added to the sample which was vortexed and
incubated on ice for a further 5 min. The sample was
centifuged at 10,000 rpm (Sorval SS34 rotor) for 15 min at 
4^C and the supernatant extracted once with 
phenol/chloroform (1 :1 ) and precipitated with 2 vols of 
ethanol at RT for 15—30 min. The DNA was pelleted at 10,000 
rpm (Sorval SS34 rotor) for 15 min at 4°C, washed in 70%
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ethanol and lyophilised. The DNA pellet was resuspended in 
100 ul TE containing 2 ul of 10 mg/ml RNase A solution at 
37°C for 30 min. The DNA was precipitated by the addition of 
60 ul of 20% polyethylene glycol 6000, 2.5 M NaCl for 1 h at 
4°C. The sample was centrifuged in a high speed microfuge 
for 5 min, the pellet washed in ethanol and lyophilised 
before resuspending in 18 ul TE.
2 ul of 2 M NaOH was added to the 18 ul DNA sample 
and left at RT for 5 min. The denatured DNA was 
precipitated by the addition of 8 ul of 5 M ammonium acetate 
and 100 ul of ethanol for 5 min at -7 0°C. The DNA was 
pelleted in a high speed microfuge for 10 min, washed in 70% 
ethanol and lyophilised. The pellet was resuspended in 20 
ul of H2O and 3 ul were used for dideoxy sequencing 
reactions.
(b) dideoxy sequencing
The sequencing reactions were performed using T7
DNA polymerase following the manufacturer’s protocol
(Pharmacia). 3 ul of denatured DNA sample were incubated
with 5 ul of f^O, 1 ul of TM buffer (280 mM Tris.HCL (pH
7.5), 150 mM MgCl^r 350 mM NaCl) and 1 ul (5 ng) of
universal or T7 promoter primer at 37°C for 30 min to allow
annealing of the primer to the DNA template. In the
meantime, labelling reactions were set up in Eppendorf tubes
such that for one set of reactions (i.e. G, A, T and C) the
mix contained 1 ul of 100 mM DTT, 2 ul of labelling mix (2
3 5
uM dGTP, dCTP, TTP) 20 uCi [ - SJdATP and 3 units of T7 DNA 
polymerase.
Termination mixes contained 150 uM dGTP, dATP, 
dCTP, TTP and 15 uM of either dideoxy (dd) ATP (A-mix), or 
ddCTP (C-mix), or ddGTP (G-mix), or ddTTP (T-mix), 20 mM 
Mg C l2 / 4 0 mM Tris.HCl (pH 7.5) and 50 mM NaCl. 2.5 ul of 
termination mix was added to Eppendorf tubes labelled G, A,
T or C and incubated at 3 7°C. After the 30 min annnealing 
reaction, the labelling reaction (5.5 ul) was added to the 
annealing mix and 3.5 ul of the mixture added to each of the 
G,A,T,C tubes containing the corresponding termination mix. 
The samples were incubated at 3 7°C for 15 min and the 
reaction stopped by adding 4 ul of stop dyes (95% deionised 
formamide containing 20 mM EDTA (pH 7.5), 0.05% (w/v) xylene
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cyanol and 0.05% BPB). The samples were boiled for 2-3 min 
at 100°C and 2-3 ul of each reaction resolved on a 6% 
denaturing polyacrylamide sequencing gel {4 (b)}.
19. DNase I footprinting assays
(a) chemical sequencing reactions
3 1 end-labelled DNA fragments were cleaved using 
the chemical methodology of Maxam and Gilbert (1980). This 
involves the modification of bases, in reactions that are 
relatively base-specific, followed by cleavage at the 
modified bases by piperidine. As these reactions served as 
markers for locating the bases protected from DNase I 
digestion by DNA binding protein, only G and G+A reactions 
were used.
Uniquely end-labelled DNA restriction fragments 
were generated by 3' end-labelling a restriction enzyme 
site, inactivating the large fragment polymerase by heating
to 70°C for 10 min and cutting the plasmid with a second
enzyme to release the uniquely end-labelled fragment. The 
fragment was purified on a non-denaturing polyacrylamide gel 
as described in 4(b) and 10 cpm aliquots reacted to modify 
purine bases. The end-labelled DNA was first heated to 90°C 
for 1 min in the presence of 1 ug sonicated carrier DNA and 
chilled on ice.
(i) G reaction
The labelled DNA (10-15 ul) was incubated with 200 
ul of G buffer (50 mM sodium cacodylate (pH 8 ), 10 mM M g C ^
and 1 mM EDTA) and 1 ul of dimethyl sulphate at RT for 10
min. The reaction was stopped by the addition of 5 0 ul of 
DMS stop buffer (1.5 M NaOAc, 1 M 2-mercaptoethanol, 40 
ug/ml sonicated carrier DNA) and DNA precipitated with 750 
ul of ethanol in a dry ice/ethanol bath and pelleted for 5 
min in a high speed microfuge. The DNA was resuspended in 
250 ul of 2 M NH^OAc, 0.1 mM EDTA, precipitated with 750 ul 
of ethanol in a dry ice/ethanol bath, pelleted, washed and 
lyophilised.
(ii) G+A reaction
The labelled DNA (10 ul) was mixed with an equal
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volume of , 3 ul of pyridinium formate (4% formic acid pH 
adjusted to 4 by the addition of piperidine - 15ul/ml of 
solution) and incubated at 3 7°C for 2 5 min. The sample was 
chilled in a dry ice/ethanol bath, lyophilised, resuspended 
in 20 ul H^O, and lyophilised again.
(iii) piperidine cleavage reaction
10 ul of 5 M NH^OH was added to all dried modified 
DNA samples, without mixing, and lyophilised. Then, 100 ul 
of 1 M piperidine was added to each sample and heated at 
90°C for 30 min. Samples were chilled and transferred to a 
new tube containing 10 0 ul of 2 M NH4OAc, 0.1 mM EDTA. DNA 
was precipitated by the addition of 800 ul of ethanol in a 
dry/ice ethanol bath, pelleted, washed and lyophilised.
(b) DNase I footprinting assay
These assays were performed essentially as 
described by Dynam (1987) and Preston et a l . (1988). DNA
binding reactions were set up as described in section 17,
5 ousing 10 cpm of labelled probe. After incubation at 25 C
for 20 min, MgCl^ and DNase I were added to final
concentrations of 5 mM and 6 ug/ml respectively. After
further incubation at 25°C for 3 min, digestion was
terminated by the addition of EDTA to a final concentration
of 10 mM. Samples were loaded onto an 8% non-denaturing
polyacrylamide gel. After electrophoresis, the wet gel was
exposed to autoradiography film for 1 h at 4°C. Bands
containing complexed and free DNA were excised and the DNA
recovered by electroelution was extracted sequentially with
phenol and chloroform and precipitated with ethanol.
Recovered DNA fragments were analysed on 6% denaturing
polyacrylamide gels together with markers obtained by G and
G+A sequencing reactions performed on both strands of the
DNA as described in part (a). Prior to electrophoresis, all
lyophilised samples were resuspended in stop dyes {section
18(b)} and heated to 100°C for 2 min.
In some experiments, the binding reactions were
directly extracted with phenol and chloroform and then
ethanol precipitated. The mixture of bound and free DNA
recovered was analysed on a denaturing polyacrylamide gel as
described above.
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20. Oligonucleotide-directed mutagenesis
Specific deletions and point mutations were 
introduced into the pSTl9 ori -containing fragment 
essentially as described by Mead et al . (1986) and Kunkel
(1985). The method of Kunkel employs a labile uracil-rich 
parental DNA strand isolated from an E .coli strain which 
lacks the enzymes uracil DNA glycosylase (ung ) and dUTPase 
(dut ). When these bacteria are transformed with pTZ 
phagemid vectors and subsequently grown and superinfected 
with helper phage in medium containing a high uridine 
concentration, uracil is incorporated into newly synthesised 
ssDNA. Following the annealing of the mutagenic 
oligonucleotide to extracted uracil-rich ssDNA and 
conversion to dsDNA in vitro, the DNA molecules are 
transformed back into an ung+ , dut+ strain (e.g. DHl). In 
this host the uracil rich strand undergoes extensive repair 
synthesis, hence enriching for the plasmid molecules 
containing the specific mutation.
(a) procedure for obtaining and purifying uracil-rich ssDNA
E.coli BW313 (ung , dut ) were transformed with 
pSTl9 and 12.5 ml of an overnight culture used to inoculate 
250 ml of 2 x YT broth containing 0.25 mg/ml of uridine.
Once the bacteria had grown to an O.D. of 0.3 at 630 nm, the 
culture was infected with phage M13 R408 at a moi of 10. 
After an 8 h infection, the culture was pelleted at 9,000 
rpm (Sorval GSA rotor) for 10 min. The phage containing 
ssDNA in the supernatant could be stored at 4°C. The phage 
were precipitated by adding 1/4 vol of 20% polyethylene 
glycol 6000, 3.5 M NH^OAc, incubating on ice for 30 min and 
then pelleted at 12,000 rpm (Sorval SS34 rotor) for 15 min. 
The tube was well drained and the pellet lyophilised 
thoroughly before resuspension in 200 ul of TE. The DNA was 
extracted with phenol/chloroform (1 :1 ) until no interface 
was visible (approximately 6-7 times). Following ethanol 
precipitation and lyophilisation, the pellet was resuspended 
in 20 ul f^O.
(b ) site-directed mutagenesis
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The appropriate mutagenic oligonucleotide was 5 1 
phosphorylated by incubating 100 ng of oligonucleotide in 
ligase buffer {9(c)} with 2 units of polynucleotide kinase 
at 37°C for 30 min. Half of the reaction was annealed to 
the complementary uracil-rich ssDNA at a molar ratio of 10:1 
by incubating at 65°C for 10 min and allowing to cool slowly 
to RT. Ds DNA was synthesised using the Klenow fragment of 
DNA polymerase I and T4 DNA ligase in the presence of 100 uM 
of all four dNTPs, 1 mM ATP and 10 0 ug/ml of gene 3 2 
protein. The reaction mix was incubated at 15°C and 1/4 of 
the products used to transform E.coli DHl (ung+ , dut+ ) to 
ampicillin resistance. Individual colonies were picked and 
plasmids carrying the desired mutations were identified by 
sequencing the complete insert as described in section 18.
21. Computing
Computer analysis of DNA and protein sequence were 
performed on the MicroVAX 11 and PDP 11/14 computers in this 
department, using primarily the University of Wisconsin 
Genetics Computer Group software package.
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CHAPTER 3 ; RESULTS
SECTION 3A : Origin binding activity in cells infected 
with wt HSV-1
As described in the introduction, Elias et al. 
(1986) demonstrated the presence of a protein in HSV-1 
infected cell nuclear extracts that bound to a specific 18 
bp sequence at the left hand end of the HSV-1 ori
O
palindrome (Fig. 1.6). The origin binding activity was 
detected using nuclear extracts from large numbers of 
infected cells (20-30 g) which had been partially purified 
on a phosphocellulose column. Fractions from the column 
were incubated with an ori -containing DNA fragment andO
binding activity measured using nitrocellulose 
filter-binding assays. Any unbound double-stranded DNA 
passes through the filter while protein-DNA complexes are 
retained.
My primary aim was to identify the viral gene 
encoding this origin binding activity. As it was envisaged 
that this would involve assaying many different nuclear 
protein preparations (e.g. from transfected cells) for 
origin binding activity, it was important to develop a more 
convenient assay which would not require such large numbers 
of cells and could be performed on unfractionated nuclear 
extracts.
My initial experiments therefore attempted to 
develop a sensitive gel retardation assay which would allow 
identification of origin binding activity from a small 
number of infected cells. This technique (developed by 
Fried and Crothers, 1981) involves the incubation of protein 
extracts with DNA fragments or oligonucleotides containing 
putative protein binding sites. Mixtures are loaded onto 
native polyacrylamide gels and protein-DNA complexes 
separated from unbound DNA on the basis of the lower 
electrophoretic mobility of the former species (Garner and 
Revin, 1981). It is possible to detect sequence-specific 
binding activity, even in crude extracts, by adding an 
excess of unlabelled carrier DNA to the binding reactions
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with which other DNA binding proteins will preferentially 
interact (Garner and Revin, 1981; Schneider et al ., 1986).
1. Detection of ori^ binding activity in nuclear
extracts from HSV-1 infected cells
(a) cloning of a functional ori„ into plasmid pTZl9U
The family of pTZ vectors is well suited for 
carrying out a variety of molecular manipulations such as 
site-directed mutagenesis, in vitro transcription and 
dideoxy sequencing since these plasmids include a T7 
promoter and a phage origin of replication which allows the 
production of single-stranded DNA (Mead et al ., 1986). As 
it was envisaged that these features would prove useful 
throughout the course of this project, these vectors were 
routinely used. A 100 bp BamHI-Sall ori fragment from
D
plasmid pS19, which was previously shown to contain a 
functional origin of replication (Stow and McMonagle, 1983) 
was therefore re-cloned into the corresponding restriction 
sites of plasmid pTZl9u, yielding plasmid pSTl9. This 
fragment was chosen as it was a convenient size for use as a 
probe in gel retardation assays and was known to contain the 
18 bp protein binding site identified by Elias et al.
(1986).
To verify that the viral origin within pSTl9 could 
still function, a plasmid amplification assay was carried 
out in which the replicative ability of pSTl9 was tested 
together with a plasmid, pSl, which contains a known 
functional 535 bp ori -fragment (Stow and MCxMonagle, 1983)O
and the vector plasmid pST!9U. Plasmids were transfected 
into BHK cells which were subsequently either mock-infected 
or superinfected with wt HSV-1 to provide helper functions. 
Samples of DNA extracted from cells 16 h post infection (pi) 
were cleaved with EcoRI and Dpnl and replicated 
(DpnI-resistant) plasmid molecules were detected by Southern 
blotting using ^P-labelled pATl53 DNA as probe (pATl53 
detects DNA sequences of the pTZ family of vectors since 
these plasmids contain the same ampicillin resistance gene 
and plasmid origin of DNA synthesis).
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The results of this assay are shown in Fig. 3.1.
As expected, HSV-1 encoded functions facilitated the 
replication of both pSl and pSTl9 (tracks 2 and 4) but not 
pTZl9U (track 6 ). The level of replication achieved with 
pSTl9 which contains the minimal ori sequence was lower
b
than that obtained with pSl which is consistent with 
published observations for plasmid pS19 which show that 
sequences flanking the core origin have an enhancing effect 
on origin activity (Stow and McMonagle, 1983).
Nevertheless, this assay demonstrates that the 100 bp 
fragment within pST19 retains its ability to function as an 
origin of DNA replication.
Dideoxy sequencing verified that the insert in 
pST19 had a sequence identical to that published for the 
pS19 insert sequence (Stow and McMonagle, 1983; see Fig. 
3.27; section 3C). Plasmid pSTl9 was therefore used as a 
source of HSV-1 °rig sequence in subsequent experiments.
The BamHI-Sall fragment was routinely end-labelled, purified 
and used as probe in gel retardation assays.
(b) demonstration of ori„ binding activity in cells
b
infected with wt HSV-1
In initial experiments, nuclear extracts of HSV-1 
infected BHK cells were prepared 8 h pi using a method of 
Piette et a l . (1988) {method A}. Proteins from either 
mock-infected or infected nuclei were eluted in 600 mM NaCl, 
precipitated in (NH^^SO^ and redissolved in buffer B 
containing 100 mM NaCl. These extracts were incubated with 
the end-labelled orig-containing BamHI-Sall fragment of 
pST19, in the presence of sonicated calf thymus DNA which 
competes for any non-sequence-specific binding activity. 
Reaction mixtures were analysed by polyacrylamide gel 
electrophoresis.
Fig. 3.2 shows the pattern of retarded bands 
obtained using this assay. No binding activity was detected 
in extracts from mock-infected cells (track 1). Using HSV-1 
infected cell extracts, a major retarded band, A, and a 
weaker band, B, were evident which represent protein-DNA 
complexes (track 2). In addition, some smeared binding was 
seen at the top of the gel. When the amount of infected
pS1 pST19 pTZ19U pST19 
a b a b  a b a b
Figure 3.1 Replication of plasmids containing HSV-1 ori O^
fragments
Monolayers of BHK cells (50 mm Petri dishes) were 
transfected with pSl (which contains a 535 bp 
ori -containing fragment from HSV-1 BamHl x cloned intoO
pATl53), pTZl9U or pSTl9 (which consists of a 100 bp ori^
fragment (Stow and McMonagle, 1983) cloned into pTZl9U) and
either mock-infected (tracks a) or superinfected with HSV-1
(tracks b) at 37°C for 16 h. Samples containing 1/15 of the
DNA recovered from each monolayer were digested with EcoRI
plus Dpnl and the fragments separated by electrophoresis,
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transferred to nitrocellulose and hybridised to P-labelled 
pATl53. An autoradiograph of the washed filter is shown. 
Solid arrowheads indicate Dpnl resistant replicated plasmid 
DNA (unit length pSl -4.2 kbp and pSTl9 -3 kbp) and the open 
arrowhead indicates Dpnl digested input plasmid DNA.
10Obp Haelll
Figure 3.2 Gel retardation analysis of extracts of wt HSV-1 
infected cells
32
Nuclear extract was incubated with P end-labelled 100 
bp pST19 ori^ fragment either in the absence of competitor
O
DNA (tracks 2 and 3) or in the presence of 100-fold molar 
excesses of unlabelled 100 bp orig fragment (track 4) or 
Haelll fragment from the HSV-1 Bam y; region containing 
sequence unrelated to ori sequence (track 5). Track 1
O
contains nuclear extract from mock-infected BHK cells and 
tracks 2-5, extract from cells infected with wt HSV-1. The 
products were separated by electrophoresis in a 8% 
non-denaturing polyacrylamide gel. "A" and "B" indicate 
major retarded complexes and "F", the free probe.
Tracks 1 and 2 contained 5 ug of nuclear extract and tracks
3-5 contained 7.5 ug of nuclear extract.
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cell extract was increased, band B appeared more prominent 
(track 3). To verify the specificity of binding, a 100-fold 
molar excess of the unlabelled ori_ fragment or of a 
similarily sized Haelll fragment from the HSV-1 Bam y region 
containing sequence unrelated to HSV-1 ori was added to the
O
assay to compete for specific binding (track 4 and 5). The 
orig but not the Haelll fragment effectively eliminated 
bands A and B indicating that these complexes were specific 
for the orig fragment. Thus, the gel retardation assay can 
identify origin-specific binding using unfractionated 
nuclear extracts from small numbers of cells.
2. Identification of protein binding sites
in HSV-1 orig
(a) binding of an HSV-1 induced protein to two sites 
in_oris
Using DNase I footprinting, Elias et a l . (1986), 
demonstrated the presence of an 18 bp sequence at the left 
hand end of the HSV-1 ori„ palindrome which was protected by 
an HSV-1 encoded protein(s) (see Fig. 3.3 site I). A 
related sequence is also present in an inverted orientation 
at the right hand side of the palindrome (Fig. 3.3 site II). 
To determine whether the complexes A and B in Fig. 3.2 
resulted from protein binding to site I and/or site II, 
double-stranded oligonucleotides containing site I and II 
sequences were synthesised and tested for their ability to 
act as competitor DNAs.
The results of these assays are shown in Fig. 3.4. 
Both sits I (track 2) and site II (track 3) oligonucleotides 
were able to compete for binding to orig, resulting in the 
disappearance of retarded complexes A and B (track 1). This 
indicates that both sites I and II within orig are 
recognised by the origin binding protein. To further 
substantiate that binding can occur at sites I and II within 
ori , the double-stranded oligonucleotides were end-labelled
O
and used as probes in a gel retardation assay. Fig. 3.5
demonstrates that both oligonucleotides contain
sequence-specific protein binding sites. A single retarded
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Figure 3.3 Location of a further sequence within the HSV-1
ori_s region related to the binding site 
identified by Elias et al. (1986)
90 bp from the orig region are shown (Stow and 
McMonagle, 1983) and the 45 bp palindrome is indicated by 
arrows. The shaded region overlapping the left end of the 
palindrome represents an 18 bp sequence (HSV site I) which 
is protected from DNase I digestion by an HSV-1 encoded 
protein(s) (Elias et a l ., 1986). A related sequence is also 
found in an inverted orientation at the right end of the 
palindrome (HSV site II). Site I and site II aligned 
sequences are shown below with mismatches marked by dots.
The underlined region in site I represents an 11 bp sequence 
which is conserved in HSV-1 ori^, HSV-2 orig , HSV-2 ori^ and 
VZV orig.
Figure 3.4 Competition of binding of HSV-1 encoded protein
to HSV-1 ori,-, by ds oligonucleotides
Nuclear extract from cells infected with wt HSV-1 was 
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incubated with P-labelled pSTl9 ori fragment in the 
absence of competitor DNA (track 1) or in the presence of 
100-fold molar excesses of unlabelled ds oligonucleotides I 
or II containing sequences from ori site I (track 2) orO
site II (track 3) respectively.
Oligonucleotide I : 5' GATCCGCGAAGCGTTCGCACTTCGTCCCA
GCGCTTCGCAAGCGTGAAGCAGGGTCTAG 5 1
OLigonucleotide II : 5' GATCTGGGGCGAAGTGCGAGCACTTCGCG
ACCCCGCTTCACGCTCGTGAAGCGCCTAG 5 1
Underlined residues correspond to those shown in Fig. 
3.3. The products were separated by electrophoresis in a 8% 
non-denaturing polyacrylamide gel. "A1 and "3" indicate 
retarded complexes and "F", the free probe.
oligo I oligo II 
a b a b
I
* ■ *  m
Figure 3.5 Gel retardation analysis of extracts of wt HSV-1
infected cells using oligonucleotide probes
32Nuclear extract was incubated with P-labelled 
oligonucleotide I (Fig. 3.4) or oligonucleotide II (Fig.
3.4) either in the absence (tracks a) or in the presence of 
100-fold molar excess of unlabelled oligonucleotide I 
(tracks b). The products were separated by electrophoresis 
in a 5% non-denaturing polyacrylamide gel. "A" indicates a 
retarded complex observed with both oligonucleotides
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complex was seen with both oligonucleotide I and 
oligonucleotide II (tracks 1 and 3). Adding a 100-fold 
molar excess of the 100 bp ori fragment effectively 
competed for binding to both sites (tracks 2 and 4). These 
results (Weir et a l ., 1989) map a binding site (site II) not 
initially identified by Elias et a l . (1986) and are in 
agreement with subsequent work by Olivo et a l . (1988), Elias 
et a l . (1988) and Koff and Tegtmeyer (1989). Furthermore, 
they suggest that complexes A and B observed with the 100 bp 
orig fragment represent binding to a single site (either 
site I or II) and both sites respectively.
(b) comparison of the binding affinity of sites I
and II
Competition experiments were carried out to 
determine the relative binding affinity of the ori binding 
activity observed in HSV-1 infected cells for sites I and 
II. In these experiments, a different protocol was used for 
the preparation of nuclear extracts. This procedure, 
essentially as described by Dignam et al. (1983) and 
modified by Preston et a l . (1988) {method B}, avoided
(NH^^SO^ precipitation of extracted proteins and was found 
to give higher reproducibilty and consistency in the yield 
and activity of ori binding protein. It was used for all
O
subsequent experiments unless otherwise stated.
Nuclear extract from HSV-1 infected cells was 
incubated with labelled oligonucleotides I or II in the 
presence of increasing amounts of either unlabelled 
oligonucleotide. Fig. 3.6 shows competition of binding to 
labelled site I oligonucleotide in the presence of a 2.5,
25, 50 and 250-fold molar excess of unlabelled 
oligonucleotides I and II (tracks 1-10). Using 
oligonucleotide I as competitor, a 25-fold molar excess 
almost eliminated the signal intensity of complex A (track 
3) while a 250-fold molar excess of oligonucleotide II was 
required to produce a similar reduction in signal intensity 
(track 10). These results indicate that the origin binding 
protein has a higher affinity for binding site I than site
II. Comparison of the two competitors therefore suggests an 
approximate 10-fold difference in binding affinity between

Figure 3.6 Comparison of the relative binding affinity of 
the origin binding activity in wt HSV-1 
infected cells for sites I and II
32(a) Nuclear extract was incubated with P-labelled 
oligonucleotide I either in the absence of competitor DNA 
(tracks 1 and 6 ) or in the presence of increasing amounts of 
unlabelled oligonucleotide I (tracks 2-5) or II (tracks 
7-10): tracks 2 and 7 =2.5-fold molar excess; tracks 3 and 8 
=25-fold molar excess; tracks 4 and 9 =50-fold excess; 
tracks 5 and 10 =250-fold excess.
The products were separated by electrophoresis in a 5% 
non-denaturing polyacrylamide gel. "A" indicates retarded 
complexes.
(b) The reciprocal experiment was carried out in which
32nuclear extract was incubated with P-labelled 
oligonucleotide II either in the absence of competitor DNA 
(tracks 11 and 16) or in the presence of increasing amounts 
of unlabelled oligonucleotide II (tracks 12-15) or I (tracks 
17-20): tracks 12 and 17 = 2 .5-fold molar excess; tracks 13 
and 18 =25-fold molar excess; tracks 14 and 19 =50-fold 
excess; tracks 15 and 20 =250-fold excess. The assays were 
electrophoresed as described in part (a).
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site I and II.
Similar results were obtained in the reciprocal 
experiment where competition of protein binding to site II 
labelled sequences was investigated (tracks 11-20). A 
250-fold molar excess of unlabelled oligonucleotide II was 
required to almost eliminate the formation of complex A 
whereas a 25-fold molar excess of oligonucleotide I produced 
a similar effect (tracks 15 and 18).
Lower mobility complexes were also present in these 
assays and probably arise as a consequence of the 
modification in the preparation of nuclear extracts. These 
lower mobility bands do appear to be affected by the 
presence of a specific competitor. In addition, the relative 
amount of these bands varied considerably from extract to 
extract whereas the major small retarded fragment (complex 
A) was always prevalent. The significance of these other 
complexes will be discussed in section 4.
3. Characterisation of origin binding activty
(a) time course of origin binding protein (OBP) 
production in HSV-1 infected cells
To ascertain at which point in the virus lytic 
cycle the origin binding activity was synthesized, BHK cells 
were either mock-infected or infected with HSV-1 strains 
17syn+ or KOS and cell extracts made at various time 
intervals after infection. These extracts were assayed for 
binding activity using oligonucleotide I as probe. Two 
HSV-1 strains were tested to ensure that the binding 
activity observed with Glasgow strain 17syn* was not due to 
some unique property of this virus strain. Because other 
laboratories (e.g. Elias et al., Challberg et al .) were 
examining origin binding activity of strain KOS, this strain 
was used for comparison with strain 17 syn+ .
Fig. 3.7 shows the binding activity in 
mock-infected and infected cells harvested at 3, 6, 9, 12,
18 and 24 h after virus addition. No significant 
differences were observed in the binding pattern obtained 
with the two viruses. Complex A was detected at 3 h after
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Figure 3.7 Gel retardation analysis of extracts from wt 
HSV-1 strain 17 syn+ and KOS at various times 
after infection
Nuclear extracts were prepared from either mock-infected 
(MI) cells, or cells infected with wt HSV-1 Glasgow strain
17 syn+ (17+ ) or wt HSV-1 strain KOS (KOS) at 3, 6, 9, 12,
18 and 24 h after infection at 37°C. The extract was
3 2incubated with P-labelled oligonucleotide I and the 
products separated by electrophoresis in a 5% non-denaturing 
polyacrylamide gel. The order of the three samples for the 
6, 9, 12, 18 and 24 h time points is the same as for 3 h.
The slowest migrating complex in KOS extracts appeared to be 
more prevalent and migrated more slowly than the slowest 
migrating complex in 17 syn+ tracks. This might reflect a 
difference in the level of proteolytic activity between KOS
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virus addition and was produced in maximum amounts at 6-9 h. 
The activity subsequently remained at a stable level 
throughout the time course with a slight drop in activity at 
24h. Of the lower mobility complexes previously observed 
(Fig. 3.6), the middle band appears to be host specific 
while the others are virus induced.'^ The early detection of 
origin binding activity suggests that the binding activity 
may be encoded by an IE or E gene.
(b) the origin binding activity is not synthesised 
in cells infected with tsK at NPT
At NPT, the HSV-1 mutant t_sK (Preston, 1979a) 
overproduces IE polypeptides and RRl yet fails to activate 
later classes of viral genes due to the synthesis of a 
non-functional Vmwl75 polypeptide. Nuclear extracts were 
made (using method A) from either mock-infected cells or 
cells infected with t_sK at 31°C and 38.5°C and analysed 
using a gel retardation assay. The results are shown in 
Fig. 3.8(a). At the permissive temperature, binding 
activity was detected in t_sK infected cells (track a; 31°C). 
However, at 38.5°C no activity was detected in tsK-infected 
cells (track a; 38.5°C) whereas binding activity is observed 
in cells infected with wt at 38.5°C (see Fig. 3.11 track 2 
at 38.5°C). This indicates that the binding activity is not 
due to one of the functional IE polypeptides synthesised in 
_tsK-inf ected cells and suggests that it is probably encoded 
by an early or late viral gene or may possibly be a function 
of the Vmwl75 polypeptide. The early appearance (3 h p i ) of 
binding activity and its kinetics of synthesis suggest that 
the protein may be synthesised as an early gene product, 
consistent with a presumed role in DNA synthesis.
(c) binding activity in HSV-2 infected cell extracts
Extracts made from cells infected with HSV-2 strain 
HG52 were analysed for binding to site I oligonucleotide.
Fig. 3.8(b) shows that a retarded complex is observed in 
HSV-2 infected cell extract which exhibits the same mobility 
as complex A formed with HSV-1 infected cell extract. The 
origin binding activity is therefore encoded by both virus
tsK
3 1 °C  3 8 .5 °C
(a) a b a b
(b )  HSV-1 HSV-2
Figure 3.8 Gel retardation analysis of extracts from cells
infected with tsK at 31°C and 38.5°C and HSV-1 
0
and HSV-2 at 37 C.
(a) Nuclear extract was prepared from cells infected with 
tsK at 31°C and 38.5°C and incubated with "^P-labelled 
oligonucleotide I either in the absence (tracks a) or in the 
presence of 100-fold molar excess of unlabelled 
oligonucleotide I (tracks b). The products were separated 
by electrophoresis in a 5% non-denaturing polyacrylamide 
gel. "A" represents a retarded complex.
(b) Nuclear extract was prepared from cells infected with wt
HSV-1 Glasgow strain 17syn+ or wt HSV-2 strain HG52 at 3 7°C
3 2and incubated with P-labelled oligonucleotide I. The 
products were electrophoresed as abcve.
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types. The failure to detect a mobility difference between 
HSV type 1 and 2 complexes unfortunately ruled out the 
possibilty of using intertypic recombinants to map the gene 
encoding the origin binding activity.
(d) estimation of the molecular weight of the QBP
complex in HSV-1 infected cells
A technique involving electrophoresis of 
protein-DNA complexes on non-denaturing polyacrylamide gels 
of graded porosity has previously been used to obtain crude 
estimates of the molecular weights of protein-DNA complexes 
(Huet and Sentenac, 1987; van Huijsduijnen et a l ., 1987).
The principle of the separation technique is that the 
protein/DNA complex migrates through progressively smaller 
pores (regulated by the gel concentration) and finally stops 
and concentrates where the pore size is too small to allow 
further migration. Separation at this stage is related to 
size, although in the earlier stages of the gel, the 
separation is based on both charge and size (Anderson et 
al., 1972) .
This method was used to estimate the size of 
complex A. HSV-1 infected cell extract was incubated with 
labelled oligonucleotide I and complexes separated on a
5-25% gradient gel along with pre-stained molecular weight 
markers. Electrophoresis was continued until the 
protein-DNA complexes stopped migrating (approximately 36 h 
at 4°C). Under these conditions the unbound DNA 
consistently ran off the bottom of the gel. By comparison 
with gels which were electrophoresed for shorter time 
periods, the fastest migrating complex shown in Fig. 3.9 
corresponds to complex A. The other bands located towards 
the top of the gel represent the slow migrating complexes 
previously seen in Fig. 3.7. By comparison with the 
molecular weight markers, the migration of complex A 
corresonds to it having an approximate molecular weight of 
45,000. Given that approximately 20kD is contributed by the 
weight of the double-stranded oligonucleotide, a crude 
estimate of the molecular weight of the protein fraction of 
this complex is around 25,000.
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Figure 3.9 Estimation of the molecular weight of the OBP 
complex in HSV-1 infected cells
Nuclear extract from HSV-1 infected cells was incubated 
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with P-labelled oligonucleotide I and the products were 
separated by electrophoresis in a 5-25% gradient 
non-denaturing polyacrylamide gel along with pre-stained 
molecular weight markers which were as follows: 26.6 kD -
triosephosphate isomerase; 36.5 kD - lactic dehydrogenase; 
48.5 kD - fumarase; 5 8 kD - pyruvate kinase; 8 4 kD - 
fructose-6-phosphate kinase; 116 kD - beta-galactosidase; 
180 kD - alph^macrogobul in. The products were 
electrophoresed until the protein-DNA complexes stopped 
migrating (approximately 36 h at 4°C) and the gel was then 
fixed and exposed to autoradiography film. Under the 
conditions of electrophoresis, the free DNA ran off the 
bottom of the gel, hence the fastest migrating complex 
corresponds to complex A (see Fig. 3.7). The positions of 
the molecular weight markers in the gel are indicated by 
arrowheads.
SECTION 3B : Identification and expression of the 
HSV-1 gene encoding OBP
Having developed the gel retardation assay for 
detecting OBP, I next attempted to identify the HSV-1 gene 
which encoded this activity. At about this time (mid 1987)
I learned that iMark Challberg's laboratory had shown that a 
set of seven HSV-1 genes (TJL5, UL8, UL9, UL29, UL30, UL42 
and UL52) were necessary and sufficient for replication of 
an HSV orig-containing plasmid (subsequently published by Wu 
et a l ., 1988). It seemed likely that OBP might play an 
essential role in HSV DNA replication and be encoded by one 
of these seven genes. Furthermore, previous studies on the 
products of UL29 (dbp), UL30 (£ol) and UL42 (dsDBP) (see 
section 1C) suggested that these proteins did not function 
as sequence-specific DNA binding proteins. Thus, the most 
likely candidates for encoding OBP were UL5, UL8, UL9 and 
UL52, the products of which, at that time, had not been 
identified in HSV infected cells. Several approaches were 
adopted to identify which, if any, of the genes essential 
for DNA replication encoded the origin binding activity.
1. Unsuccessful attempts at identifying the
HSV-1 gene encoding OBP
(a) analysis of HSV-1 DNA negative ts mutants with 
lesions in six of the seven replication genes
Six DNA negative t_s mutants were available whose 
lesions mapped to the following replication genes: tsO 
(UL5), tsS (UL9), tsl205 (UL30; pol), tsl206 (UL52), tsl234
(UL42) and ts!235 (UL29; dbp). No ts mutant mapping to the
UL8 gene was available. I decided to assay nuclear extracts
from cells infected with these mutants at permissive and NPT
for origin binding activity. The success of this approacn 
would depend upon the presence of a ts mutation within the 
gene encoding OBP leading to the synthesis at NPT of a 
polypeptide affected in DNA binding activity.
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To confirm their DNA negative phenotypes, the ts
mutants were tested for their ability to amplify plasmid
pSTl9 (containing a functional HSV-1 orig sequence) at
permissive (31°C) and non-permissive (38.5°C and 39.5°C;
NPT) temperatures. Cells were transfected with pSTl9 and
either mock-infected or superinfected with each tss mutant or
wt HSV-1 to provide helper functions. Samples of DNA
extracted from the cells 16 h pi were cleaved with EcoRI and
Dpnl. Replicated plasmid molecules were detected by
32Southern blotting using P-labelled pATl53 DNA as probe.
Each mutant was able to replicate pSTl9 as well as wt HSV-1
at 31°C (Fig. 3.10 tracks 2-8 at 31°C). At 38.5°C, tsO, tsS 
and ts!235 were unable to support amplification of p3Tl9 
(tracks 3, 4 and 8 at 38.5°C) while tsl20 5, ts!206 and 
ts!234 produced low levels of plasmid amplification compared 
to wt (tracks 5, 6, 7 and 2 at 3 8.5°C). At 39.5°C, only the 
ts mutant mapping to UL52, jtsl206 exhibited detectable 
amplification (track 6 at 39.5°C) albeit at a lower level 
than wt HSV-1 (track 2 at 39.5°C). Thus, all ts mutants 
were clearly impaired in DNA synthesis at NPT but some 
exhibited a slightly leaky phenotype at 38.5°C.
Nuclear extracts from cells infected with 
individual ts mutants at 31°C, 33.5°C and 39.5°C were 
incubated with labelled oligonucleotide I and resolved on 
polyacrylamide gels (Fig. 3.11). Nuclear extracts from 
cells infected with ts mutants at 31°C contained similar 
levels of binding activity to wt HSV-1 (tracks 2-8 at 31°C). 
At 38.5°C, all mutants exhibited some binding activity 
although, in each case, this was lower than that seen with 
an extract from cells infected with wt HSV-1 at 38.5°C 
(tracks 2-8 at 38.5°C). A similar situation was observed at 
39.5°C (tracks 2-8 at 39.5°C).
These results suggest that either:
(1) none of the mutants tested has a lesion in the gene 
specifying origin binding activity i.e. the gene 
not tested, (JL8, may encode this function, or
(2) one of the mutations does lie in the gene encoding 
OBP but the lesion does not disrupt its binding 
activity. This might occur if the polypeptide
___________ 31° C_____________   38.5 °C
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Figure 3.10 Replication of an ori^-containing plasmid 
by trans-acting products from HSV-1 DNA 
negative ts mutants
BHK ceils were transfected with pSTl9 and either 
mock-infected (tracks 1) or superinfected with wt HSV-1 or 
HSV-1 DNA negative ts mutants as follows: wt HSV-1 (tracks
2); tsO [UL5] (tracks 3); tsS [UL9] (tracks 4); tsl205 
[UL30] (tracks 5); tsl206 [UL52] (tracks 6); tsl234 [UL42] 
(tracks 7); tsl235 [UL29] (tracks 8). Cells were 
subsequently incubated for 16 h at 31 C, 38.5 C or 39.5 C as 
indicated. 1/15 of the DNA recovered from each monolayer 
was digested with EcoRI plus Dpnl and the fragments 
separated by electrophoresis, transferred to nitrocellulose 
and hybridised to ^^P-labelled pATl53. An autoradiograph of 
the washed filter is shown.
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Figure 3.11 Gel retardation analysis of extracts from cells
infected with individual HSV-1 DNA negative 
ts mutants
Nuclear extracts were prepared from either mock-infected
cells (tracks 1) or cells infected with wt HSV-1 or HSV-1
DNA negative _ts mutants: wt HSV-1 (tracks 2); tsO (tracks
3); tsS (tracks 4); ts!205 (tracks 6); ts!234 (tracks 7);
ts!235 (tracks 8). Cells were subsequently incubated at
31°C, 3 8.5°C and 39.5°C for 8 h as indicated. Extracts were 
32incubated with P-labelled oligonucleotide I and the 
products separated by electrophoresis in a 5% non-denaturing 
polyacrylamide gel.
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synthesised at NPT regained some activity under the 
conditions of the binding assay or if the tj> lesion 
disrupted some function of the polypeptide other 
than its ability to bind to ori .
O
Attempts were made to test the thermal stability of 
the OBP present in extracts from cells infected with wt 
HSV-1 and ts mutants at 31°C, but no significant differences 
between the t_s mutants were observed in these experiments. 
Attempts to increase the binding temperature to 3 9°C were 
unsuccessful and wt origin binding activity could not be 
consistently detected under these conditions.
(b ) detection of origin binding activity in cells 
infected with Xbal-digested HSV-1 DNA
Challberg (1986) demonstrated that a set of five 
plasmids, containing Xbal fragments of HSV-1 DNA, enabled 
amplification of an orig-containing plasmid in transfected 
tissue culture cells. Thus, Xbal did not inactivate any of 
the replication genes or IE genes required for early gene 
expression. His laboratory then sub-cloned these fragments 
and seven plasmids containing individual HSV-1 genes were 
identified, which contained all necessary trans-acting 
functions required to replicate an origin-containing 
plasmid, provided that plasmids encoding IE gene products 
were supplied to allow their expression (Wu et a l ., 1988).
I therefore performed transfection experiments to 
determine whether ori -binding activity could be detected in 
nuclear extracts from cells transfected with plasmids 
containing individual replication genes and activated by one 
or more IE genes. To test the validity of this approach, 
cells were transfected with 10 ug of Xbal-digested HSV-1 DNA 
and nuclear extracts prepared 24 h later. Fig. 3.12 shows 
the formation of complex A with labelled oligonucleotide I 
in the presence of nuclear extract from these cells (track 
3). This activity was competed by an excess of unlabelled 
oligonucleotide I (track 4). No specific activity was seen 
in control transfected cell extracts (track 1). To check 
that the HSV-1 DNA was digested to completion, samples of 
digested DNA were analysed on agarose gels. In addition, no
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Figure 3.12 Gel retardation analysis of extracts from cells 
transfected with Xbal-digested HSV-1 DNA
BHK cells were transfected with 15 ug of calf thymus
carrier DNA (MT) or 5 ug of calf thymus DNA plus 10 ug of
Xbal-digested DNA (T) and nuclear extracts prepared 24 h
32later. The extract was incubated with P-labelled 
oligonucleotide I either in the absence (tracks a) or 
presence of a 100-fold excess of unlabelled oligonucleotide 
I (tracks b). The products were separated by 
electrophoresis in a 5% non-denaturing polyacrylamide gel.
"A" indicates a retarded complex.
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progeny virus was detected on plates transfected in 
parallel, therefore the OBP activity observed in Fig. 3.12 
was not due to the replication and spread of progeny virus.
Having established that it was possible to detect 
origin binding activity in cells transfected with 
Xbal-digested HSV-1 DNA, experiments were carried out 
whereby cells were co-transfected with plasmids pGX58 and 
pJR3 (IE-3 and IE-1 gene) and pGX25 (UL5 gene + UL8 gene) or 
pGXl25 (UL8 gene + UL9 gene) or pNNl (UL29 gene) or pNN3 
(UL30 gene) or p9-4 (UL42 gene) or pGX94 (UL52 gene).
Despite testing various transfection conditions, no origin 
binding activity was detected with any of these 
combinations. Possible explanations for the failure to 
observe activity using this approach are discussed in 
section 4.
2. Origin binding activity induced by tsK
recombinant viruses
(a) identification of the HSV-1 gene encoding OBP
Four tsK recombinant viruses, jtsK/UL5, tsK/UL8, 
tsK/UL9 and tsK/UL52 were obtained from J. Calder in our 
laboratory. The construction of these viruses is briefly 
outlined in Fig. 3.13. The genes, UL5, UL8, UL9 and UL52 
were individually recombined into the genome of the HSV-1 ts 
mutant, _tsK, under the control of the IE-3 gene promoter.
At 38.5°C, tsK accumulates IE polypeptides but is unable to 
induce the expression of early and late genes (Preston,
1979a; Watson and Clements, 1980). Labelled polypeptides 
synthesised at 38.5°C by the recombinant viruses are 
indistinguishable from tsK, except for a single additional 
polypeptide corresponding to the product of the inserted 
gene (J.M. Calder, unpublished results). Since these 
viruses overexpress the UL5, UL8, UL9 and UL52 gene products 
(and had in fact initially allowed their identification) I 
decided to test whether any of these viruses might induce 
origin binding activity. This approach was possible because 
tsK is negative for OBP at NPT {Fig. 3.8(a)}.
BHK cells were infected with wt HSV-1, jtsK or the
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Figure 3.13 Construction of tsK recombinant viruses
(J. M. Calder)
The figure shows a schematic diagram of the construction 
of tsK recombinant viruses individually expressing four of 
the HSV-1 replication genes: UL5, UL8, UL9 and UL52. The 
coding sequences of the genes were individually linked to a 
copy of the IE-3 promoter and placed within the coding 
sequences of a plasmid copy of the HSV-1 TK gene (contained 
within HSV-1 BamHI £) which was then recombined with tsK DNA 
at the permissive temperature. TK minus recombinants were 
isolated and screened for the presence of the inserted gene. 
Labelled polypeptides synthesised at 38.5°C by the 
recombinant viruses are indistinguishable from tsK, except 
for a single additional polypeptide corresponding to the 
product of the inserted gene (J.M. Calder, unpublished 
results).
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four recombinant viruses at 38.5°C and nuclear extracts 
prepared 8 h later. The extracts were analysed in a gel 
retardation assay using labelled oligonucleotide I as probe 
{Fig. 3.14(a)}. No DNA binding activity was observed in 
either mock-infected or tsK-infected cell extracts (tracks 1 
and 3) apart from a weak host band which was evident in all 
tracks. As previously observed, extracts from cells 
infected with wt HSV-1 generated a major retarded complex,
A, and some minor bands (track 2). The only other extract 
which caused retardation of the probe was from cells 
infected with the tsK/UL9 recombinant virus (track 6). 
Despite the difference in binding pattern observed between 
this virus and wt HSV-1 (i.e. the presence of material which 
failed to enter the gel and a smeared retardation throughout 
the length of the track), similar patterns were consistently 
observed with the tSK/UL9 recombinant alone. As with wt 
HSV-1 extract, diffuse bands of lower mobility were observed 
whereas a band co-migrating with complex A was notably 
absent.
Fig. 3.14(b) shows that the pattern of binding seen 
with the tsK/UL9 recombinant virus is sequence-specific.
The addition of a 100-fold excess of unlabelled 
oligonucleotide I but not oligonucleotide X (which is of 
similiar size to oligonucleotide I but of unrelated DNA 
sequence) efficiently competed for binding to labelled DNA 
(tracks 2 and 3).
As the tsK/UL9 recombinant differs from tsK only in 
its ability to express the UL9 gene product at the NPT, 
these results indicate that the UL9 polypeptide is 
responsible for the observed sequence-specific binding to 
oligonucleotide I. However, because the binding pattern was 
different from wt HSV-1, it was not possible to conclude 
that UL9 was responsible for formation of complex A.
(b) effect of protease digestion on the binding
activity from cells infected with the tsK/UL9 
recombinant
It was rather surprising that the pattern of 
retardation observed using extracts from cells infected with
the t_sK/UL9 recombinant was very different from that seen
(a) 1 2 3 4 5 6 7 (b) 1 2 3
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Figure 3.14 Gel retardation analysis of extracts from cells
infected with tsK recombinant viruses
(a) Nuclear extract was prepared from cells incubated at 
38.5°C and reacted with ^P-labelled oligonucleotide I.
Track 1, mock-infected cells; tracks 2-7, cells infected 
with wt HSV-1, tsK, tsK/UL5, tsK/UL3, tsK/UL9 or tsK/UL52 
respectively. Products were separated by electrophoresis in 
a 5% non-denaturing polyacrylamide gel. "A" indicates the 
major complex detected with wt HSV-1 extract.
(b) Nuclear extract from cells infected with jtsK/UL9 was
32incubated with P-labelled oligonucleotide I either in the 
absence of competitor DNA (track 1) or in the presence of 
100-fold molar excess of oligonucleotide I (track 2) or 
oligonucleotide X containing an unrelated sequence (track
3) .
Oligonucleotide X : 5 1 GATCGGATATGCTAATTAAATACAT
GCCTATACGATTAATTTATGTG 5 1
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with extracts from wt HSV-1 infected cells. However, 
experiments using pore-gradient gel electrophoresis, to 
ascertain the molecular weight of complex A, had suggested a 
molecular weight of around 45,000, clearly inconsistent with 
the binding of an intact UL9 polypeptide (predicted 
molecular weight of 94,000) to oligonucleotide I. One 
possible explanation was that complex A might contain only a 
fragment of the UL9 polypeptide. To examine this 
possibility, proteinase K was added to binding reactions 
containing t_sK/UL9 nuclear extract and labelled 
oligonucleotide I and the resulting complexes analysed as 
before (Fig. 3.15). Addition of proteinase K to the binding 
reactions caused a reduction in the amount of lower mobility 
complexes and the simultaneous appearance of a faster 
migrating species (tracks 4 and 5). This species had a 
similar electrophoretic mobility to that of complex A (track 
7). No such faster migrating complex was detected when 
extracts from mock-infected cells or cells infected with tsK 
were similarity treated with proteinase K (data not shown). 
These experiments therefore suggest that the addition of 
proteinase K to extracts containing the UL9 polypeptide 
results in the cleavage of the polypeptide and production of 
a relatively protease-resistant fragment, which retains 
DNA-binding activity, and produces a complex of comparable 
size to the complex found using extracts from cells infected 
with wt HSV-1.
(c ) demonstration that complex A formed with wt HSV-1
infected cell extract contains the UL9 polypeptide
Antibodies to UL5, UL8, UL9 and UL52 gene products 
were kindly provided by Dr. M. D. Challberg. The rabbit 
antisera were raised against decapeptides from the carboxy 
termini (C-termini) of the gene products and were known to 
be reactive with the corresponding polypeptides (Olivo et 
al. , 1988). Following a 10 min incubation of nuclear 
extract from cells infected with wt HSV-1 with labelled 
oligonucleotide I, antibodies reactive with UL5, UL8, (JL9 or 
UL52 polypeptides were added to the reactions and after a 
further 10 min incubation, the products were analysed on a 
native polyacrylamide gel.
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Figure 3.15 Effect of proteinase K on the tsK/UL9 complex
Nuclear extract from cells infected with recombinant
32j^sK/UL9 was incubated with P-labelled oligonucleotide I 
either in the absence of proteinase K (track 1) or in the 
presence of 1, 10, 100, 1000 or 2000 ng of proteinase K 
(tracks 2-6 respectively), wt HSV-1 extract was assayed in 
parallel in the absence of proteinase (track 7). The 
products were separated in a 5% non-denaturing 
polyacrylamide gel. "a 'indicates the major complex formed 
with wt extract.
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Fig. 3.16 track 1 shows wt HSV-1 DNA binding 
activity in the absence of added antibody. Antibodies to 
UL5 (track 2), UL8 (track 3), and UL52 (track 5) had a 
minimal effect on the pattern of retarded fragments.
However, the addition of antibody to the UL9 gene product 
resulted in the disappearance of the major retarded complex 
A and its replacement by a more slowly migrating form, A 1 
(track 4). This result indicates the interaction of 
anti-UL9 antibody molecules with complex A and demonstrates 
that at least part of the UL9 polypeptide must be present in 
complex A. As the antibody was raised against a C-terminal 
decapeptide, this region of the protein is included in the 
complex.
3. Expression of fragments of the UL9 gene in E.coli
The above experiments strongly implicate the UL9 
protein (and possibly its C-terminal region) in binding to 
specific sequences (sites I and II) within HSV-1 ori . To
O
ensure that this interaction was not due to the involvement 
of any other host or viral protein, it was decided to 
attempt to express the binding activity encoded by UL9 in 
heterologous systems. In addition, it was hoped that by 
expressing specific domains of the UL9 gene, further 
information on the binding site could be obtained.
To determine whether origin binding activity could 
be expressed in E.coli and to attempt to locate the DNA 
binding domain, three plasmids were obtained from Dr. N. D. 
Stow which contained fragments of the UL9 gene inserted into 
an expression vector. Details of the plasmids are shown in 
Fig. 2.2. section 2A. Plasmid pBl contains approximately the 
C-terminal 1/3 of the gene (encoding 317 amino acids), 
plasmid pP31, the C-terminal 2/3 (encoding 591 amino acids) 
and plasmid pX8, the amino (N) terminal 2/3 (encoding 524 
amino acids) cloned in frame into the vector pRIT2T. This 
expression vector contains 780 bp (encoding 260 amino acids) 
of the Staphylococcus aureus protein A gene under the 
control of the phage lambda P promoter. The constructs 
were transformed into the E .coli strain Kl2AHlAtrp which 
contains a ts lambda cl repressor. To induce synthesis of
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Figure 3.16 Effect of antisera on the wt HSV-1 complex
Nuclear extract from cells infected with wt HSV-1 was 
3 2incubated with P-labelled oligonucleotide I either in the 
absence of added antiserum (track 1) or in the presence of 
antisera reactive with the UL5, UL8, UL9 or UL52 gene 
products (tracks 2, 3, 4 and 5 respectively). The products 
were separated by electrophoresis in a 5% non-denaturing 
polyacrylamide gel. "A" and "A1" indicate the major 
complexes formed in the absence of antiserum or the presence 
of antiserum against the UL9 gene product respectively.
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the protein A/UL9 fusion proteins, bacterial cultures, 
propagated at 28°C, were rapidly shifted to 42°C and 
incubation continued for 75 min. Extracts prepared from 
heat-induced bacteria were tested for origin binding 
activity using labelled oligonucleotide I as probe.
No binding activity was detected in extracts from 
the host bacteria alone (KIL) or from bacteria containing 
the vector plasmid pRIT2T (KR2){Fig. 3.17 KIL and KR2 (a)}. 
Of the three hybrid plasmids, pBl {KBl (a)} and pP31 {KP31 
(a)} but not pX8 {KX8 (a)} encoded DNA binding activity. 
Adding an excess of unlabelled oligonucleotide I to KBl and 
KP31 assays effectively competed for binding {KBl and KP31 
(a)}. The C-terminal 317 amino acids of the UL9 polypeptide 
specified by plasmid pBl therefore contain all the amino 
acid sequences required for sequence-specific binding to 
site I within orig.
Interestingly, the binding activity encoded by 
pP31, expressing 2/3 of the UL9 polypeptide was reminiscent 
of the binding activity seen with an extract from cells 
infected with the tsK/UL9 recombinant i.e. a smeared pattern 
of retardation towards the top of the gel with little 
distinct formation of protein-DNA complexes. In contrast, 
the binding activity in KBl extract formed a distinct 
complex, C.
The activity encoded by pBl also bound to the 100 
bp ori^,-containing fragment, isolated from pSTl9, and was 
efficiently competed by the addition of unlabelled 
oligonucleotide I and II but not oligonucleotide X (Fig.
3.18 tracks 1-4). Binding to the 100 bp fragment produced a 
major complex (marked C in Fig. 3.18) and a fainter lower 
mobility complex (marked D ) . When the amount of KBl extract 
added to the assay was increased, the signal intensity of 
band D increased to a level similar to that of band C (track 
5). This suggests that band C represents binding to a 
single site and band D, binding to sites I and II. Hence, 
adding more UL9 protein increases the proportion of probe 
fragment which has two occupied binding sites. The fainter 
higher mobility bands visible in most tracks probably result 
from the presence of a small amount of partially degraded 
fusion protein in the extract.
Fig. 3.18 also demonstrates that the UL9 fusion
KIL KR2 KB1 KP31 KX8 
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Figure 3.17 Gel retardation analysis of the Staphylococcus 
aureus protein A encoded fusion protein
Extracts were prepared from untransformed heat-induced
bacteria (KIL), or from heat-induced bacteria transformed
with the vector pRIT2T (KR2) or one of the three hybrid
plasmids containing fragments of the UL9 gene; pBl (KBl),
pP31 (KP31) or pX8 (KX8). Extracts were incubated with 
32P-labelled oligonucleotide I in the absence of competitor 
DNA (tracks a) or in the presence of 100-fold molar excess 
of oligonucleotide I (tracks b). Products were separated by 
electrophoresis in a 5% non-denaturing polyacrylamide gel. 
"C" indicates the major complex formed with KBl extract.
I
Q  O
Figure 3.18 Gel retardation analysis of the pBl encoded
fusion protein
Binding reactions were performed with extract from heat
induced bacteria transformed with pBl (tracks 1-5 and 7-13)
or from cells infected with wt HSV-1 (track 6). The probe 
32
rragments were P end-labelled pSTl9 100 bp oriQ fragment
32 "
(tracks 1-5) or P-labelled oligonucleotide I (tracks
6-13). A 20 fold excess of unlabelled oligonucleotide I
(track 2), oligonucleotide II (track 3) or oligonucleotide X
(track 4) was added as competitor DNA. The products were
separated by electrophoresis in an 8% non-denaturing
polyacrylamide gel. "C" and "D" indicate major complexes
observed with KBl extract and "A", the major complex from
HSV-1 infected cell extract. Increasing the amount of KBl
extract in the assay (track 5; 8 ug of total protein)
increased the signal intensity of band D (compare tracks 1
and 5).
Tracks 7-10 show the effect of adding proteinase K on 
the KBl complex. KBl extract was incubated with probe 
either in the absence of proteinase K (track 7) or in the 
presence of 1, 10 or 100 ng of proteinase K (tracks 8-10).
Antiserum reactive with UL9 or UL52 was added to binding 
reactions (tracks 12 and 13) resulting in the disappearance 
of complex C (track 11) and the appearance of a retarded 
complex at the top of the gel indicated by the bold 
arrowhead.
104
protein encoded by pBl (predicted molecular weight 63,000) 
forms a complex with a significantly lower mobility than 
complex A formed using extracts from cells infected with wt 
HSV-1 and oligonucleotide I (tracks 6 and 7). This is in 
agreement with complex A containing only a proteolytic 
fragment of the UL9 polypeptide. As with tsK/UL9 infected 
cell nuclear extract, adding proteinase K to KBl extract 
reduced the amount of slowly migrating complex C and 
resulted in the concomitant appearance of a faster migrating 
species which exhibited a mobility similar to that of 
complex A (tracks 7-10). The mobility of the KBl complex C, 
was further retarded by the addition of antibodies reactive 
with the UL9 and UL52 polypeptides to the binding reaction 
(tracks 11-13). The ability of both antibodies to recognise 
complex C is due to the presence of an IgG binding domain 
within the protein A moiety of the fusion protein and 
confirms that the fusion protein is responsible for the 
formation of complex C.
4. Expression of the DNA binding domain of the UL9
gene by in vitro transcription and translation
Earlier attempts to express the intact UL5, UL8,
LJL9 and UL52 gene products by in vitro transcription and 
translation using pTZ vectors proved largely unsuccessful. 
However, independent verification that the C-terminal 317 
amino acids of the UL9 gene product contained DNA binding 
activity was obtained by in vitro transcription and 
translation of this region using a fusion protein construct 
with the N-terminal 68 amino acids originating from the 
Vmw65 protein (encoded by UL48). The construction of this 
chimeric gene is outlined in Fig. 3.19. Plasmids pMC.in4 
and pMC.inl7 were obtained from Dr. C. Ace. The plasmids 
contained a copy of the UL48 gene, encoding Vmw65 (491 amino 
acids), with 12 bp BamHI linker insertions, 222 bp and 1431 
bp downstream from the start of the coding sequence 
respectively. These plasmids were known to enable efficient 
transcription and translation of Vmw65 in vitro. The 
polypeptide product of the Vmw65 gene does not contain any 
intrinsic DNA binding activity and therefore was not
pMC.tn4
- c f e t
0 74
R1 : :
i -  H
pMC.in17
491 471 491 
< ►
pMC.d el
R1
74/471 491
+ 317 amino acids of UL9
pMC.9B1
471 491
cloned into pT Zl9U
pTZ9B1
T 7
12 74 471 491
Figure 3.19 Contraction of plasmid pTZ9Bl
Plasmids pMC.in4 and pMC.inl7 were obtained from Dr.C. 
Ace. Each plasmid contained a copy of the UL48 gene 
(encoding Vmw6 5; 491 amino acids) with 12 bp BamHI linker 
insertions, 7 4 and 471 amino acids downstream from the start 
of the protein coding sequence (marked 0). The UL48 gene 
has two AUG start codons either side of a Sail restriction 
enzyme site (hatched boxes). Both codons are utilised in 
the initiation of in vitro translation of the protein coding 
sequence (C. Ace, pers comm).
pMC.inl7 was cleaved with BamHI plus EcoRI as shown and 
the C-terminal fragment (indicated by arrows) encoding 20 
amino acids of Vmw6 5 and the polyadenylation signals was 
cloned into BamHI-EcoRI digested pMC.in4 yielding pMC.del 
which contains a unique BamHI site at position 74/471. A 
BamHI fragment encoding the C-terminal 317 amino acids of 
the UL9 gene (see Fig. 2.2, section 2A) was cloned, in 
frame, into the unique BamHI site of pMC.del. The resulting 
plasmid, pMC.9Bl was cleaved with Sail plus EcoRI and the 
resulting fragment cloned into Sall-EcoRI digested pTZl9U 
yielding pTZ9Bl. This construct contains a single AUG start 
codon 15 nucleotides downstream from the Sail site.
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expected to interfere with the DNA binding activity of the 
UL9 gene. Plasmids pMC.in4 and pMC.inl7 were cleaved with 
BamHI and EcoRI and fragments containing the promoter and 
polyadenylation signals of the gene were isolated and 
ligated to form plasmid pMC.del (Fig. 3.19). The C-terminal 
317 amino acids of the UL9 gene were cloned, in frame, into 
the unique BamHI site of pMC.del. The resulting plasmid, 
pMC.9Bl was cleaved with Sail and EcoRI and cloned into 
Sall-EcoRI digested pTZl9U containing a T7 promoter, 
yielding pTZ9Bl.
For the in vitro transcription assay, 2ug of
plasmid DNAs were linearized with EcoRI and incubated with
all four NTPs (A, G, C, U), T7 RNA polymerase and synthetic
5'mRNA caps at 37°C. An aliquot of the transcription
products was added to rabbit reticulocyte lysate containing 
35
S-methionine and labelled protein products were analysed 
by SDS-PAGE gel electrophoresis {Fig. 3.20(a)}. Labelled 
proteins were detected corresponding to the expected 
products of plasmid pTZ9Bl (9B1) and the intact Vmw65 gene 
itself (Vmw65). No additional band was observed with the 
intact UL9 gene plasmid compared to the absence of any added 
plasmid (UL9 and C). The Vmw65/UL9 fusion protein which 
utilizes the stop codon of the UL9 gene contains 385 amino 
acids (predicted molecular weight of 43,000). As expected 
the Vmw65/UL9 fusion protein had a higher electrophoretic 
mobility than Vmw6 5.
Unlabelled in vitro translation products were 
tested in a gel retardation assay using labelled 
oligonucleotide I as probe. Sequence-specific binding 
activity was observed only with the Vmw65/UL9 fusion protein 
(Fig. 3.20(b) 9B1). As expected, this complex had a higher 
electrophoretic mobility than the bacterial fusion protein 
(predicted moleculer weight of 63,000). This confirms the 
previous finding that the C-terminal region of the UL9 gene 
encodes a DNA binding activity specific for orig sequences.
5. Interaction of the UL9 DNA binding domain with ori^
as analysed by DNase I footprinting assays
Ori sequences protected from DNase I digestion by
O
(b) C UL9 9B1 Vmw65
(a) C UL9 9B1 Vmw65
*
Figure 3.20 In vitro transcription and translation of the 
C-terminal region of UL9
(a) In vitro transcription assays were carried out using
pTZUL9 [UL9] (the intact UL9 gene cloned into pTZl9U),
pTZ9Bl [9B1] (see Fig. 3.19), pTZVmw65 [Vmw65] (the intact
UL48 gene cloned into pTZl9R) or no plasmid DNA (C). An
aliquot of the transcription product was added to rabbit
35 .reticulocyte lysate containing S-methiomne and labelled 
protein products were analysed by SDS-PAGE gel 
electrophoresis. Labelled proteins corresponding to the 
expected products of pTZ9Bl and Vmw65 are indicated by 
arrowheads.
(b) Gel retardation analysis of unlabelled in vitro 
transcription and translation products. An aliquot of the
in vitro transcription assays described in part (a) were
. 35 .
added to reticulocyte lysate without S-methionine.
32
Unlabelled protein products were incubated with P-labelled 
oligonucleotide I and analysed in a 5% non-denaturing 
polyacrylamide gel.
106
the intact UL9 protein have been determined by Elias and 
Lehman (1988) and Olivo et al . (1988) using the DNase I 
footprinting method developed by Galas and Schmitz (1978). 
Having shown that the C-terminal 317 amino acids of the UL9 
protein contained orig-specific DNA binding activity, it was 
of interest to compare the interactions of the protein A/UL9 
fusion protein and intact UL9 protein with orig*
The principle of the DNase I footprinting technique
is that following addition of DNase I to a protein-DNA 
binding reaction, the protein bound to a uniquely 
end-labelled DNA fragment will protect its binding site from
digestion by the enzyme. Thus, when digested DNAs are
extracted and run on a denaturing polyacrylamide gel, 
digested fragments corresponding to cleavage within the 
binding site will be under-represented in the gel compared 
with DNA digested in the absence of protein. By comparison 
with Maxam and Gilbert sequencing reactions of the probe 
fragment, the residues protected by the protein can be 
determined.
The 100 bp ori fragment was digested with either
O
BamHI or Sail and 3' end-labelled using the Klenow fragment 
of DNA pol I. Labelled DNAs were extracted and re-digested 
with either Sail or BamHI respectively and the excised 100 
bp fragment separated from labelled vector sequences on a 
polyacrylamide gel. These uniquely 3' end-labelled 
fragments were incubated with increasing amounts of KBl 
extract under the conditions used for gel retardation 
assays. DNase I was added to the reactions and following a 
brief period of digestion, DNAs were extracted and analysed 
on a denaturing polyacrylamide gel together with G and G+A 
Maxam and Gilbert sequencing reactions performed on the 
probe fragment, and probe digested in the absence of protein 
extract. Protection of sequences in the region of binding 
site I was detected on both strands and weak protection of 
site II on the Sail labelled strand {Fig. 3.21(a)}. Sites 
hypersensitive to DNase I digestion were evident within the 
AT-rich region of the probe digested both in the presence 
and absence of KBl extract and also to the top of the 
protected region covering binding site I. Surprisingly, 
there were many more bands in tracks in which the probe had 
been treated with DNase I in the presence of bacterial
BamHI Sail BamHI Sail
Bam HI Sa 11
G G /A 1 2 3 4 G G /A  1 2  3 4
BamHI S a ilBinding Sites Binding Sites
Figure 3.21 DNase I protection of HSV-1 ori„ by the UL9
S
DNA binding domain —
(a) The pSTl9 100 bp ori insert was uniquely 3'O
end-labelled at either the BamHI or Sail terminus as 
indicated and incubated with increasing amounts of extract 
from heat induced bacteria transformed with pBl; 2.5 ug 
(track 2), 5 ug (track 3) or 7.5 ug (track 4) of total 
protein. Following a brief period of digestion with DNase 
I, DNAs were extracted and analysed on a 6% denaturing 
polyacrylamide gel together with markers generated by 
partial cleavage at G residues (G) or at G and A residues 
(G/A) and probe digested with DNase I in the absence of 
protein extract (track 1). Arrows indicate the AT-rich 
region of the orig palindrome. To the right of the 
autoradiograph, protected regions corresponding to binding 
sites I on BamHI and Sail labelled strands are marked by 
bold lines and weaker protection of binding site II on the 
Sail labelled strand by dashed lines.
(b) Reactions were set up as described in part (a) using 7.5 
ug of KBl extract or extract from heat induced bacteria 
transformed with control vector pRIT2T (KR2). Partial 
digestion with DNase I was performed prior to the resolution 
of complexes on a non-denaturing gel. DNA was extracted 
from bands corresponding to free DNA in the KR2 assay (track
1) and the upper KBl complex (track 2) [equivalent to 
complex D in Fig. 3.18 (track 5)] and resolved on a 6% 
denaturing polyacrylamide gel together with markers as 
described in part (a) (not shown).
To the right of autoradiograph, clearly protected 
regions corresponding to binding sites I and II on the BamHI 
labelled strand and site I on the Sail labelled strand are 
shown as solid lines. A weakly protected region 
corresponding to binding site II on the Sal I labelled 
strand is shown as a dashed line.
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extract than in its absence. Also, careful examination 
suggests that the presence of bacterial extract results in 
the shifting of more than 50% of the label in major bands 
produced by DNase I in the absence of extract to a position 
equivalent to the removal of one nucleotide (exemplified by 
the four major bands in the AT-rich region; tracks 3 and 4).
Using the above method incomplete protection 
resulted in weak footprinting, probably due to the failure 
of the protein to saturate all binding sites. Therefore in 
an attempt to improve the quality of the footprinting assay, 
DNase I treated binding reactions were first applied to a 
preparative non-denaturing gel and after brief 
autoradiography of the wet gel, gel slices containing major 
complexes were excised (corresponding to complex D in Fig. 
3.18 track 5), electroeluted and analysed on a denaturing 
polyacrylamide gel. In an attempt to eliminate the 
differential effect on the mobility of bands caused by KBl 
extract (above), probe fragment was incubated with an 
equivalent amount of control extract, KR2, and also 
electrophoresed on the preparative gel. Hence, using this 
method, the free DNA band has undergone similar DNase I 
digestion in the presence of bacterial extract to the 
protein/DNA complex. Fig. 3.21(b) shows clearer protection 
of sequences corresponding to binding site I and II on the 
BamHI labelled strand and site I on the Sail labelled strand 
also weak protection of site II on the Sail labelled strand. 
Again, the bands arising from the protein/DNA complex 
migrated slightly faster through the gel than the 
corresponding bands from free DNA, despite both fragments 
having been incubated initially with protein extract. The 
reason for this is unknown but it may reflect a property of 
the truncated UL9 protein or the differential expression of 
a host function in the KBl cells. Ideally, the extent of 
complex formation should be adjusted so that bands 
corresponding to protein/DNA complexes and free probe can be 
obtained from a single binding reaction.
Nevertheless, these footprints confirm that the
retarded complexes observed in gel retardation assays are
due to the UL9 fusion protein binding to specific sequences
within ori . Moreover, the protected sequences shown in 
3
Fig. 3.21(b) are very similar to those described by Elias
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and Lehman (1988) using purified UL9 and Koff and Tegtmeyer 
(1989) who used nuclear extract from HSV-1 infected Vero 
cells.
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SECTION 3C : The importance of the UL9 protein binding sites 
within ori^ for HSV DNA synthesis
The above sections identified OBP as the product of 
the UL9 gene. Since the results of Wu et a l . (1988) had 
shown that UL9 protein was essential for DNA synthesis, and 
two binding sites for the protein had been identified within 
orig, I further investigated the importance in DNA 
replication of UL9 binding to these two sites.
1. The role of UL9 binding sites I and II for
ori„ activity
b
Published reports mapping the core ori sequences
O
of HSV-1 and HSV-2 have brought into question the 
requirement for the second UL9 binding site, site II. Fine 
mapping of the core ori of HSV-2 identified an essential
O
region of 75 bp {Fig. 3.22(a)}. Removing 7 bp from the left
hand side of this region or 4 bp from the right, caused a
significant reduction in ori^ activity (Lockshon and 
Galloway, 1988) suggesting that an intact binding site II
was required for efficient ori activity, as were sequences
at the left hand side of binding site I. Examination of 
these sequences to the left of site I reveals the presence 
in inverted orientation of an 11 bp element, differing in 
only one position from the corresponding 11 bp sequence 
present within binding site I and also conserved in VZV orig 
(section ID). This sequence is designated motif III 
{Fig.3.22(b)}.
In contrast, Deb and Doelberg (1988) reported that 
a 67 bp origin fragment lacking binding site II {Fig.
3.22(a)} replicated as well as a wt 100 bp ori -containing
O
plasmid suggesting that site II is unimportant for ori
O
activity.
In an attempt to resolve this conflict, I therefore 
used site-directed mutagenesis of plasmid pSTl9 to 
investigate the role of binding sites I and II and sequence 
motif III in origin activity.
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Figure 3.22
(a) DNA sequence of the regions specifying ori„ activity
O
in HSV-1 and HSV-2
The DNA sequence of the 90 bp region specifying ori
O
activity in HSV-1 is shown (Stow and McMonagle, 1983). The 
insert in plasmid pSTl9 extends an additional 10 residues to 
the right. The corresponding region in HSV-2 is shown below 
with sequence differences marked by solid bars. The core 
HSV-2 orig sequence defined by Lockshon and Galloway (1988) 
is contained within the dotted lines. The core HSV-1 ori 
region defined by Deb and Doelberg (1988) is similarily 
marked. The 45 bp palindromes are indicated by arrows.
The 11 bp conserved sequence located within binding 
sites I and related sequences corresponding to site II and 
motif III, are boxed. These 11 bp sequences were deleted 
from plasmid pSTl9 by site-directed mutagenesis yielding 
plasmids pSTl9delI, pSTl9delII and pSTl9delIII respectively.
(b) Alignment of the three deleted sequences
The sequences deleted from site I, site II and motif III 
are represented in the same orientation. Mismatches are 
indicated by dots.
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(a) site-directed deletion mutagenesis of ori .^
In order to examine the requirement for UL9 protein
binding sites in initiating replication from HSV-1 ori ,
S
specific deletions were introduced into pSTl9. The method 
of Kunkel et al. (1987) employing a labile uracil-rich 
parental DNA strand was used to enrich for the required 
mutant plasmids. The oligonucleotides used to delete 
corresponding 11 bp sequences from within site I, site II 
and motif III contained 15 bases from either side of the 
region to be deleted. These oligonucleotides were 
phosphorylated and annealed to single-stranded uracil-rich 
pST19 DNA. Oligonucleotide primed in vitro DNA synthesis of 
the complementary strand of pSTl9 was carried out using the 
Klenow fragment of DNA pol I. Following ligation, the 
plasmids were used to transform E.coli strain DHl. The 
parental uracil-rich pST!9 strand is extensively degraded in 
these bacteria and repair synthesis of the DNA strand 
complementary to the strand carrying the mutation occurs in 
vivo. Plasmids containing the required 11 bp deletions from 
within site I, II and motif III were identified by DNA 
sequencing of plasmid DNA from individual colonies (Fig. 
3.23). The resulting plasmids, pSTl9delI, pSTl9delII, and 
pST19delIII contain 11 bp deletions from within sites I, II 
and motif III respectively {Fig. 3.22(b)}.
(b) ori activity of deleted plasmids
O
The replicative activities of the mutated viral
origins were compared with those of the parental plasmid
pST19 and the vector pTZl9[J. Plasmids were transfected into
BHK cells which were subsequently either mock-infected or
superinfected with HSV-1 to provide helper functions.
Samples of DNA extracted from the cells 16 h pi were cleaved
with EcoRI and Dpnl and replicated plasmid molecules were
?2detected by Southern blotting using ~ P-labelled pATl53 DNA 
as probe. HSV-1 encoded functions facilitated the 
replication of pST19 but not pTZl9U {Fig. 3.24; STl9(b) and 
pTZ(b)}. Replication of pSTl9delIII was slightly reduced 
{dlll(b)} and pST19delII {dll(b)} was greatly reduced in
pST 19 I del I I del II I del III
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Figure 3.23 Dideoxy sequencing of plasmids containing 
11 bp deletions within ori„
O
Dideoxy sequencing reactions were performed using 
plasmid pST19 and three plasmids containing 11 bp deletions 
within orig as shown in Fig. 3.22 i.e. pSTl9 dell (del I), 
pSTl9delII (del II) and pSTl9delIII (del III). The sequence 
of the orig inserts read from the gel were as follows:
pST19 : CCGGCGCCAGTGCTCGCACTTCGCCCTAATAATATATATATATTGGGACG 
AAGTGCGAACGCTTCGCGTTCTCACTTCTTTTACCCGGCGGCC
del I : CCGGCGCCAGTGCTCGCACTTCGCCCTAATAATATATATATATTGGGACC7 
CTTCGCGTTCTCACTTCTTTTACCCGGCGGCC
del II: CCGGCGCCJGCGCCCTAATAATATATATATATTGGGACGAAGTGCGAACG 
CTTCGCGTTCTCACTTCTTTTACCCGGCGGCC
dellll: CCGGCGCCAGTGCTCGCACTTCGCCCTAATAATATATATATATTGGGACG 
AAGTGCGAACGCTTCGCTTTTACCCGGCGGCC
Arrowheads mark the position of deleted sequences. The 
positions of broken lines beside a run of T residues 
illustrate the deletions in plasmids del I, del II and del 
III relative to pSTl9.
Figure 3.24 Replication of plasmids containing mutations
within ori0
BHK cells were transfected with pTZl9U (pTZ), pSTl9
(ST19), pSTl9dell (d I), pSTl9delII (d II) or pSTl9delIII (d
III) as indicated and either mock-infected (tracks a) or
superinfected with HSV-1 (tracks b). Samples containing
1/15 of the DNA recovered from each monolayer were digested
with EcoRI plus Dpnl and the fragments separated by
electrophoresis, transferred to nitrocellulose and 
32hybridised to P-labelled pAT!53. An autoradiograph of the 
washed filter is shown.
Ill
comparison to pSTl9. No pSTl9delI replication products were 
detectable (dl(b)}.
To compare activities of the mutant origins, 
regions of the nitrocellulose filter corresponding to the 
positions of the replicated plasmid molecules, detected by 
autoradiography, were excised and the radioactivity 
determined in a scintillation counter. The counts per 
minute for three independent experiments are shown in Table
3.1. Assigning a value of 100% to the activity of pSTl9, 
corresponding values of 46%, 44% and 36% were found for 
pST19delIII and 10%, 7.7% and 4.3% for pSTl9delII. In each 
experiment, pSTl9delI replication was not detectable,by 
autoradiography. A comparison of autoradiographs exposed 
for various time intervals indicated that the activity of 
this plasmid was less than 0.1% the activity of pSTl9. 
pST19delI activity was not detectable after exposing the 
filter for five days while pSTl9 activity was just 
detectable after exposing the same filter for approximately 
1/1000 of the time i.e. 7 mins.
These results therefore demonstrate that the 
removal of 11 bp elements from binding sites I and II causes 
quantitatively different effects. Disruption of site I 
abolishes detectable ori activity whereas some residual 
origin function remains when part of site II is deleted. 
Although deletion of motif III caused only a 2-fold drop in 
detectable ori activity, this element, nevertheless,
O
appears to play some role in enabling efficient replication.
(c ) binding of the UL9 DNA binding domain to 
deleted copies of ori„
O
Gel retardation assays were performed to examine
the interaction of the UL9 polypeptide with mutated copies
of ori . The mutated oriQ inserts from plasmids pSTl9delI, s ^
pST19delII, pST19delIII and pSTl9 were excised by digestion 
with BamHI-Sall, end-labelled and purified. Labelled probe 
fragments were incubated with KBl extract (in the absence 
and presence of a 10-fold excess of unlabelled 
oligonucleotide I) or with control extract, KR2, and the 
resulting complexes resolved on a polyacrylamide gel.
Retarded complexes were observed only with the KBl
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Table 3.1 Summary of three experiments measuring the
replication activity of three mutant 
ori0 plasmids
O
Replication assays were performed as described in Fig.
3.1. using plasmids DTZ19U (control), pSTl9 (pSTl9), 
pSTl9dell (dell), pSTl9delII (delll) and pSTl9delIII 
(dellll). Regions of the filter corresponding to the 
positions of the replicated plasmid DNA were excised and the 
radioactivity determined in a scintillation counter. The 
average counts per minute (A.C. cpm) are shown for duplicate 
samples. These counts are corrected for background by 
subtracting the control value for that experiment. The wt 
oric plasmid pSTl9 is assigned a value of 100% activity and 
the corresponding values for the mutant orig plasmids are 
listed below.
The cpm given for experiment 3 were obtained from the filter 
shown in Fig. 3.24.
extract, and in each case, the presence of an excess of 
unlabelled oligonucleotide I competed for binding to the 
probe (Fig. 3.25). Two major retarded complexes were seen 
with both pST19 and pSTl9delIII probes (STl9(b) and dlll(b)} 
but only a single major complex with pST19delI and 
pST19delII (dl(b) and dll(b)}. These results indicate that 
the introduction of an 11 bp deletion at either binding site 
I or site II results in the loss of a major retarded 
complex. This confirms the earlier suggestion (section 3A) 
that the higher mobility weight complex represents binding 
to a single site and the lower mobility complex, binding to 
two sites within ori . Although the deletion of binding
O
site I abolished detectable ori activity, it would appear
O
that the mutated origin retains the ability to bind to the 
UL9 protein.
Protein-DNA interactions within the origin region 
were not significantly altered in the absence of motif III, 
and as with pST19, two major complexes were observed.
2. Further examination of the role of motif III
Deleting motif III resulted in a small but 
reproducible decrease in the replicative ability of the 
ori -containing plasmid, pSTl9, but had no apparent effect
O
on the formation of protein-DNA complexes with UL9 protein. 
Because the sequence of motif III is very similar to sites I 
and II, the possibility exists that the ability of UL9 
protein to recognise this binding site is masked in the 
presence of the other binding sites. To examine whether, in 
the absence of other binding sites, the UL9 protein might 
interact with motif III, a duplex oligonucleotide containing 
this sequence was therefore synthesised and used as a probe 
in gel retardation assays.
KBl extract was incubated with labelled 
oligonucleotides containing motif III or binding site I and 
resolved on a polyacrylamide gel {Fig. 3.26(a)}. As 
previously observed, sequence-specific binding to 
oligonucleotide I occurred {oligo 1(a)} but no retarded band 
was observed with motif III oligonucleotide {oligo 111(a)}. 
This demonstrates that the failure to detect binding to 
motif III within wt ori^ is not due to interference caused
ST 19 d III d I d II
a b c a b c  a b c a b e
Figure 3.25 Gel retardation analysis of the binding of the 
UL9 fusion protein to fragments containing 
deletions within the ori,, region
O
The BamHI plus Sail inserts from pSTl9, pSTl9delI,
pSTl9delII and pSTl9delIII (ST19, d I , d II and d III
32
respectively) were P end-labelled to comparable specific 
activities and incubated with control extract KR2 (tracks a) 
or KBl extract either in the absence of competitor DNA 
(tracks b) or in the presence (tracks c) of a 10-fold molar 
excess of unlabelled oligonucleotide I. The positions of 
the major complexes, resolved in an 8% non-denaturing 
polyacrylamide gel are indicated by arrowheads.
oligo I oligo III oligo I oligo pml
a b a b  a b a b
(a)  (b)
Figure 3.26 Gel retardation analysis of the binding of the 
UL9 fusion protein to labelled oligonucleotides
3 2(a) Oligonucleotides I and III (see below) were P-labelled 
to comparable specific activites and incubated with KBl 
extract either in the absence of competitor DNA (tracks a) 
or in the presence of a 100-fold molar excess of unlabelled 
oligonucleotide I (tracks b). Complexes were analysed in a 
5% non-denaturing polyacrylamide gel. Oligonucleotide III 
contains the motif III sequence.
Oligonucleotide III 5 1 GATCTAAAAGAAGTCAGAACGCGA
ATTTTCTTCAGTCTTGCGCTCTAG 5'
32(b) Oligonucleotide I and pml were P-labelled to 
comparable specific activities and incubated with KBl 
extract as described in part (a). Oligonucleotide pml is 
identical to oligonucleotide I in containing the binding 
site I sequence except for the substitution of a single G 
residue with a T residue as found at the equivalent position 
in motif III (shown in Fig. 3.22b and underlined below).
Oligonucleotide pml:
5 1 GATCCGCGAAGCGTTCTCACTTCGTCCCA
GCGCTTCGCAAGAGTGAAGCAGGGTCTAG 5'
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by UL9 binding to sita I.
3. A point mutation within binding site I which
abolishes the ability of UL9 to bind and an 
ori„-containinq plasmid to replicate
(a) effect of the point mutation on binding
As motif III and the corresponding 11 bp sequence 
within binding site I differ at only a single nucleotide 
{marked in Fig. 3.22(b)} I decided to examine the effect of 
introducing this single base difference from motif III into 
site I. A duplex oligonucleotide (oligonucleotide pml) was 
synthesised which was identical to oligonucleotide I in 
containing the binding site I sequence except for the 
substitution of a single G residue with a T residue as found 
at the equivalent position in motif III. KBl extract was 
incubated with labelled oligonucleotides I or pml and the 
products analysed on a polyacrylamide gel {Fig. 3.26(b)}.
No retarded bands were observed with oligonucleotide pml 
{oligo pml(a)} but, as expected, a retarded band was 
observed with oligonucleotide I. Hence, this point mutation 
within binding site I is sufficient to abolish interaction 
with the UL9 protein.
(b) effect on ori,., activity
O
As the single base change described above resulted 
in the inability of site I to interact with the UL9 protein, 
the effect of this single point mutation on ori activity 
was also investigated. Using the oligonucleotide-directed 
mutagenesis method outlined in 3C part 1, the point mutation 
was introduced into plasmid pST19 using a 20 mer 
oligonucleotide. The presence of the single base change 
within site I of the resulting plasmid, pSTl9pmI, was 
verified by DNA sequencing (Fig. 3.27). The replicative 
ability of plasmid pSTl9pmI was compared with the parental 
plasmid pST19, pST19delI and pST19delII.
Plasmids were transfected into BHK cells which were 
either mock-infected or superinfected with HSV-1 to provide
pST19 |pST19pml
G A T  cl G A T C
Figure 3.27 Dideoxy sequencing of plasmid pST!9pmI
containing a point mutation within ori^
Using site-directed mutagenesis, a single G residue 
within binding site I of ori was substituted with a T
O
residue (see Fig. 3.22(b) and the legend to Fig. 3.26). 
Individual colonies were picked and a plasmid pSTl9pmI 
carrying the desired mutation (i.e C to A, since the 
sequence was obtained from the complementary strand) was 
identified by sequencing the ori insert. The wt C residue 
in pSTl9, indicated by a bold arrowhead, is absent from 
pSTl9pmI (open arrowhead) and a novel A residue (bold 
arrowhead) appears in pSTl9pmI which is not found in pSTl9 
(open arrowhead).
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helper functions. Samples of DNA extracted from cells were 
cleaved with EcoRI and Dpnl and replicated molecules 
detected by Southern blotting. Fig. 3.28(a) demonstrates 
that the introduction of the point mutation within binding 
site I was as effective as the 11 bp deletion in abolishing 
orig activity. No detectable replicative products were 
observed with pSTl9pmI or pSTl9 dell {pml(b) and dl(b)}).
A gel retardation assay was performed to examine 
the interaction of the UL9 protein with pST19pmI ori . The
O
mutated BamHI-Sall ori -containing fragment from pSTl9pmI 
was end-labelled and incubated with KR2 or KBl extract and 
the products analysed on a polyacrylamide gel. As expected, 
the pST19pmI behaved similarily to pSTl9delI as only one 
major complex was detected {Fig. 3.28(b); pml(b)}. These 
results demonstrate that a single point mutation within the 
UL9 protein binding site I of HSV-1 ori can effectively
O
prevent protein interacting with this sequence and can also 
eliminate the ability of an ori -containing plasmid to
O
replicate.
4. Binding of the UL9 protein to the VZV ori„
Stow and Davison (1986) demonstrated that HSV-1 
encoded functions could amplify plasmids containing VZV ori 
sequences, albeit at low efficiency (approximately 5% of 
that observed for HSV-1 ori ). It was suggested that the 11
O
bp sequence located to the left hand side of the VZV 
palindrome and conserved in HSV binding site I, may play a 
role in origin recognition.
Based on the observation that the C-terminal 317 
amino acids of the UL9 polypeptide exhibited 
sequence-specific DNA binding activity, the C-terminal 322 
amino acids of the VZV homologue to the HSV-1 UL9 gene, gene 
51, have been similiarly expressed in E.coli and shown to 
bind to specific sequences within the VZV viral origin of 
DNA replication using gel retardation assays (Stow et a l ., 
in press). Three binding sites for the VZV gene 51 protein 
were identified within VZV oris r lying in the same 
orientation and on the same side of the palindrome. Each 
site contains an 11 bp sequence which is either identical or
(b) ST19 pm I
a b a b
8 :  «
«MMi * j4
Mm MM
Figure 3.28 Replication and binding activity of pSTl9pmI
(a) BHK cells were transfected with pTZl9 (pTZ), pSTl9
(ST19), pSTl9pmI (pml), pSTl9delI (d I) and pSTl9delII (d
II) as indicated and either mock-infected (tracks a) or
superinfected with HSV-1 (tracks b ) . Samples containing
1/15 of the DNA recovered from each monolayer were digested
with EcoRI plus Dpnl and the fragments separated by
electrophoresis, transferred to nitrocellulose and 
32hybridised to P-labelled DAT153. An autoradiograph of the 
washed filter is shown. The faint bands visible in the 
lower portion of the figure represent Dpnl digestion 
products of unreplicated input plasmid DNA molecules.
32
(b) Gel retardation analysis using P end-labelled BamHI 
plus Sail insert fragments of plasmid pSTl9 and pSTl9pmI. 
Labelled DNA fragments were incubated with control extract 
KR2 (tracks a) or KBl extract (tracks b)and the products 
separated by electrophoresis in a 8% non-denaturing 
polyacrylamide gel. The major complexes are indicated by 
arrowheads.
(a)
pTZ ST19 pm I d I d l l
a b a b a b a b a b
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very similar to that of the 11 bp sequence in site I of HSV 
ori„ {see Fig. 3.29(b) and (c)}.iD
To compare the interaction of the two homologous 
proteins with the VZV origin, DNase I footprints were 
performed using either a Hindlll or EcoRI labelled 259 bp 
VZV orig fragment from pV02 containing the two binding sites 
closest to the palindrome, designated motifs A and C in Fig. 
3.29. Extracts from bacteria expressing the UL9 fusion 
protein (KBl extract) or the gene 51 fusion protein (KV51 
extract) were incubated with the probe and treated with
DNase I. The DNase I digested protein/DNA complexes were
resolved on a preparative polyacrylamide gel. Two major 
retarded complexes were obtained with each extract similar
to those seen for the protein A/UL9 fusion protein binding
to HSV ori^ (see Fig. 3.25 track 2). DNA from bands 
corresponding to the upper and lower (i.e. lower and higher 
mobility) KV51 complexes , the upper KBl complex and the 
free DNA probe was extracted and analysed on a denaturing 
gel (Fig. 3.30).
Protection of sequences in the region of both 
motifs A and C was detected in the upper complex formed 
between KV51 extract and probe labelled at the Hindlll 
terminus. The corresponding complex formed with probe 
labelled at the EcoRI site showed clearer protection in the 
region of motif A but a weaker footprint over motif C. The 
patterns obtained with the upper complex formed using KBl 
extract and the two probe fragments were almost 
indistinguishable from those formed with KV51 extract 
demonstrating that the two viral polypeptides are capable of 
binding to the same DNA sequences. Sites hypersensitive to 
DNase I digestion were observed within the AT-rich region of
CKvoa HI fraqrv\Jortt CEccP-l f r m fc r v t j)
the palindrome with KV51 extract a . and “with KBl^ . The ^ 
lower complexes formed with KV51 extract exhibited partial 
protection over both A and C motifs suggesting that they 
contain DNA molecules with the fusion protein bound to one 
or other site.
UL9 protein is therefore able to interact with the 
same binding sites in VZV ori as the VZV gene 51 protein. 
Moreover, these sites are closely related in sequence to the 
mapped binding sites in HSV-1 orig* The ability of UL9 
protein to bind to VZV °rig is consistent with the
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Fiqure 3.29 Location and sequence of the VZV ori„
O
(a) The structure of the VZV genome is shown and the 
position of both copies of ori are indicated.
O
(b) The sequence of the Kpnl plus Clal fragment containing 
oric is shown (nucleotides 109,893-110,350 in the sequence 
of Davison and Scott, 1986). The palindromic sequence is 
marked by arrows and motifs A, B and C are boxed. The three 
motifs form part of the sequence of three binding sites for 
the VZV homologue of the UL9 protein, the gene 51 product.
(c) The motifs A, B and C are aligned and compared to the 11 
bp element from binding site I (I) of HSV-1 orig (Fig.3.25).
H ind lll E c o R I
GA G F B1 51l 51y F B1 51,_ 51y GA G
Fiqure 3.30 DNase I protection of VZV ori„ by HSV-1 UL9 andb
VZV gene 51 fusion proteins
The plasmid pV02 ori insert was uniquely 3 1
O
end-labelled at either the EcoRI or Hindlll terminus as 
indicated and allowed to form complexes with KBl extract 
(containing the UL9 fusion protein) or KV51 extract 
(containing the VZV gene 51 fusion protein). Partial 
digestion with DNase I was performed prior to the resolution 
of complexes in a non-denaturing polyacrylamide gel. DNA 
was extracted from bands corresponding to free DNA (F), 
upper KBl complex (Bl), lower KV51 complex (51 ) and upper 
KV51 complex (51y ) [comparable to upper and lower complexes 
seen with KBl and HSV-1 orig? Fig. 3.25, track 2] and 
analysed in a 6% denaturing gel together with markers 
generated by partial cleavage at G and A residues (GA) or at 
G residues (G). The position of sequence motifs A and C are 
shown and the G residues within these motifs indicated 
(strands labelled at the Hindlll and EcoRI sites correspond 
to the top and bottom strands in Fig. 3.29 respectively. 
These sites are located adjacent to the Clal and Rsal sites 
respectively).
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previously observed ability of HSV-1 to activate replication 
of plasmids containing VZV orig (Stow and Davison, 1986).
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CHAPTER 4: DISCUSSION
1. The HSV-1 origin binding protein
(a) Identification of the HSV-1 gene encoding the
origin binding protein
A major objective of my work was to identify the 
HSV-1 gene product which binds specifically to HSV-1 ori 
(Elias et a l ., 1986). Using tsK recombinant viruses 
individually expressing four of the seven HSV-1 replication 
genes, the UL9 gene was identified as the only replication 
gene whose product was required for origin binding activity. 
This result (Weir et al ., 1989) is in complete agreement 
with the results of Olivo et a l . (1988) who expressed this 
viral protein in a baculovirus vector and assayed for 
binding activity by immunoprecipitation and DNase I 
footprinting.
The origin binding activity was also detected in 
nuclear extracts from cells infected with wt HSV-1 and 
HSV-2. This observation is consistent with the fact that 
HSV-1 and HSV-2 are closely related alphaherpesviruses and 
that the UL9 Drotein binding sites within HSV-1 ori„ are 
conserved in HSV-2 ori . Independent verification that theO
UL9 gene product exhibited origin binding activity was 
obtained using an E.coli expression system and an in vitro 
transcription and translation system.
The t_s mutant, tsS, whose lesion maps to the UL9 
gene (Matz et al., 1983), exhibited a tight DNA negative 
phenotype at NPT yet produced similar levels of origin 
binding activity to t_s mutants whose mutations map to five 
other essential replication genes. This indicates that the 
mutation does not irreversibly affect the structural DNA 
binding requirements of the UL9 protein. Moreover, marker 
rescue experiments, using fragments of the UL9 gene have 
shown that the mutation lies in the N-terminal 2/3 of the 
gene (E. C. Stow, unpublished results).
The level of origin binding activity observed in 
nuclear extracts from cells infected with individual DNA
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negative ts mutants at NPT was significantly reduced in 
comparison with wt HSV-1. Although the UL9 protein is able 
to enter the nucleus in the absence of DNA replication (Weir 
et a l ., 1989) it is possible that it may exhibit reduced 
stability under these conditions. Careful examination of 
the replication assays performed with ;ts mutants and of the 
gel retardation assays using nuclear extract from cells 
infected with the t_s mutants does suggest some correlation 
between DNA phenotype and the level of DNA binding activity
i.e. t_sl205, 1206 and 1234 which were slightly leaky at 
38.5°C do show slightly increased levels of origin-binding 
activity at 38.5°C as does ^§1206 at 39.5°C.
(b) Size of the UL9 protein in cells infected with wt
HSV-1 or the tsK/UL9 recombinant
By developing a gel retardation assay, I was able 
to distinguish different mobilities of complex depending on 
the source of protein extract. These results are 
interesting to compare with other published reports which 
have examined UL9 activity using the same technique. The 
complex with the highest mobility found in wt HSV-1 infected 
cell extracts, complex A (e.g. Fig. 3.5), clearly contains 
only a portion of the intact UL9 gene product. This complex 
is very similar to the major complex described by Koff and 
Tegtmeyer (1988) using extracts from HSV-1 infected Vero 
cells. Crude estimates of the molecular weight of the 
protein moiety in complex A were around 25,000, clearly 
inconsistent with the binding of an intact UL9 polypeptide 
(molecular weight 94,000). Aside from complex A, specific 
lower mobility complexes were sometimes observed in nuclear 
extracts from wt HSV-1 infected cells. These complexes 
probably contain larger forms of UL9 polypeptide. The 
intensity of these bands was found to vary from extract to 
extract, probably as a result of varying levels of 
proteolytic activity. The small UL9 protein fragment 
forming complex A was however, always the predominant 
species.
Elias and Lehman (1988) purified UL9 from HSV-1 
infected Vero cells and observed a major polypeptide of 
molecular weight 83,000 and two smaller fragments of 45,000
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and 38,000. Considering that the method used to estimate 
the size of the protein fragment in complex A is very crude, 
it is possible that the 38,000 molecular weight fragment is 
equivalent to that forming complex A. Elias and Lehman 
obtained a very different pattern of binding for the 83,000 
molecular weight protein in gel retardation assays from that 
which I obtained with extracts from cells infected with wt 
HSV-1. However, their binding pattern was similar to that 
seen with extract from cells infected with the tsK/UL9 
recombinant which appears to express an undegraded UL9 
polypeptide with molecular weight around 91,000 (J. Calder, 
personal communication). In both cases, a significant 
proportion of the labelled protein failed to enter the gel 
and a smeared pattern of binding was observed throughout the 
length of the track. These results suggest that in extracts 
from HSV-1 infected cells, the UL9 polypeptide may be 
subject to varying degrees of proteolytic cleavage. This 
was also demonstrated in vitro by adding protease to tsK/UL9 
recombinant extract. A smaller protein fragment was 
generated which was relatively protease resistant and 
exhibited a similar mobility to complex A.
Whether the smaller UL9 fragments observed in this 
work and by Koff and Tegtmeyer (1988) are physiologically 
significant or whether they merely reflect proteolytic 
activity occuring during extraction is unknown.
The observation that extracts from cells infected 
with the £ sK/UL9 recombinant do not contain the cleaved form 
of the protein i.e. do not produce complex A, suggests that 
the proteolytic cleavage occurs as a consequence of the 
virus infection. The fact that extracts from cells infected 
with DNA negative t_s mutants produced complex A indicates 
that the proteolytic activity, if virus encoded, is 
synthesised before the onset of DNA replication (i.e. 
probably as an IE or E function).
Although the interaction of intact UL9 polypeptide 
with labelled probe fragments produced a smeared pattern in 
a gel retardation assay, this binding was nevertheless 
sequence-specific. The smearing may occur as a result of 
aggregation and/or dissociation of complexes during 
incubation of the binding reactions and gel electrophoresis. 
This pattern would appear to be dependent upon the UL9
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sequence present, as complexes containing only proteolytic 
fragments of UL9 or the C-terminal 317 amino acids of the 
protein synthesised in the E .coli expression system produced 
much tighter bands. The smearing may therefore be a 
consequence of interactions involving the N-terminal portion 
of the polypeptide. Interestingly, extracts containing the 
C-terminal 2/3 of the UL9 polypeptide exhibited a similar 
binding pattern to that of the intact UL9 protein i.e. 
smeared binding with little formation of sharply resolved 
protein-DNA complexes. This suggests that sequences from 
the central 1/3 of the protein may be involved in 
protein/protein interactions. The formation of large 
complexes comprised of several monomers or dimers of origin 
binding proteins has previously been observed with the 
E.coli dnaA protein at oriC, the bacteriophage lambda 0 
protein at the lambda ori and also SV40 T-ag at the SV40 
core origin (section IE).
(c) Sequence-specific binding specified by the
C-terminal 1/3 of the UL9 polypeptide
Expression of fragments of the UL9 polypeptide in 
E.coli demonstrated that the C-terminal 317 amino acids 
specifies all the structural information required for 
sequence-specific recognition and binding. This was 
independently verified by transcribing and translating this 
fragment in vitro. These experiments exclude the 
possibility that sequence-specific recognition of DNA by the 
UL9 protein occurs in conjunction with cellular nuclear 
proteins.
The E.coli expression system provided a very 
convenient source of DNA binding activity. The bacterial 
extracts were simple to prepare and the DNA binding activity 
remained stable at -70°C for at least six months. Such a 
system should prove useful for deletion/insertion 
mutagenesis of the 317 amino acid fragment to map precisely 
the structural requirements for DNA binding activity.
Assuming that the proteolytic DNA binding fragment 
of the UL9 protein seen in HSV-1 infected cell extracts lies 
within the molecular weight range of 25,000-30,000, this 
fragment probably contains only 230-270 amino acids. The
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pTZ vectors could be conveniently used for introducing 
specific amino acid changes into the C-terminal region. The 
effect of these changes could be assayed by in vitro 
transcription and translation or following introduction into 
the E .coli fusion protein expression vector. As the binding 
activity produced by in vitro transcription and translation 
of the C-terminal 1/3 of the UL9 gene was lower than that 
seen with the E.coli extracts, it is possible that small 
changes in the ability of the protein to bind DNA may be 
difficult to detect. However, as the in vitro system was 
not fully optimised in this work, the potential of this 
system remains to be determined.
C-terminal DNA binding domains have previously been 
noted for other herpesvirus proteins for example the oriP 
binding protein of EBV, EBNA-1 (Rawlins et al ., 1988), and 
also the major ssDBP of HSV-1 encoded by UL29 (Leinbach and 
Heath, 1988) which binds in a sequence-independent manner. 
Following on from the work described in this thesis, the 
C-terminal 322 amino acids of the VZV homologue to the UL9 
protein, the gene 51 product, were also shown to bind in a 
sequence-specific manner to VZV orig (Stow et a l ., submitted 
for publication). Structurally distinct DNA binding domains 
have been identified in a variety of other proteins, often 
on the basis of their resistance to the action of added 
protease e.g. CAAT-box binding protein (van Huijsduijnen et 
al ., 1987), lambda integrase (de Vargas et a l ., 1988),
Vmwl75 (Paterson and Everett, 1988; Faber and Wilcox, 1988) 
and glucocorticoid/progesterone steroid receptors (Tsai et 
al., 1988).
(d) Identification of two UL9 protein binding sites
within HSV ori„
(i) using synthetic oligonucleotides
Competition experiments using synthetic 
oligonucleotides demonstrated the presence within HSV-1 ori
O
of two binding sites for the UL9 protein. This was in 
contrast to a contemporaneous report of Elias et al. (1986) 
of only a single binding site (binding site I). The second 
site, site II, contains a sequence related to site I and is
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present in an inverted orientation at the right hand end of 
the palindrome. Identification of this second binding site 
within orig (Weir et a l ., 1989) was also made independently 
by Elias and Lehman (1988) and Olivo et a l . (1988). 
Additional competition experiments demonstrated that the UL9 
polypeptide has approximately a 10-fold higher affinity for 
binding site I than site II. This result is in agreement 
with the work of Elias and Lehman (1988) who measured the 
half lives of UL9 complexes formed with site I and site II 
by adding an excess of specific competitor DNA at various 
times to reactions which had reached equilibrium. The UL9 
complex with site I was approximately 10 times more stable 
than that with site II. The reason for the HSV ori
O
containing UL9 binding sites of differing affinities is not 
known but possibly they may serve as a signal for 
determining the position within a specific DNA strand of a 
nicking site for initiation of rolling circle replication or 
confer some directionality on the synthesis of daughter DNA 
strands. The sequence of HSV-1 ori (which is a perfect 
palindrome) indicates that within this origin, two identical 
UL9 binding sites are present.
(ii) by DNase I footprint analysis
Gel retardation assays using the C-terminal 
fragment of the UL9 polypeptide produced two distinct 
complexes with ori DNA. DNase I footprint analysis of the 
lower mobility complex illustrates that this complex 
represents binding to sites I and II within ori (Fig.
O
3.21). Several other groups have carried out DNase I 
footprint analysis of UL9 binding to ori and in one
O
instance methylation interference assays were used to 
establish which G residues are in direct contact with the 
protein. The results of these studies are summarised in 
Fig. 4.1.
In general, the protected sequences are very 
similar. Using HSV-1 infected cell extract, Koff and 
Tegtmeyer (1988) and Deb and Deb (1989) detected binding to 
site I alone. It is interesting to observe that the 
C-terminal DNA binding domain of the UL9 protein appears to 
protect a similar number of bases at site I as purifed
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Fiqure 4.1 DNase I protection of the HSV-1 ori„ by UL9
O
The diagram shows the core HSV-1 ori sequence (Stow andO
McMonagle, 1983) . The results of the DNase I footprint 
shown in Fig. 3.21(b) are marked as solid black bars. DNase 
I footprints of UL9 binding to orig have been performed by 
several other groups of workers and are summarised in the 
diagram and referenced in the key. Bold circles within the 
protected region of Koff and Tegtmeyer (1988) highlight four 
G residues, which by methylation interference assays, were 
found to contact the UL9 protein.
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intact UL9 protein (Elias and Lehman, 1988; Olivo et a l ., 
1988). Using the C-terminal DNA binding domain, weaker 
protection was observed at site II over a smaller region. 
This probably reflects the lower affinity of UL9 binding to 
this site. However, both Elias and Lehman (1988) and Olivo 
et_al. (1988) using purified intact UL9 and baculovirus 
expressed UL9 respectively detected strong protection over a 
larger area. It has been suggested by Challberg and Kelly 
(1989) that the footprinting assays of Elias and Lehman 
(1988) and Olivo et al., (1988) indicate that the affinity 
of UL9 for the two sites when present together is equal. 
However, careful examination of the published data reveals 
that at lower UL9 protein concentrations, site I is 
completely protected before site II, substantiating the 
results of the affinity studies using synthetic 
oligonucleotides containing individual binding sites. The 
protected region identified by Olivo et al. (1988) at site 
II is distinctive in that it extends into and covers most of 
the AT-rich region of the palindrome, especially on one 
strand of the DNA. Elias and Lehman (1988) noted that 
increasing the UL9 concentration in their footprinting 
assays resulted in less frequent cutting in the AT-rich 
region and an increased intensity of some bands immediately 
to the left of binding site I. These alterations may be a 
consequence of UL9 binding to additional sites, 
protein/protein interactions between molecules bound to 
sites I and II or altered conformation in the DNA induced by 
binding of protein to both sites. This latter possibilty is 
a common feature of origin recognition proteins binding 
adjacent to AT-rich regions (Zahn and Blattner, 1985a; 
Borowiec and Hurwitz, 1988b).
Methylation interference assays by Koff and 
Tegtmeyer (1988) have identified four G residues within 
binding site I which are contacted by the UL9 protein (Fig.
4.1). The core area of interference is confined to an 8 bp
sequence 5 1 - qaAGCGTG"3 ' * This se9ment corresponds exactly 
to two inverted and overlapping repeated sequences with the 
consensus sequence 5 1-GT(T/G)CG-31 and reads:
5'-GTTCG-31
3'-GCGTG-51
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This inverted motif is perfectly conserved in ori and ori
S Xj
of all sequenced human alphaherpesviruses except for binding 
site II of HSV-1 and HSV-2 ori in which the motif is 
5'-GCTCG-3'. It is interesting to note that even with the 
small footprint observed at site II with the E.coli 
C-terminal extract, the CG overlapping region between the 
inverted repeats is clearly protected. This observation 
confirms the importance of this region for binding. It is 
not known whether the T to C change is sufficient to account 
for UL9 binding to site I and II with differing affinities.
The presence of overlapping inverted DNA binding
• inmotifs with/xorigins of DNA replication has previously been 
well documented for the T-ag binding site of polyoma virus. 
The T-ag binds to a pentanucleotide motif in a palindrome 
containing two direct repeats on each arm. The inverted 
repeats closest to the centre of the palindrome overlap by 
two base pairs (Trienzenberg and Folk, 1984) .
The results of Koff and Tegtmeyer (1988) suggest 
that the UL9 protein may bind to the inverted repeat as a 
dimer. There is however no published evidence to suggest 
that this the case. Following purification of UL9 from 
infected cells, Elias and Lehman (1988) stated that the 
polypeptide exists as a monomer which tends to aggregate at 
low ionic strengths. However, other reports have cited 
unpublished sedimentation coefficients determined for 
purified baculovirus recombinant UL9 protein as 
demonstrating that the protein predominantly exists as a 
stable homodimer (cited in Challberg and Kelly, 1989) .
2. Analysis of the predicted amino acid sequence
of the LJL9 gene
The sequence of the UL9 gene has been determined 
and the amino acid sequence of the encoded protein predicted 
(McGeoch et al., 1988a,b; Fig. 4.2). The UL9 gene appears 
to encode a large globular protein with few particularly 
distinctive features. Nevertheless, analysis of the 
predicted primary structure has revealed some interesting
Primary and Secondary Structure of the UL9 Polypeptide
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Figure 4.2 Primary and secondary structure of the UL9 
polypeptide
The predicted amino acid sequence (1-851) of the 
HSV-1 UL9 protein is shown in the single letter amino acid 
code. Secondary structure was predicted by the GARNIER 
program using the method of Garnier et a l ., (1978) and is 
shown below the sequence. C= random coil; E= beta sheet; H= 
alpha helix; T= turn. Acidic and basic residues are 
highlighted - and + above the amino acid sequence. Site 'A' 
and 'B' refer to the purine NTP-binding site identified by 
Gorbalenya and Koonin (1989). Underlined sequences (labelled 
1-4) correspond to regions containing putative HTH motifs 
and leucines (indicated by *) refer to potential leucine 
zipper motifs.
features:
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(i) the purine NTP-binding motif
McGeoch et al . (19 88b) examined the predicted amino
acid sequences of the HSV-1 DNA replication genes for the
presence of several consensus elements associated with DNA
binding, nuclear entry and nucleotide binding. In this
manner, a consensus sequence derived by Walker et a l . (1982)
associated with ATP-binding sites was located in the UL5
gene. The presence of a variety of motifs suggested that
the UL5 protein could potentially encode a helicase activity
(Hodgeman, 1988) and not surprisingly, this protein has been
identified as one of the polypeptides associated with a
three-subunit helicase/primase complex which can utilise ATP
and GTP (Crute et al ., 1989) . UL5 alone however does not
exhibit helicase activity (Calder and Stow, submitted for
publication).
More recently, Gorbalenya et al. (1989) and
Gorbalenya and Koonin (1989) have carried out a systematic
analysis of protein sequences containing the purine
NTP-binding motif and have located a further example within
the N-terminal region of the UL9 protein.
The NTP-binding motif consists of two distinct
domains: an 'A" site and located adjacent on its C-terminal
side, a 'B' site (Gorbalenya and Koonin, 1989). The 'A'
site motif consists of:
<hydrophobic stretch>(G/A)xxGxGK(S/T)
where x represents any amino acid and the hydrophobic
stretch normally contains at least two hydrophobic residues
out of five. From X-ray crystallography data, the GxG
flexible loop structure is thought to bind the phosphate
group of ATP or GTP. The 'B' site motif consists of:
<hydrophobic stretch>D(E/D)
The hydrophobic stretch should contain at least three
hydrophobic residues out of five. Again, X-ray data have
2+suggested that the invariant D residue chelates Mg
Site 'A' of the UL9 gene motif is clearly located 
between residues 77-89 (Fig. 4.2; site A) where three out of 
five residues are hydrophobic in the hydrophobic stretch.
Site B is located between residues 169-175 (Fig. 4.2; site
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B) where four hydrophobic residues out of five are found in 
the hydrophobic stretch.
X-ray crystallography data have also shown that 
both motifs are usually folded in a beta sheet-turn-alpha 
helix structural unit with the N-terminal hyrophobic beta 
strands being the most highly conserved. To look for such 
structures in the purine NTP-binding site of UL9, a computer 
prediction of the potential secondary structure of the UL9 
protein was performed using the GARNIER program which makes 
use of the algorithms of Garnier et a l . (1978). The program 
determines the liklihood of each residue being in one of 
four secondary structures; H (alpha helix), E (extended 
chain/beta sheet), T (reverse turn) or C (random coil). The
predictions are about 40% accurate for small globular 
proteins but of questionable application to larger globular 
proteins where little structural information is known. The 
output of the GARNIER prediction for the UL9 protein is 
shown in Fig. 4.2. Not surprisingly, the hydrophobic 
stretches of site A and site B are predicted to fold as beta 
sheets. There is also a predicted turn in site A at the 
first invarient G (residue 85).
The study by Gorbalenya and Koonin (19 89) of viral 
and cellular proteins containing such NTP binding motifs 
allowed the delineation of four large superfamilies of 
proteins based on criteria such as statistically significant 
sequence similarities and the presence of distinct highly 
conserved sequences in addition to the 'A' and 'B' motifs of 
the NTP binding pattern. The UL5 protein was assigned to 
superfamily 1 and UL9 to superfamily 2. Proteins from each 
of these two families contain seven conserved regions which 
span most of the polypeptide chain. As both families 
contain proteins known or thought to encode helicase 
activity, this would suggest some intrinsic helicase 
activity associated with the UL9 protein. Unpublished 
experiments from M. Challberg's laboratory and our own (J. 
Calder personal communication) have used model substrates 
containing single and double-stranded regions and detected a 
helicase activity associated with UL9 which is ATP 
dependent.
This raises the interesting possibility that the 
UL9 protein, in addition to recognising and binding
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specifically to orig and ori^, can locally unwind a short 
stretch of DNA at the origin in an analogous manner to SV40 
T-ag. The SV40 T-ag carries out the dual role of opening 
strands of duplex DNA at the origin and at the replication 
forks (Stahl et al ., 1986; Wold et a l .f 1987). In HSV, 
these functions may be carried out by separate proteins; UL9 
at the origin, and the UL5/UL8/UL52 helicase/primase complex 
at the replication forks. Alternatively, the relatively 
large helicase/primase complex may require a 'melted' region 
of DNA produced by the action of the UL9 protein at the 
origin in order to make its initial attachment. A similar 
situation has been previously described for the dnaB 
helicase of E.coli (section IE). There is no convincing 
evidence as yet, that the UL9 protein binds or hydrolyses 
ATP or is capable of unwinding dsDNA at the HSV origin.
As described in part 1(a) marker rescue experiments 
have indicated that the mutation in t_sS (UL9 mutant) is 
located in the N-terminal 2/3 of the protein. It is 
interesting to speculate that the mutation may in fact 
disrupt the helicase activity which would suggest an 
essential role in replication for this activity. As the 
sequence-specific recognition and binding of UL9 are 
specified by the C-terminal 1/3 of the polypeptide, the 
helicase function is clearly not required for these 
activities.
(ii) potential DNA binding motifs
Analysis of information derived from published 
sequences of DNA binding proteins and X-ray crystallography 
has allowed the identification and characterisation of 
conserved structural motifs by which many proteins recognise 
DNA or dimerise (Anderson et al ., 1981; Fairall et al.,
1986; Landschulz et a l ., 1988; Johnson and McKnight, 1989). 
These motifs have mainly been identified in prokaryotic and 
eukaryotic transcription regulatory proteins and products of 
cellular oncogenes which bind as dimers to their DNA binding 
sites. Whether one should expect to find such motifs within 
an HSV replication protein is questionable. However, 
analysis of the amino acid sequence of UL9, with a view to 
the identification of DNA binding motifs, has produced some
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interesting observations:
(a) helix-turn-helix (HTH) motif
The HTH motif was initially characterised through 
analysis of the DNA binding domains of three prokaryotic 
regulatory proteins (Anderson et a l ., 1981; Pabo and Lewis, 
1982; Steitz et al ., 1982). The essential structural 
components of the binding domain consist of two short alpha 
helices separated by a beta turn located within a 22 amino 
acid stretch. The carboxy terminal helix, helix 3, 
interacts with the major groove of the DNA and is locked in 
place by hydrophobic interactions with helix 2 which is 
positioned over helix 3, relative to the DNA.
Brennan and Matthews (19 89) have compiled a 
statistical procedure for identifying putative HTH motifs. 
The putative amino acid sequence is compared with a 'master' 
set of prealigned sequences, 22 amino acids long, taken from 
proteins known, or highly likely to contain, HTH motifs.
The sequence of interest is given a probability score by 
evaluating the correspondence between every possible 22 
amino acid segment of the protein and the 'master' set. By
inspection of the 'master' set sequence alone, four common 
characteristics for such motifs have been proposed:
(1) residue 9 of the 22 amino acid segment should be a 
glyci ne
(2) residues 4 and 15 should not be charged
(3) residues 3-8 and 15-20 should be proline free (being 
within alpha helices)
(4) residue 5 should not be a beta-branched residue (being 
wedged between the two helices)
Manually scanning the amino acid sequence of the 
UL9 protein identified a 22 amino acid segment at positions 
731-752 (1; Fig. 4.3) which closely fits these criteria 
except for a proline at residue 20. The statistical scoring 
method did not produce a significant score for this segment.
A computer program compiled by Dr. A. Bailey in 
this department, using the scoring method of Dodd and Egan 
(1987) (which is similar to Brennan and Matthews (1989) but 
based on a larger 'master' set of HTH proteins) was used to
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search every 22 amino acid segment of the UL9 protein. The 
top four scoring regions are marked in Fig. 4.3; position 
731 - score: 841; position 793 - score: 771; position 765 - 
score: 464; position 706 - score: 305. A genuine HTH motif 
normally scored 1100 and above while random protein 
sequences scored less than 600. Hence putative motifs at 
positions 3 and 4 can probably be disregarded. Although the 
scores of putative motifs at positions 1 and 2 are not very 
significant, it is interesting that these two segments lie 
within the DNA binding domain. No distinctive HTH secondary 
structure was identified in each of these segments. It will 
be interesting to see if future fine mapping of the minimal 
domain required for DNA binding correlates with the 
requirement for these two putative HTH segments.
(b) leucine zipper motif
The leucine zipper DNA binding motif, first 
described by Landschulz et al . (1988) consists of two 
distinct parts; a structural region involved in dimerisation 
of the protein and an adjacent N-terminal DNA binding 
domain, rich in basic amino acids. The structural region 
contains a repeat of 4-5 leucine residues separated by seven 
amino acid residues within a sequence that can form a stable 
alpha helix with the leucine residues present on one face of 
the protein molecule. The protein monomers are thought to 
bind in a parallel configuration as a result of interactions 
between the leucine containing helices. The dimerisation 
leads to a unique positioning of basic regions from the two 
subunits that is critical for sequence specific binding 
(Landschulz et al., 1988).
A repeat of four leucine residues can be found 
between residues 150 and 170 of the UL9 protein (Fig. 4.2).
It is unlikely that this is significant for DNA binding for 
several reasons. This region does not have an N-terminal 30 
amino acid basic stretch and the leucines themselves do not 
appear to be part of a stable alpha helix. The leucine 
repeat lies outwith the DNA binding domain and overlaps with 
the proposed B site of the helicase domain.
A second leucine repeat is also found within the 
DNA binding domain of the protein at positions 570-593 (Fig.
4.2) but again it is doubtful whether this region is
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significant as there is no adjoining basic region and there 
are actually 8 residues between the second and third 
leucines L2 and L 3 . It has recently been shown that the 
product of the FOS oncogene is incapable of sequence 
specific interaction with DNA unless it is complexed with 
the product of the JUN oncogene, via their respective 
leucine zippers, suggesting that the zipper regions may 
promote the formation of heterodimeric DNA binding complexes 
(Distal et a l ., 1987; Kouzarides and Ziff, 1988; 
Sassone-Corsi et a l ., 1988). The possibility that following 
the formation of an open region at the origin by the UL9 
helicase, the leucine repeat, located in the N-terminal 
region, is involved in protein-protein interactions with 
other replication proteins, is open to investigation. 
Alternatively, the leucine repeats may be involved in 
dimerisation of the UL9 protein (see section (d)ii).
A third DNA binding motif, the zinc finger, has 
been identified in some eukaryotic regulatory proteins. A 
classic example of this motif is found in the eukaryotic 
transcription factor TFIIIA where a sequential and ordered 
occurrence of cysteine and histidine residues is repeated 
nine times in the amino acid sequence ( C y s - ^ -Cys-N^^Hi3-^  
-His; Rhodes and Klug, 1986). This motif is not present in 
the UL9 amino acid sequence.
(iii) location of a UL9 binding site within the UL9 
open reading frame
Having characterised the UL9 recognition sites 
within ori , a computer search of the HSV-1 sequence for
O
additional possible UL9 binding sites was conducted using 
the FIND program. Using the consensus sequence of Koff and 
Tegtmeyer (1988), YGYTCGCACT (Y=pyrimidine), the search 
located seven 10 bp sequences within the HSV-1 genome. Six 
of these sequences were located within previously identified 
UL9 binding sites; two in each copy of ori and two in oriT .
O i-i
The seventh sequence was located within the coding sequence 
of the UL9 gene, close to the N-terminal end of the 
polypeptide which differed in only 2 out of the 11 bases of 
the 11 bp conserved sequence identified by Stow and Davison 
(1986). The mismatches lie outwith the 8 bp UL9 recognition
sequence (GYTCGCAC) proposed by Koff and Tegtmeyer (19 88;
Fig. 4.3).
To investigate whether this element was recognised 
by the UL9 protein, plasmid pX8 (section 3B) was digested 
with PvuII and BamHI, yielding a 132 bp fragment containing 
the putative binding site. The fragment was end-labelled 
and incubated with control bacterial extract KR2 or KBl 
extract which contains the UL9 DNA binding domain fusion 
protein and the products analysed on a polyacrylamide gel 
(Fig. 4.3; as indicated). A single complex was obtained 
with KBl extract alone (KBl(a)} which was competed in the 
presence of specific competitor DNA {KBl(b )}. The signal 
intensity of this complex was much less than previously seen 
with KBl extract using probes containing HSV-1 ori binding 
sites. The results are consistent with this fragment 
containing a low affinity binding site for UL9 protein.
The location within coding regions of binding sites 
for the encoded protein has previously been described for 
two other origin binding proteins; S.coli dnaA (section IE) 
and the EBV EBNA-1 protein (section ID). In the case of 
EBNA-1, the coding sequence binding site is the lowest 
affinity site detected in the genome and it is thought that 
this site might faciliate as a negative feedback control for 
the expression of EBNA-1 i.e. occupation of this site only 
occurs when the protein concentration has increased beyond 
that necessary to saturate two higher affinity sites located 
at the latent phase origin of replication thereby regulating 
amplification of episomal EBV genomes (Jones et a l ., 1989). 
It is doubtful whether this particular situation is 
applicable to HSV, as there is no detectable replication of 
the HSV genome in latently infected cells. However, once 
the UL9 protein has bound to all available higher affinity 
sites at ori during lytic infection, the protein might halt
O
UL9 gene transcription by binding to this third site located 
80 bp from the cap site.
The presence of this binding site, assuming that it 
allows repression of transcription and has a lower affinity 
than the ori binding sites, may provide some explanation 
for the failure to detect origin binding activity in cells 
co-transfected with plasmids pGX58 and pJR3 (IE-3 and IE-1 
gene) and pGXl25 (UL8 + UL9 gene).
site I CGTTCGCACTT 
• •
UL9 gene TGTTCGCACTC
Figure 4.3 Gel retardation analysis of the UL9 fusion
protein binding to a fragment from the UL9 gene
Plasmid 0X8 which contains the N-terminal 2/3 of the UL9
gene was digested with PvuII plus BamHI yielding a 132 bp
fragment containing a putative UL9 binding site, indicated
32below the autoradiograph (UL9 gene). The fragment was P 
end-labelled and incubated with control extract KR2 or KBl 
extract either in the absence of competitor DNA (tracks a) 
or in the presence of a 20-fold excess of oligonucleotide I 
(track b). The products were separated in an 8% 
polyacrylamide gel. A retarded complex is indicated by an 
arrowhead.
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When HSV DNA was transfected into cells, some 
origin binding activity was detected (Fig. 3.12). The 
hypothetical model predicts that any UL9 protein produced 
during transfection will bind to six higher affinity sites 
in the HSV genome before repressing transcription by binding 
to the UL9 gene itself. Moreover, the expression of the 
other replication proteins following transfection will 
probably allow further amplification of the number of 
origins. Thus, significant amounts of the UL9 protein may 
accumulate before repression occurs. In contrast, in cells 
co-transfected with the three plasmids there is a copy of 
orig in plasmid pGX58 but because the other replication 
genes are absent, it cannot be amplified. The availability 
of fewer high affinity binding sites might therefore result 
in rapid repression of UL9 gene transcription as the protein 
binds to the lower affinity site within its own gene. As a 
consequence, insufficient UL9 protein may be synthesised to 
be detected by gel retardation analysis. This model could 
be tested by using ori -containing plasmids as carrier DNA 
in co-transfection experiments to provide a much higher 
concentration of high affinity sites and thereby reduce any 
binding to the UL9 gene itself.
The key argument against a repressive role for UL9 
is that relatively high levels of protein can be expressed 
in the baculovirus expression system (Olivo et a l ., 1988; N. 
D. Stow, unpublished results). Perhaps in insect cells the 
transcriptional machinery is not inhibited by UL9 binding.
In addition, the tsK/UL9 recombinant expresses relative high 
levels of UL9 protein in the absence of DNA replication.
Six UL9 protein binding sites are available within the HSV 
genome but it is unlikely that this small number would be 
sufficient to prevent rapid repression by the UL9 
polypeptide. Possibly significant is the high efficiency of 
transcription directed by the IE-3 promoter in this 
construct in comparison to the lower presumed activity of 
the UL9 promoter.
3. The-role of UL9 and its recognition sites in 
initiation of HSV DNA synthesis
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The site-directed mutagenesis experiments described 
in section 3C demonstrate that a functional binding site I 
is essential for orig activity, whereas the binding of UL9 
protein to site II is not an absolute requirement. The 
requirement for site I is in agreement with the deletion 
analysis of Lockshon and Galloway (1988) and also the 
results of Deb and Deb (1989). The latter workers showed 
that a 6 bp deletion affecting this site was inactive in 
both UL9 binding and replication. The observation that a 
single point mutation within site I also abolished both 
replicative ability and the interaction of UL9 at this site 
strongly suggests that the abolition of ori activity is 
directly related to the failure of UL9 protein to bind to 
this site and not to any physical alterations in the spacing 
of the other sequence elements within ori . The position of
O
the inactivating point mutation within site I corresponds to 
the second of two bases within the UL9 protein recognition 
sequence at which the inverted pentanucleotides overlap 
(Fig. 4.3 Koff and Tegtmeyer, 1988). In addition, the G 
residue within the wt sequence which was replaced by a T 
residue represents one of the essential contact residues for 
the UL9 protein identified by methylation interference 
assays (Koff and Tegtmeyer, 1988). These results 
demonstrate that this base plays a key role in the UL9 
protein interaction with ori.g*
Conflicting results have previously been reported 
concerning the role of site II in HSV ori activity. Deb 
and Doelberg (1988) reported that a mutated ori whichO
lacked the entire binding site II region functioned as 
efficiently in a plasmid amplification assay as wt ori 
{Fig. 3.22(a)}. In contrast, in defining the minimal 
sequence requirement for the almost identical ori of HSV-2, 
Lockshon and Galloway (1988) found that deletion of part of 
binding site II abolished detectable origin activity.
Results presented in this work demonstrate that 
although the lack of a functional binding site II causes a 
significant reduction in plasmid amplification, the presence 
of two UL9 binding sites is not an absolute requirement for 
ori activity. This result is supported by previous work of 
Stow and Davison (1986) which demonstrated that HSV-encoded 
helper functions were able to activate the orig of VZV with
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approximately 5% the efficiency of HSV-1 ori . The VZV 
origin contains sequences homologous to UL9 binding site I 
on one side of the palindrome only. Furthermore, DNase I 
footprint assays showed that the sequence-specific DNA 
binding domains of both the UL9 protein and its VZV 
counterpart interacted with these predicted sequences within 
VZV orig (Fig. 3.30) .
The reasons for the apparent differences in 
importance of binding site II in the three pieces of work 
(Lockshon and Galloway, 1988; Deb and Doelberg, 1988; this 
thesis) are not known but may include differences in virus 
strains and experimental protocols.
There is nevertheless a correlation between the 
observation that copies of ori lacking site I or site II 
exhibit undetectable or residual origin activity 
respectively and measurements of the affinity of the UL9 
protein for these sites. As described earlier, the affinity 
of the UL9 protein is approximately 10-fold higher for site 
I than for site II (Elias and Lehman, 1988; this work). The 
UL9 protein would be expected to bind more tightly to an 
origin lacking site II than to one lacking site I, which may 
account for the residual function of the origin deleted for 
site II sequences. Additionally, DNA binding studies 
(results of M.Challberg, cited in Challberg and Kelly, 1989) 
suggest that deleting site II reduces the affinity of UL9 
protein for site I which may in part account for the 
reduction in activity with the site II deletion mutant.
Although the intrinsic affinity of the UL9 protein 
for the two binding sites differs (as demonstrated using 
individual oligonucleotides containing site I and site II), 
the initial binding of UL9 to the higher affinity site I may 
induce a conformational change in the ori DNA so as toO
increase the affinity of UL9 for site II. Evidence for such 
cooperativity is provided by the work of Lockshon and 
Galloway (1988) in which a series of mutant origins were 
constructed in which n copies of the AT dinucleotide were 
inserted into the centre of the AT-rich region of the 
palindrome. As n increases from 0 to 8, replication first 
decreases to a minimum at n=3, then rises to a maximum at 
n=5 or 6 (corresponding to an insertion of approximately one 
helical turn of DNA) then decreases again. It is possible
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that this oscillation in activity corresponds to a 
requirement for the UL9 protein molecules bound to the two 
sites, to be spatially orientated in an appropriate manner. 
This arrangement may be critical to accompdate essential 
UL9-UL9 interactions.
Attempts to define the left hand boundary of a 
minimal HSV orig indicated a requirement for an 
approximately 20 bp region to the left of site I (Fig. 3.22; 
Lockshon and Galloway, 1988). As this region contains an 
almost perfect inverted repeat of site I (motif III; Fig.
3.22) it was suggested that this region might represent 
another binding site for the UL9 protein (Lockshon and 
Galloway, 1988). Gel retardation assays show that the UL9 
protein does not interact with this sequence (this work) 
which is consistent with the DNase I footprint assays 
summarised in Fig. 4.1. The possibility that binding to 
this region had not been previously detected because of the 
presence of neighbouring site I was also excluded by using 
oligonucleotides containing motif III alone.
Although motif III does not bind the UL9 protein, 
its deletion nevertheless causes a reproducible reduction in 
ori activity of 2-3 fold. In contrast, Lockshon and 
Galloway (1988) showed that an HSV-2 ori deletion mutant 
(pS207) with an end-point located within motif III was 
almost completely inactive in replication assays (Fig.
3.22). Thesedata suggests the possibility that the sequence 
TAAAAG which abuts motif III, and is present in both the 
core origin sequence of Lockshon and Galloway (1988) and 
pST19pmI, but missing from pS207, may have an important 
function in ori activity. It is interesting to note that
O
the presence of motif III and the T AAA AC- element confer a 
very strong bias toward purines on one strand of the DNA (16 
out of 1 bases). Such sequences are thought to be 
inherently unstable and as previously described in section 
IE, a sequence of this type within the SV40 core origin 
(early palindrome) is, in fact, the first region to be 
opened by T-ag. The early palindrome region is located next 
to the T-ag binding site which in turn is adjacent to the 
AT-rich element which allows T-ag to extend the replication 
bubble first initiated within the early palindrome. The 
ability of T-ag to 'melt' the early palindrome is not energy
136
dependent and constitutes a third function of the 
polypeptide in DNA replication, distinct from its ability to 
recognise the pentanucleotide motif and its energy dependent 
helicase activity.
The experiments on HSV raise the interesting 
possibility that the TAAAflGelement forms an essential part 
of an element to the left of site I which is unwound by the 
UL9 helicase activity. It is also interesting to note that 
at increased UL9 protein concentrations in footprinting 
assays, Elias and Lehman (1988) observed DNase 
hypersensitivity immediately to the left of site I which 
suggests that this region may contain single-stranded DNA or 
is at least made more susceptible to DNase I. The fact that 
the TAAA sequence is brought closer to the AT-rich centre 
of orig by deleting motif III may explain the decrease in 
orig activity.
To date, no HSV variant which lacks both copies of 
orig has been reported. This may indicate that virus 
replication requires at least one functional cis-acting 
ori , or that attempts to inactivate the origin may have 
some deleterious effect on the expression of an essential 
trans-acting gene product (Hubenthal-Voss et al., 1987; 
Hubenthal-Voss and Roizman, 1988) . The observation that 
ori function can be inactivated by a single point mutation
O
may go some way to resolving this question. It should now
be feasible to introduce a point mutation into both copies
of ori within the viral genome without affecting the 
S
expression and function of any essential trans-acting 
product specified by this region (the coding potential of 
this region remains controversial; see section. 1A, part 4).
In contrast, previous attempts to inactivate the genomic 
copies of ori have employed large deletions and insertions
O
which may have inactivated such a function.
It would appear that the sequence-specific 
recognition of the HSV-1 origin is a very early event in the 
initiation of replication. The UL9 protein had previously 
been recognised as being essential for DNA synthesis, and 
the work presented here demonstrates that its interactions 
with specific sequences in the origins plays a key role. 
Following binding, the UL9 protein probably participates in 
unwinding the viral DNA and/or assembling a replicative
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complex at the HSV origin of replication.
Future experiments will doubtless aim to 
investigate these reactions further. Important will be:
(i) defining the region of the protein responsible for 
sequence-specific binding
(ii) defining regions of the protein required for helicase 
activity and for dimerisation
(iii) a detailed analysis of the perturbation to DNA caused 
by UL9 binding to the origin (e.g. melting and 
unwindi ng)
(iv) analysis of the interactions of the UL9/ori complex 
with other components of the replicative machinery
The initiation of HSV DNA synthesis however will 
only be fully understood following the development of an in 
vitro system capable of faithful initiation. This 
development will be essential for the complete elucidation 
of the sequence of events which takes place at an HSV origin 
of replication following initial interaction with the UL9 
protein. Given that all the viral proteins required for 
replication have now been overexpressed to high levels in 
both insect and mammalian cells, such a system is now a 
realistic possibilty.
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ABSTRACT
The binding of a herpes simplex virus type 1 (HSV-1) 
encoded polypeptide to a viral origin of DNA replication has 
been studied by using a gel retardation assay. Incubation of 
nuclear extract from HSV-1 infected cells with a labelled 
origin-containing fragment resulted in the formation of a 
specific retarded complex, the migration of which was further 
reduced in the presence of an antibody reactive with the (JL9 
gene product. Introduction of an additional copy of the UL9 
gene, under the control of an immediate early (IE) promoter, 
conferred the ability to express origin binding activity at the 
non-permissive temperature upon an HSV-1 ts mutant blocked at 
the IE stage of infection. Endogenous or exogenous proteolytic 
activity revealed the presence of a relatively
protease-resistant domain which retained sequence-specific DNA 
binding activity. The C-terminal 317 amino acids of the (JL9 
gene expressed as a fusion protein in Escherichia coli also 
bound to the origin. Our results demonstrate that the (JL9 gene 
product binds to a viral origin and that sequence specific 
recognition and binding are specified by the C-terminal 37% of 
the polypeptide.
INTRODUCTION
The herpes simplex virus type 1 (HSV-1) genome is a linear 
double-stranded DNA of approximately 152 kb. Replication of 
this genome requires the presence of cis-acting elements which 
function as origins of DNA replication and of virus-encoded 
trans-acting proteins which perform essential roles in DNA 
synthesis.
The complete sequence of the HSV-1 genome has been 
determined and open reading frames capable of encoding 70 
distinct polypeptides identified (1). Two approaches have 
indicated that the products of seven of these genes (UL5, UL8, 
UL9 , UL29 , UL30, UL.42 and UL52 ) are involved in viral DNA
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replication. Firstly, genetic analyses of HSV-1 mutants have 
shown that seven complementation groups containing mutants which 
exhibit defects in DNA synthesis map to these genes (2-10). 
Secondly, Challberg and his colleagues have demonstrated, using 
a plasmid amplification assay for HSV-1 origin-dependent DNA 
replication, that the products of these seven genes are both 
necessary and sufficient for DNA synthesis (11-13). Three of 
these seven DNA replication genes encode previously well- 
characterized proteins; the major single-strand-specific DNA 
binding protein is encoded by UL29 (3,14), the viral DNA 
polymerase by UL30 (14,15), and a 65,000 molecular weight 
protein which binds sequence-independently to double stranded 
DNA by (JL42 (16,17). The products of the other four genes (UL5, 
UL8, UL9 and (JL52) have not been so well characterized and are 
presumed to be present in much lower abundance in infected 
cells.
The viral origins of DNA replication are specified by two 
distinct but related sequences. One (ori ) lies close to theJ_l
centre of the long unique (UL ) region whilst the other (orig) is
present within the inverted repeats, TRg and IRg (18-21 and
Figure la). DNA fragments of 100 bp or less which specify a
functional orig have been identified (22-24) and include a 45 bp
near perfect palindrome with a central A+T-rich region.
Although the sequence specifying ori contains a much longerJLj
(144 bp) palindrome there is high sequence similarity between 
the two origins covering the region of the o r i g  palindrome and 
approximately 40 bp to one side of it.
Using a DNase I footprinting assay Elias and his 
colleagues (25,26) have demonstrated the presence of two 
specific binding sites for a virus-induced polypeptide within 
orig. site I consists of an 18 bp region which overlaps the 
left end of the orig palindrome (Figure lb). Lower affinity 
binding occurs to site II which is present in the opposite 
orientation to site I and is identical in 15 of the 
corresponding 18 positions. Two copies of a sequence which 
differs in only one position from that of site I are similarly 
located within ori and are also assumed to act as binding 
sites. Elias and Lehman (26) showed that the origin-binding
1410
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protein (OBP) had a molecular weight of 83,000, but the viral 
gene encoding it was not identified. It seemed very likely 
however that OBP would be the product of one of the four genes 
essential for HSV-1 DNA synthesis to which a function had not 
yet been ascribed. We therefore developed a gel retardation 
assay to facilitate the testing of the U L5, U L 8 , UL9 and UL52 
gene products for origin-binding activity. Our results confirm 
and extend the very recent report by Olivo et a l . (27) that the 
UL9 gene specifies OBP.
MATERIALS AND METHODS
Cells and viruses: Baby hamster kidney 21 clone 13 (BHK) cells
(28) were grown in Eagle's medium supplemented with 10% tryptose 
phosphate broth and 10% foetal calf serum. Extracts were
7
prepared from cell monolayers (10 cells/9 0 mm plastic Petri 
dish) infected with 5-10 p.f.u./cell and incubated for 8 h at 
37°C or 38.5°C. The viruses used were wild type (wt) HSV-1 
(Glasgow strain 17, syn+ ), the HSV-1 temperature-sensitive 
mutant tsK (29) and recombinant viruses tsK/UL5, tsK/UL8, 
tsK/UL9 and tsK/UL52. The recombinant viruses contain 
additional copies of the early genes UL5, UL8, UL9 and UL52 
inserted under the control of the immediate early (IE) gene 3 
promoter within the thymidine kinase gene of ;tsK. They were 
constructed essentially as described by Hummel et a l . (30). 
Preparation of nuclear extracts: In initial experiments nuclear
extracts were prepared by the method of Piette et a l . (31) from
3 infected cell monolayers. Proteins eluted from nuclei with 
buffer B containing 600 mM NaCl were precipitated with (N H ^ ^ S O ^ 
and resuspended in 100 pi buffer B containing 100 mM NaCl. 
Subsequently it was noted that a procedure essentially as 
described by Dignam et a l . (32) and modified by Preston et a l .
(33) gave greater reproducibility in terms of yield and 
activity. The nuclear pellet from 3 cell monolayers was eluted 
with 100 pi buffer C (20 mM Hepes pH 7.9, 25% glycerol, 1.5 mM 
M g C ^ ,  0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM D T T ) containing 600 
mM NaCl and after centrifugation the supernatant extract was 
flash frozen and stored at -70°C. Protein concentrations were 
determined by using a Bio-Rad Protein Assay kit.
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Expression in Escherichia coli: Fusion proteins containing
parts of the UL9 polypeptide were synthesised using the plasmid 
vector system pRIT2T (supplied by Pharmacia; ref. 34). Two 
additional plasmids were constructed such that the Smal, BamHI, 
Sail and PstI cloning sites (Figure 6a) were positioned in the 2 
other reading frames. EcoRI cleaved pRIT2T DNA was treated with 
mung bean nuclease to remove precisely the single-stranded 
overhangs and the plasmid recircularised either in the absence 
or presence of an 8 bp EcoRI linker (G G A A T T C C ). Resulting 
plasmids pRIT2T-4 and pRIT2T+4 respectively contain deletions 
and insertions of 4 bp and their identities were confirmed by 
DNA sequencing. DNA fragments were inserted into the 
appropriate plasmid as described in Figure 6 and the constructs 
used to transform E. coli strain K12 AHlAtrp (35) to ampicillin 
resistance. Bacteria containing the desired plasmids were 
isolated and propagated at 28°C. To induce synthesis of the 
fusion protein bacteria were grown to an A630 value of 0.4 in 50 
ml L broth and rapidly shifted to 42°C for 75 min. The cells 
were harvested by centrifugation, washed twice with lOmM 
Tris-HCl pH 7.5, ImM EDTA and resuspended in 0.5 ml buffer C 
containing 600 mM K C 1 . The suspension was extensively sonicated 
and centrifuged at 11,600 g for 10 min. The resulting 
supernatant was used as extract in the binding assays.
DNA fragments and oligonucleotides: The 100 bp BamHl/Sall
orig-containing fragment from plasmid pS19 (22) was recloned 
between the corresponding sites of pTZl9U (36) and used as a 
source of the HSV-1 orig sequence (pS19 fragment). Plasmid pBY3 
contains an unrelated but similarly sized Haelll fragment of 
HSV-1 DNA originating from within BamHI y  (37) and cloned into 
the Smal site of pTZ19(J. Oligonucleotides were synthesised 
using a model 8600 Biosearch DNA synthesiser and purified on a 
15% acrylamide DNA sequencing gel. Duplex oligonucleotides were 
formed by mixing equivalent masses of the two complementary 
strands, heating to 95°C and allowing to cool slowly to room 
temperature. The duplex oligonucleotides were end-labelled and 
blunt-ended using the filling-in reactions of the Klenow 
fragment of DNA polymerase I (38). The following duplex 
oligonucleotides were used:
1 41 2
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oligonucleotide I 5 1 GATCCGCGAAGCGTTCGCACTTCGTCCCA
GCGCTTCGCAAGCGTGAAGCAGGGTCTAG 5 1
oligonucleotide II 5' GATCTGGGGCGAAGTGCGAGCACTTCGCG
ACCCCGCTTCACGCTCGTGAAGCGCCTAG 5'
oligonucleotide X 5' GATCGGATATGCTAATTAAATACAT
GCCTATACGATTAATTTATGTG 5'
Oligonucleotides I and II respectively contain the sequences of
binding sites I and II within HSV-1 orig (see Figure 1 and ref.
26). Oligonucleotide X, containing an unrelated DNA sequence, 
was kindly provided by Dr A. Bailey.
Gel retardation analysis (39): Probe fragments, 3' end-labelled
32with [ P ]deoxyribonucleoside triphosphates, were eluted from 8% 
non-denaturing acrylamide gels, extracted sequentially with 
phenol and chloroform and precipitated with ethanol. Either 1 
ng labelled oligonucleotide or 5 ng of labelled 100 bp orig 
fragment were incubated at 25°C with 2 pg sonicated calf thymus 
DNA and 5 pg extract in a 20 pi reaction mix containing 1 x 
buffer C plus 100 mM NaCl. After 20 min 5 pi loading buffer 
(25% glycerol, 0.05% bromophenol blue in 1 x TBE [90 mM 
Tris-borate, 2.5 mM E D T A ] ) were added and the samples loaded 
onto 5% polyacrylamide gels (55:1, acrylamide:N , N '-methylene 
bisacrylamide) containing 1 x TBE. Gels were run in 1 x TBE at 
25 mA for 1.5-2 h, fixed in 10% acetic acid, dried and exposed 
for autoradiography.
A ntisera: Rabbit antisera raised against decapeptides from the
C-termini of the UL5 , UL8, UL9 and UL52 gene products and 
reactive with the corresponding polypeptides (27) were kindly 
provided by Dr M.D. Challberg. 1 pi of antiserum was added to 
binding reactions.
RESULTS
Detection of orig binding activity in nuclear extracts of cells 
infected with wt H S V - 1 . The sequence of part of the 100 bp 
HSV-1 DNA insert of plasmid p S 1 9 , which specifies functional 
orig activity (22), is shown in Figure lb together with the two 
binding sites for a viral polypeptide mapped by Elias and Lehman 
(26). Double-stranded oligonucleotides containing the sequences 
of binding sites I and II (oligonucleotide I and oligonucleotide
1 41 3
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Figure 1. (a) Structure of the HSV-1 genome showing the 
locations of the origins of DNA replication. (b) DNA sequence 
from the ori region (22). The 45 bp palindrome is indicated by 
arrows and tne two binding sites identified by Elias & Lehman 
(26) are boxed.
II respectively) were synthesised and used with the 100 bp pS19 
fragment in a gel retardation assay for the presence of proteins 
binding to these sites.
In initial experiments proteins eluted with 600 mM NaCl 
from nuclei of mock-infected and HSV-1 infected cells were 
precipitated with ( N H ^ ^ S O ^  and redissolved in buffer B plus 
100 mM NaCl (31). These extracts were incubated with 
end-labelled pS19 fragments in the presence of sonicated calf 
thymus DNA and sequence specific competitor D N A s . The reaction 
products were analysed by electrophoresis through 5% 
non-denaturing polyacrylamide gels.
Figure 2 shows the results of a typical experiment. In 
the absence of added competitor DNA two retarded bands (A and B) 
representing protein-DNA complexes were detected (track 1). To 
verify the specificity of binding, 100-fold molar excesses of 
unlabelled orig fragment (track 2), oligonucleotides I and II 
(tracks 3 and 4) and the 100 bp insert of plasmid pBY3 
(containing unrelated HSV-1 DNA sequences [track 5]) were added 
to the assay. The or ig fragment and oligonucleotides I and II 
competed efficiently for binding resulting in a great decrease 
in the signal intensity of bands A and B. In contrast the pBY3 
fragment did not compete. Complexes A and B therefore result 
from site specific binding to DNA sequences present within 
oligonucleotides I and II, and probably represent the same 
activity as previously detected by DNase footprinting (26). No
1 4 1 4
N u cle ic  A cids  Research
1 2 3 4 5
Figure 2. Gel retardation analysis of extracts of HSV-1 
infected cells. Nuclear extract was incubated with 32P end- 
labelled pS19 fragment either in the absence of competitor DNA 
(track 1) or in the presence of 100-fold molar excesses of 
unlabelled pS19 fragment (track 2), oligonucleotide I (track 3), 
oligonucleotide II (track 4) or pBY3 fragment (track 5). The 
products were separated by electrophoresis in a 5% non­
denaturing polyacrylamide gel. A and B indicate specific 
retarded complexes and P the free probe.
similar activity was detected in extracts from mock-infected 
cells (e.g. Figure 3a, track 1).
The product of the UL9 gene interacts with binding site I . The
recombinant viruses tsK/UL5, tsK/UL8, tsK/UL9 and tsK/UL52 
contain additional copies of the early genes U L 5 , U L 8 , UL9 and 
UL52 inserted into the genome of the HSV-1 temperature-sensitive 
mutant tsK under the control of the immediate early (IE) gene 3 
promoter. At the non-permissive temperature (38.5°C) tsK 
accumulates IE polypeptides but fails to induce the expression
of early and late genes (29,40). The 4 recombinant viruses
exhibit polypeptide profiles at 38.5°C indistinguishable from 
tsK with the exception that each induces a single additional 
polypeptide corresponding to the product of the inserted gene 
(J.M. Calder and N.D. Stow, manuscript in preparation).
Proteins were eluted with 600 mM NaCl from the nuclei of 
mock-infected cells and from cells infected at the 
non-permissive temperature with wt HSV-1, _tsK or the four 
recombinant viruses. The extracts were tested in a gel
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Figure 3. Gel retardation analysis of extracts from cells 
infected with recombinant viruses. Nuclear extract was prepared 
from cells incubated at 38.5°C and reacted with P-labelled 
oligonucleotide I. (a) track 1, mock-infected cells; tracks 
2-7, cells infected with wt HSV-1, tjiK, _tsK/UL5, tsK/UL8, 
tsK/UL9 or tsK/UL52 respectively. "A" indicates the major 
complex detected with wt HSV-1 extract. (b) Nuclear extract 
from cells infected with tsK/UL9 was incubated in the absence of 
competitor DNA (track 1) or in the presence of 100-fold molar 
excesses of oligonucleotide I (track 2) or oligonucleotide X 
(track 3).
3 2retardation assay using P-labelled oligonucleotide I as probe 
(Figure 3a). As expected, extract from cells infected with wt 
HSV-1 generated a major complex (A) and some minor bands (track 
2). The only other extract which caused significant retardation 
of the probe fragment was from cells infected with recombinant 
virus tsK/UL9 (track 6). Although the pattern of retardation 
observed with extracts from cells infected with this virus 
varied from assay to assay the presence of material which failed 
to enter the gel and of a smear extending down most of the track 
were consistently observed. In addition, whereas somewhat 
diffuse bands migrating more slowly than complex A were usually 
seen, bands co-migrating with complex A were absent.
Figure 3b demonstrates that the pattern of retarded DNA 
probe represents sequence specific binding. Addition of a 
100-fold excess of unlabelled oligonucleotide 1 but not
1416
N u cle ic  A cids Research
1 2 3 4 5
U
iwl V i
Figure 4. Effect of antisera on the wt HSV-1 complex. Nuclear 
extract from cells infected with wt HSV-1 was incubated with 
P-labelled oligonucleotide 1 either in the absence of added 
antiserum (track 1) or in the presence of antisera reactive with 
the U L 5 , U L 8 , UL9 or UL52 gene products (tracks 2, 3, 4 and 5 
respectively). The products were analysed as described in 
Figure 2. A and A' indicate the major complexes formed in the 
absence of antiserum or in the presence of antiserum against the 
UL9 gene product respectively.
oligonucleotide X (which is a similar size but of unrelated DNA 
sequence) efficiently competed for binding.
Because the tsK/UL9 recombinant differs from _tsK only in 
its ability to express the UL9 gene product at the 
non-permissive temperature the data indicate that this 
polypeptide participates in the formation of a complex with 
binding site I.
The UL9 gene product is present in complex A formed with 
extracts from cells infected with wt H S V-1. Nuclear extract 
from cells infected with wt HSV-1 was incubated with P- 
labelled oligonucleotide I either in the absence of added 
antibody or in the presence of antibodies reactive with the U L 5 , 
UL8, UL9 or UL52 polypeptides and the products analysed on a 
non-denaturing polyacrylamide gel. Figure 4 shows that the 
antibodies which react with U L 5 , UL8 or UL52 had little effect
1 41 7
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Figure 5. Effect of proteinase K on the tsK/LJL9 complex.
Nuclear extract from cells infected with recombinant tsK/UL9 was 
incubated with P-labelled oligonucleotide I either in the 
absence of proteinase K (track 1) or in the presence of 1, 10, 
100, 1000 or 2000 ng proteinase K (tracks 1-6 respectively). Wt 
HSV-1 extract was assayed in parallel in the absence of 
proteinase (track 7). The products were analysed as described 
in Figure 2. "A" indicates the major complex formed with wt
extract.
on the pattern of retarded fragments. In contrast addition of 
antibody to the UL9 polypeptide resulted in the loss of the 
major retarded complex, A, and its replacement by a more slowly 
migrating form, A 1, indicative of the additional presence of 
antibody molecules in the complexes. Therefore at least a part 
of the UL9 polypeptide is contained within complex A, and since 
the antibody was raised against a C-terminal oligopeptide (27) 
this region of the protein must be present.
Effect of protease digestion on the binding activity from cells 
infected with the tsK/UL9 recombinant. Given that the major 
retarded complex from cells infected with wt HSV-1 reacted with 
an antibody against the UL9 polypeptide it was rather surprising 
that the pattern of retarded fragments observed using extract
141 8
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Figure 6. Expression of UL9 gene fragments in E. coli. (a) 
Structure of plasmid pRIT2T. pRIT2T-4 and pRIT2T+4 are 
essentially similar except that in pRIT2T-4 the EcoRI site is 
replaced by an Apal site. The positions of the phage lambda 
promoter, P and coding sequences for the N-terminal region of 
the Staphylococcus aureus A protein are indicated. (b)
Fragments inserted into vectors. The upper line shows the SstI 
fragment containing the UL9 gene which was initially cloned into 
the EcoRI site of p U C 8 . The N- and C-terminal regions of the 
coding sequences (black bar) are indicated. Plasmids pX8, pBl 
and pP31 contain the indicated fragments inserted in frame and 
in the appropriate orientation into pRIT2T-4, pRIT2T-4 and 
pRIT2T respectively. The C-terminal ends of the pBl and pP31 
inserts lie within the pUC8 polylinker. The nucleotide 
numbering is from McGeoch et a l . (1).
from cells infected with the _t£K/UL9 recombinant was very 
different. One possible explanation is that complex A contains 
only a fragment of the UL9 polypeptide.
Our attempts to size complex A using pore-gradient 
polyacrylamide gels (41) had suggested a molecular weight of 
approximately 45,000, clearly inconsistent with the binding of 
an intact UL9 polypeptide (molecular weight 9 4,000) to the 
labelled oligonucleotide (data not shown). We therefore 
examined the effect of proteinase K addition to binding 
reactions containing tsK/UL9 nuclear extract and labelled 
oligonucleotide I. The results (Figure 5) show that with 
increasing amount of added proteinase K there is a reduction in 
the amount of slowly migrating complexes and a concomitant 
appearance of a faster migrating species which exhibits a 
mobility very similar to that of complex A. No band of this 
mobility was detected when extracts from mock-infected cells or
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Figure 7. Gel retardation analysis of the pBl encoded fusion 
protein. Binding reactions were performed without extract 
(track 1) or with extracts from untransfomed bacteria (track 2), 
bacteria transformed with pRIT2T (track 4) or pBl (tracks 3,
5-8, 10-13), or from w_t HSV-1 infected BHK cells (track 9). The 
probe fragments were 32P-labelled oligonucleotide I (tracks 1-4, 
9-13) and pS19 fragment (tracks 5-8). Unlabelled 
oligonucleotide I (track 6), oligonucleotide II (track 7) and 
oligonucleotide X (track 8) were added as competitors. Antisera 
reactive with UL9 and UL52 respectively were added to the 
reactions shown in tracks 12 and 13. C and A indicate the major 
complexes from bacteria containing pBl and from wt HSV-1 
infected cells.
cells infected with tsK were similarly treated with proteinase K 
(data not shown).
The data thus suggest that the addition of proteinase K to 
extracts containing the UL9 polypeptide results in the cleavage 
of the polypeptide and the generation of a relatively 
protease-resistant domain which retains DNA binding activity. 
Expression of the DNA binding domain of UL9 in Escherichia coli. 
Three DNA fragments representing approximately the N-terminal 
2/3 and C-terminal 2/3 and 1/3 of the UL9 coding sequences were 
cloned in the correct reading frame into the vector pRIT2T or an 
appropriate frameshift derivative (see Figure 6 and Materials 
and Methods). The constructs were introduced into E. coli 
strain K12AHlAtrp, extracts prepared from heat induced bacteria, 
and tested for binding activity using ^ P - l a b e l l e d
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oligonucleotide I. No binding activity was detected in extracts 
from the host bacteria alone or following the introduction of 
the vector pRIT2T (Figure 7, tracks 2 and 4). Of the three 
hybrid plasmids pBl (track 3) and pP31 but not pX8 encoded 
binding activity. The activity encoded by pBl also binds to the 
100 bp orig-containing fragment and is efficiently competed by 
the addition of unlabelled oligonucleotides I and II but not 
oligonucleotide X (tracks 5-8). The C- terminal 317 amino acids 
of the U9 polypeptide therefore contain all the amino acid 
sequences required for sequence-specific binding to sites I and 
II within orig.
Figure 7 also shows that the fusion protein encoded by pBl 
(predicted molecular weight 63,000) forms a complex which 
exhibits a considerably lower mobility than complex A formed 
using extract from cells infected with wt HSV-1 (tracks 9 and 
10), in agreement with complex A containing only a proteolytic 
fragment of the UL9 polypeptide. The mobility of the pBl 
complex was further reduced by the addition of antibodies 
reactive with the UL9 or UL52 polypeptides to the binding 
reaction (tracks 11-13). The ability of both these antibodies 
to bind to the DNA protein complex results from the presence of 
the protein A moiety in the pBl fusion protein, and verifies 
that the hybrid protein is responsible for the observed binding.
DISCUSSION
The initial objective of the experiments presented in this 
paper was to identify the HSV-1 gene product which recognises 
the two specific binding sites within HSV-1 or ig characterised 
by Elias and Lehman (26). The expression of binding activity in 
E. coli indicates that the only viral polypeptide essential for 
this activity is encoded by the UL9 gene and very strongly 
suggests that this gene product is directly responsible for 
sequence specific binding. Our identification of the UL9 
polypeptide as an origin-binding protein is in complete 
agreement with the recent results of Olivo et a l . (27) who 
expressed this viral protein in a baculovirus expression system 
and assayed for binding by an immunoprecipitation assay and 
DNase footprinting.
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In addition to expressing binding activity in E. coli we 
also detected binding using nuclear extracts from cells infected 
with wt HSV-1 or the recombinant virus tsK/UL9. Competition 
experiments with synthetic oligonucleotides demonstrated that in 
each instance the binding target contained sequences homologous 
to binding sites I and II initially characterised by Elias and 
Lehman (26). The baculovirus-expressed UL9 polypeptide 
protected similar DNA sequences in DNase footprinting 
experiments (27).
By employing a gel retardation assay we were able to 
distinguish different sizes of complex formed by the addition of 
extracts from various sources. These results are interesting to 
compare with other recent reports which examined origin-binding 
activity by the same technique. The rapidly migrating complex A 
detected with extracts from cells infected with wt HSV-1 clearly 
contains only a portion of the UL9 gene product. This complex 
appears to be similar to the major complex described recently by 
Koff and Tegtmeyer (42). In contrast Elias and Lehman (26) 
purified origin binding activity from virus infected cells and 
observed a major (presumably intact) polypeptide of molecular 
weight 83,000 and two smaller components. This preparation gave 
a very different pattern, more closely resembling that obtained 
with tsk/UL9 extracts, in a gel retardation assay. This 
suggests that in extracts of cells infected with wt HSV-1 the 
UL9 polypeptide may be subjected to varying extents of 
proteolytic cleavage. We do not know whether the small forms 
observed by ourselves and by Koff and Tegtmeyer (42) are of any 
physiological significance or whether they merely reflect 
proteolytic activity occurring during the isolation procedure. 
The observation that extracts made ih parallel from cells 
infected with the tsk/(JL9 recombinant do not contain the cleaved 
form of the polypeptide responsible for the formation of complex 
A suggests that the proteolytic activity occurs as a consequence 
of infection proceeding from the IE to early and late stages, 
and could thus possibly be virus encoded.
Although interaction of intact (JL9 polypeptide with 
labelled probe fragments produces a smeared pattern in a gel 
retardation assay this nevertheless represents sequence-specific
1 4 2 2
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binding (Figure 3 and ref. 26). The smearing may occur because 
of aggregation and/or dissociation of complexes during 
incubation of the binding reactions and gel electrophoresis.
This behaviour is not so noticeable in complexes containg only 
proteolytic fragments of (JL9 or fragments synthesized in E. coli 
where much "tighter" bands are observed. The smearing may 
therefore be a consequence of interactions involving the 
N-terminal region of the (JL9 polypeptide.
By expressing a fragment of the UL9 polypeptide in E. coli 
we have demonstrated that the C-terminal 317 amino acids specify 
all the structural information required for sequence-specific 
recognition and binding. A similar situation has previously 
been noted for another herpesvirus sequence-specific DNA binding 
protein, EBNA-1 of Epstein-Barr virus, the C-terminal domain of 
which is able to bind to its target recognition sequence (43).
In addition, discrete domains of several other proteins are 
known to be responsible for sequence-specific binding to DNA and 
these are often relatively resistant to the action of added 
protease (41, 44-48).
It is likely that sequence-specific recognition of the 
HSV-1 origins of DNA replication is a very early event in 
initiation of HSV-1 DNA synthesis. Following binding of the UL9 
polypeptide to the origins, regions of the protein not involved 
in direct interaction with DNA probably participate in other 
functions which may include interacting with other replication 
proteins, or unwinding or nicking DNA to facilitate the 
initiation of DNA synthesis. Expression systems for the UL9 
polypeptide such as those described in this paper should prove 
useful in the study of these functions.
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